NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Collaborating Centre for Women’s and Children’s Health (UK). Fertility: Assessment and Treatment for People with Fertility Problems. London: Royal College of Obstetricians & Gynaecologists; 2013 Feb. (NICE Clinical Guidelines, No. 156.)

  • Update information September 2017: Recommendations on the medical and surgical management of endometriosis (chapter 10) have been stood down, as these have been superseded by the publication of the NICE guideline on endometriosis.

Update information September 2017: Recommendations on the medical and surgical management of endometriosis (chapter 10) have been stood down, as these have been superseded by the publication of the NICE guideline on endometriosis.

Cover of Fertility

Fertility: Assessment and Treatment for People with Fertility Problems.

Show details

21References

References from 2004 guideline

1.
Hull MG, Glazener CM, Kelly NJ, Conway DI, Foster PA, Hinton RA, et al. Population study of causes, treatment, and outcome of infertility. BMJ. 1985;291:1693–7. [PMC free article: PMC1418755] [PubMed: 3935248]
2.
School of Public Health; University of Leeds; Centre for Health Economics; University of York, Research Unit; Royal College of Physicians. The management of subfertility. Effective Health Care. 1992;1(3):1–240.
3.
Thonneau P, Marchand S, Tallec A, Ferial ML, Ducot B, Lansac J, et al. Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988–1989). Hum Reprod. 1991;6:811–6. [PubMed: 1757519]
4.
Brinsden P, Hartshorne G, Hirsh A, Owen E. Reproductive Medicine: From A to Z. Oxford; Oxford University Press; 1998.
5.
Oxman AD, Sackett DL, Guyatt GH. Users’ guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. JAMA. 1993;270:2093–5. [PubMed: 8411577]
6.
Guyatt GH, Sackett DL, Cook DJ. Users’ guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA. 1993;270:2598–601. [PubMed: 8230645]
7.
Guyatt GH, Sackett DL, Cook DJ. Users’ guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA. 1994;271:59–63. [PubMed: 8258890]
8.
Jaeschke R, Guyatt G, Sackett DL. Users’ guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA. 1994;271:389–91. [PubMed: 8283589]
9.
Jaeschke R, Guyatt GH, Sackett DL. Users’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994;271:703–7. [PubMed: 8309035]
10.
Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based Medicine. How to Practice and Teach EBM. Edinburgh: Churchill Livingstone; 2000.
11.
Scottish Intercollegiate Guidelines Network. SIGN 50:A Guideline Developers’ Handbook. Edinburgh: Scottish Intercollegiate Guidelines Network; 2001.
12.
Garceau L, Henderson J, Davis LJ, Petrou S, Henderson LR, McVeigh E, et al. Economic implications of assisted reproduction techniques: a systematic review. Hum Reprod. 2002;17:3090–109. [PubMed: 12456608]
13.
Philips Z, Barraza-Llorens M, Posnett J. Evaluation of the relative cost-effectiveness of treatments for infertility in the UK. Hum Reprod. 2000;15:95–106. [PubMed: 10611196]
14.
Devlin N, Parkin D. Funding fertility: issues in the allocation and distribution of resources to assisted reproductive technologies. Hum Fertil (Camb). 2003;6(2 Suppl):S2–6. [PubMed: 12869768]
15.
Collins J. An international survey of the health economics of IVF and ICSI. Hum Reprod Update. 2002;8:265–77. [PubMed: 12078837]
16.
Eccles M, Mason J. How to develop cost-conscious guidelines. Health Technol Assess. 2001;5:1–69. [PubMed: 11427188]
17.
Ferreira-Poblete A. The probability of conception on different days of the cycle with respect to ovulation: an overview. Adv Contracept. 1997;13:83–95. [PubMed: 9288325]
18.
te Velde ER, Eijkemans R, Habbema HDF. Variation in couple fecundity and time to pregnancy, an essential concept in human reproduction. Lancet. 2000;355:1928–9. [PubMed: 10859034]
19.
Bongaarts J. A method for the estimation of fecundability. Demography. 1975;12:645–60. [PubMed: 1213216]
20.
Wood JW. Fecundity and natural fertility in humans. Oxf Rev Reprod Biol. 1989;11:61–109. [PubMed: 2697833]
21.
Schwartz D, Mayaux MJ. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with 173 azoospermic husbands. Federation CECOS. N Engl J Med. 1982;306:404–6. [PubMed: 7057832]
22.
Noord-Zaadstra BM, Looman CWN, Alsbach H, Habbema JDF, te Velde ER, Karbaat J. Delaying childbearing: effect of age on fecundity and outcome of pregnancy. BMJ. 1991;302:1361–5. [PMC free article: PMC1670055] [PubMed: 2059713]
23.
Vessey MP, Wright NH, McPherson K, Wiggins P. Fertility after stopping different methods of contraception. BMJ. 1978;1:265–7. [PMC free article: PMC1602681] [PubMed: 620301]
24.
Singh NP, Muller CH, Berger RE. Effects of age on DNA double-strand breaks and apoptosis in human sperm. Fertil Steril. 2003;80:1420–30. [PubMed: 14667878]
25.
te Velde E. Are subfertility and infertility on the increase? Tijdschrift voor Fertiliteitsonderzoek. 1992;6:5–8.
26.
Schwartz D, Macdonald PDM, Heuchel V. Fecundability, coital frequency and the viability of ova. Popul Stud. 1980;34:397–400. [PubMed: 22077133]
27.
MacLeod J, Gold RZ. The male factor in fertility and infertility. V. Effect of continence on semen quality. Fertil Steril. 1952;3:297–315. [PubMed: 12980152]
28.
Freund M. Interrelationships among the characteristics of human semen and factors affecting semen-specimen quality. Reprod Fertil. 1962;4:143–59. [PubMed: 13959612]
29.
Poland ML, Moghissi KS, Giblin PT, Ager JW, Olson JM. Variation of semen measures within normal men. Fertil Steril. 1985;44:396–400. [PubMed: 4029428]
30.
Perloff WH, Steinberger E. In vivo survival of spermatozoa in cervical mucus. Am J Obstet Gynecol. 1964;88:439–42. [PubMed: 14123421]
31.
Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N Engl J Med. 1995;333:1517–21. [PubMed: 7477165]
32.
Wilcox AJ, Dunson D, Baird DD. The timing of the “fertile window” in the menstrual cycle: day specific estimates from a prospective study. BMJ. 2000;321:1259–62. [PMC free article: PMC27529] [PubMed: 11082086]
33.
Dunson DB, Baird DD, Wilcox AJ, Weinberg CR. Day-specific probabilities of clinical pregnancy based on two studies with imperfect measures of ovulation. Hum Reprod. 1999;14:1835–9. [PubMed: 10402400]
34.
Bauman JE. Basal body temperature: unreliable method of ovulation detection. Fertil Steril. 1981;36:729–33. [PubMed: 7308516]
35.
Martinez AR, van Hooff MH, Schoute E, van der Meer M, Broekmans FJ, Hompes PG. The reliability, acceptability and applications of basal body temperature (BBT) records in the diagnosis and treatment of infertility. Eur J Obstet Gynecol Reprod Biol. 1992;47:121–7. [PubMed: 1459325]
36.
Corson SL. Self-prediction of ovulation using a urinary luteinizing hormone test. J Reprod Med. 1986;31:760–3. [PubMed: 3761282]
37.
Templeton AA, Penney GC, Lees MM. Relation between the luteinizing hormone peak, the nadir of the basal body temperature and the cervical mucus score. Br J Obstet Gynaecol. 1982;89:985–8. [PubMed: 7171522]
38.
Guida M, Tommaselli GA, Palomba S, Pellicano M, Moccia G, Di Carlo C, et al. Efficacy of methods for determining ovulation in a natural family planning program. Fertil Steril. 1999;72:900–4. [PubMed: 10560997]
39.
Guermandi E, Vegetti W, Bianchi MM, Uglietti A, Ragni G, Crosignani P. Reliability of ovulation tests in infertile women. Obstet Gynecol. 2001;97:92–6. [PubMed: 11152915]
40.
Kopitzke EJ, Berg BJ, Wilson JF, Owens D. Physical and emotional stress associated with components of the infertility investigation: perspectives of professionals and patients. Fertil Steril. 1991;55:1137–43. [PubMed: 2037107]
41.
Zaadstra BM, Looman CW, te Velde ER, Habbema JD, Karbaat J. Moderate drinking: no impact on female fecundity. Fertil Steril. 1994;62:948–54. [PubMed: 7926140]
42.
Jensen TK, Hjollund NH, Henriksen TB, Scheike T, Kolstad H, Giwercman A, et al. Does moderate alcohol consumption affect fertility? Follow up study among couples planning first pregnancy. BMJ. 1998;317:505–10. [PMC free article: PMC28642] [PubMed: 9712595]
43.
Olsen J, Bolumar F, Boldsen J, Bisanti L. Does moderate alcohol intake reduce fecundability? A European multicenter study on infertility and subfecundity. European Study Group on Infertility and Subfecundity. Alcohol Clin Exp Res. 1997;21:206–12. [PubMed: 9113254]
44.
Juhl M, Nyboe Andersen AM, Gronbaek M, Olsen J. Moderate alcohol consumption and waiting time to pregnancy. Hum Reprod. 2001;16:2705–9. [PubMed: 11726599]
45.
Hakim RB, Gray RH, Zacur H. Alcohol and caffeine consumption and decreased fertility. Fertil Steril. 1998;70:632–7. [PubMed: 9797089]
46.
Joesoef MR, Beral V, Aral SO, Rolfs RT, Cramer DW. Fertility and use of cigarettes, alcohol, marijuana, and cocaine. Ann Epidemiol. 1993;3:592–4. [PubMed: 7921305]
47.
Royal College of Obstetricians and Gynaecologists. Alcohol Consumption in Pregnancy Guideline No 9. London: RCOG Press; 1999.
48.
Department of Health. Sensible Drinking. The Report of an Inter-Departmental Working Group. 1995. [Accessed 7 January 2004]. [www​.doh.gov.uk/alcohol​/pdf/sensibledrinking.pdf]
49.
Juhl M, Olsen J, Andersen AM, Gronbaek M. Intake of wine, beer and spirits and waiting time to pregnancy. Hum Reprod. 2003;18:1967–71. [PubMed: 12923158]
50.
Brzek A. Alcohol and male fertility (preliminary report). Andrologia. 1987;19:32–6. [PubMed: 3688475]
51.
Marshburn PB, Sloan CS, Hammond MG. Semen quality and association with coffee drinking, cigarette smoking, and ethanol consumption. Fertil Steril. 1989;52:162–5. [PubMed: 2744185]
52.
Dunphy BC, Barratt CL, Cooke ID. Male alcohol consumption and fecundity in couples attending an infertility clinic. Andrologia. 1991;23:219–21. [PubMed: 1741485]
53.
Oldereid NB, Rui H, Purvis K. Life styles of men in barren couples and their relationship to sperm quality. Int J Fertil. 1992;37:343–9. [PubMed: 1360454]
54.
Department of Health. Alcohol and Health. Drinking Sensibly. 2002. [Accessed 7 January 2004]. [www​.doh.gov.uk/alcohol/alcoholandhealth​.htm]
55.
Augood C, Duckitt K, Templeton AA. Smoking and female infertility: a systematic review and meta-analysis. Hum Reprod. 1998;13:1539. [PubMed: 9688387]
56.
Hughes EG, Brennan BG. Does cigarette smoking impair natural or assisted fecundity? Fertil Steril. 1996;66:679–89. [PubMed: 8893667]
57.
Vine MF, Margolin BH, Morrison HI, Hulka BS. Cigarette smoking and sperm density: a meta-analysis. Fertil Steril. 1994;61:35–43. [PubMed: 8293842]
58.
Merino G, Lira SC, Martinez-Chequer JC. Effects of cigarette smoking on semen characteristics of a population in Mexico. Arch Androl. 1998;41:11–5. [PubMed: 9642454]
59.
Zhang JP, Meng QY, Wang Q, Zhang LJ, Mao YL, Sun ZX. Effect of smoking on semen quality of infertile men in Shandong. China Asian J Androl. 2000;2:143–6. [PubMed: 11232793]
60.
Trummer H, Habermann H, Haas J, Pummer K. The impact of cigarette smoking on human semen parameters and hormones. Hum Reprod. 2002;17:1554–9. [PubMed: 12042277]
61.
Dunphy BC, Barratt CLR, von Tongelen BP, Cooke ID. Male cigarette smoking and fecundity in couples attending an infertility clinic. Andrologia. 1991;23:223–5. [PubMed: 1741486]
62.
Kunzle R, Mueller MD, Hanggi W, Birkhauser MH, Drescher H, Bersinger NA. Semen quality of male smokers and nonsmokers in infertile couples. Fertil Steril. 2003;79:287–91. [PubMed: 12568836]
63.
Jensen TK, Henriksen TB, Hjollund NH, Scheike T, Kolstad H, Giwercman A, et al. Adult and prenatal exposures to tobacco smoke as risk indicators of fertility among 430 Danish couples. Am J Epidemiol. 1998;148:992–7. [PubMed: 9829871]
64.
Hull MG, North K, Taylor H, Farrow A, Ford WC. Delayed conception and active and passive smoking. The Avon Longitudinal Study of Pregnancy and Childhood Study Team. Fertil Steril. 2000;74:725–33. [PubMed: 11020514]
65.
Hughes EG, Lamont DA, Beecroft ML, Wilson DMC, Brennan BG, Rice SC. Randomized trial of a ‘stage-of-change’ oriented smoking cessation intervention in infertile and pregnant women. Fertil Steril. 2000;74:498–503. [PubMed: 10973645]
66.
Clausson B, Cnattingius S, Axelsson O. Preterm and term births of small for gestational age infants: a population-based study of risk factors among nulliparous women. Br J Obstet Gynaecol. 1998;105:1011–7. [PubMed: 9763054]
67.
Raymond EG, Cnattingius S, Kiely JL. Effects of maternal age, parity, and smoking on the risk of stillbirth. Br J Obstet Gynaecol. 1994;101:301–6. [PubMed: 8199075]
68.
Kleinman JC, Pierre MB Jr, Madans JH, Land GH, Schramm WF. The effects of maternal smoking on fetal and infant mortality. Am J Epidemiol. 1988;127:274–82. [PubMed: 3337083]
69.
Wilcox A, Weinberg C, Baird D. Caffeinated beverages and decreased fertility. Lancet. 1988;2:1453–6. [PubMed: 2904572]
70.
Christianson RE, Oechsli FW, van den Berg BJ. Caffeinated beverages and decreased fertility. Lancet. 1989;1:378. [PubMed: 2563522]
71.
Joesoef MR, Beral V, Rolfs RT, Aral SO, Cramer DW. Are caffeinated beverages risk factors for delayed conception? Lancet. 1990;335:136–7. [PubMed: 1967434]
72.
Olsen J. Cigarette smoking, tea and coffee drinking, and subfecundity. Am J Epidemiol. 1991;133:734–9. [PubMed: 2018028]
73.
Hatch EE, Bracken MB. Association of delayed conception with caffeine consumption. Am J Epidemiol. 1993;138:1082–92. [PubMed: 8266910]
74.
Florack EIM, Zielhuis GA, Rolland R. Cigarette smoking, alcohol consumption, and caffeine intake and fecundability. Prev Med. 1994;23:175–80. [PubMed: 8047523]
75.
Alderete E, Eskenazi B, Sholtz R. Effect of cigarette smoking and coffee drinking on time to conception. Epidemiology. 1995;6:403–8. [PubMed: 7548349]
76.
Stanton CK, Gray RH. Effects of caffeine consumption on delayed conception. Am J Epidemiol. 1995;142:1322–9. [PubMed: 7503053]
77.
Bolumar F, Olsen J, Rebagliato M, Bisanti L. Caffeine intake and delayed conception: a European multicenter study on infertility and subfecundity. European Study Group on Infertility Subfecundity. Am J Epidemiol. 1997;145:324–34. [PubMed: 9054236]
78.
Curtis KM, Savitz DA, Arbuckle TE. Effects of cigarette smoking, caffeine consumption, and alcohol intake on fecundability. Am J Epidemiol. 1997;146:32–41. [PubMed: 9215221]
79.
Caan B, Quesenberry CP Jr, Coates AO. Differences in fertility associated with caffeinated beverage consumption. Am J Public Health. 1998;88:270–4. [PMC free article: PMC1508200] [PubMed: 9491020]
80.
Jensen TK, Henriksen TB, Hjollund NH, Scheike T, Kolstad H, Giwercman A, et al. Caffeine intake and fecundability: a follow-up study among 430 Danish couples planning their first pregnancy. Reprod Toxicol. 1998;12:289–95. [PubMed: 9628552]
81.
World Health Organization. World Health Organization Technical Report Series. Geneva: World Health Organization; 1995. Physical Status: The Use and Interpretation of Anthropometry; p. 854. [PubMed: 8594834]
82.
Jensen TK, Scheike T, Keiding N, Schaumburg I, Grandjean P. Fecundability in relation to body mass and menstrual cycle patterns. Epidemiology. 1999;10:422–8. [PubMed: 10401878]
83.
Bolumar F, Olsen J, Rebagliato M, Saez-Lloret I, Bisanti L. Body mass index and delayed conception: a European multicenter study on infertility and subfecundity. Am J Epidemiol. 2000;151:1072–9. [PubMed: 10873131]
84.
Zaadstra BM, Seidell JC, Van Noord PA, te Velde ER, Habbema JD, Vrieswijk B, et al. Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. BMJ. 1993;306:484–7. [PMC free article: PMC1676805] [PubMed: 8448457]
85.
Guzick DS, Wing R, Smith D, Berga SL, Winters SJ. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril. 1994;61:598–604. [PubMed: 8150098]
86.
Clark AM, Roberts BG. Maximizing weight loss in the overweight infertile patient: a prospective randomized controlled trial; 16th Annual Meeting of ESHRE, 2000; Hum Reprod; Bologna, Italy. 2000; 2000. pp. 65–66. Abstract No. O-162.
87.
Bellver J, Rossal LP, Bosch E, Zuniga A, Corona JT, Melendez F, et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril. 2003;79:1136–40. [PubMed: 12738508]
88.
Hamilton-Fairley D, Kiddy D, Watson H, Paterson C, Franks S. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br J Obstet Gynaecol. 1992;99:128–31. [PubMed: 1554664]
89.
Kort HI, Massey JB, Elsner CW, Toledo AA, Mitchell-Leef D, Roudebush WE. Men with high body mass index values present with lower numbers of normal-motile sperm cells. Abstract no. P-355. Fertil Steril. 2003;80(Suppl 3):S238.
90.
Kort HI, Massey JB, Witt MA, Mitchell-Leef D, Durrance MH, Roudebush WE. Sperm chromatin integrity is related to body mass index: men presenting with high BMI scores have higher incidence of sperm DNA fragmentation. Abstract no. P-333. Fertil Steril. 2003;80(Suppl 3):S232.
91.
Chung WS, Sohn JH, Park YY. Is obesity an underlying factor in erectile dysfunction? Eur Urol. 1999;36:68–70. [PubMed: 10364658]
92.
Wentz AC. Body weight and amenorrhea. Obstet Gynecol. 1980;56:482–7. [PubMed: 7422193]
93.
Knuth UA, Hull MG, Jacobs HS. Amenorrhoea and loss of weight. Br J Obstet Gynaecol. 1977;84:801–7. [PubMed: 588489]
94.
Bates GW, Bates SR, Whitworth NS. Reproductive failure in women who practice weight control. Fertil Steril. 1982;37:373–8. [PubMed: 6800847]
95.
Van der Spuy ZM, Steer PJ, McCusker M, Steele SJ, Jacobs HS. Outcome of pregnancy in underweight women after spontaneous and induced ovulation. BMJ. 1988;296:962–5. [PMC free article: PMC2545435] [PubMed: 3129109]
96.
Mieusset R, Bujan L. Testicular heating and its possible contributions to male infertility: a review. Int J Androl. 1995;18:169–84. [PubMed: 7591190]
97.
Hjollund NH, Storgaard L, Ernst E, Bonde JP, Olsen J. Impact of diurnal scrotal temperature on semen quality. Reprod Toxicol. 2002;16:215–21. [PubMed: 12128094]
98.
Hjollund NH, Bonde JP, Jensen TK, Olsen J. Diurnal scrotal skin temperature and semen quality. Int J Androl. 2000;23:309–18. [PubMed: 11012789]
99.
Thonneau P, Bujan L, Multigner L, Mieusset R. Occupational heat exposure and male fertility: a review. Hum Reprod. 1998;13:2122–5. [PubMed: 9756281]
100.
Tiemessen CH, Evers JL, Bots RS. Tight-fitting underwear and sperm quality. Lancet. 1996;347:1844–5. [PubMed: 8667967]
101.
Munkelwitz R, Gilbert BR. Are boxer shorts really better? A critical analysis of the role of underwear type in male subfertility. J Urol. 1998;160:1329–33. [PubMed: 9751347]
102.
Gold EB, Lasley BL, Schenker MB. Introduction: rationale for an update. Reproductive hazards. Occup Med. 1994;9:363–72. [PubMed: 7831586]
103.
Sharpe RM. Lifestyle and environmental contribution to male infertility. Br Med Bull. 2000;56:630–42. [PubMed: 11255550]
104.
Hruska KS, Furth PA, Seifer DB, Sharara FI, Flaws JA. Environmental factors in infertility. Clin Obstet Gynecol. 2000;43:821–9. [PubMed: 11100299]
105.
Tas S, Lauwerys R, Lison D. Occupational hazards for the male reproductive system. Crit Rev Toxicol. 1996;26:261–307. [PubMed: 8726164]
106.
Figa-Talamanca I, Traina ME, Urbani E. Occupational exposures to metals, solvents and pesticides: recent evidence on male reproductive effects and biological markers. Occup Med (Lond). 2001;51:174–88. [PubMed: 11385122]
107.
Baranski B. Effects of the workplace on fertility and related reproductive outcomes. Environ Health Perspect. 1993;101(Suppl 2):81–90. [PMC free article: PMC1519945] [PubMed: 8243410]
108.
Paul M. Occupational reproductive hazards. Lancet. 1997;349:1385–8. [PubMed: 9149713]
109.
Oliva A, Spira A, Multigner L. Contribution of environmental factors to the risk of male infertility. Hum Reprod. 2001;16:1768–76. [PubMed: 11473980]
110.
Bisanti L, Olsen J, Basso O, Thonneau P, Karmaus W. Shift work and subfecundity: a European multicenter study. J Occup Environ Med. 1996;38:352–8. [PubMed: 8925318]
111.
Tuntiseranee P, Olsen J, Geater A, Kor-anantakul O. Are long working hours and shiftwork risk factors for subfecundity? A study among couples from southern Thailand. Occup Environ Med. 1998;55:99–105. [PMC free article: PMC1757544] [PubMed: 9614393]
112.
Clifton DK, Bremner WJ. The effect of testicular X-irradiation on spermatogenesis in man. A comparison with the mouse. J Androl. 1983;4:387–92. [PubMed: 6654753]
113.
Brent R, Meistrich M, Paul M. Ionizing and nonionizing radiations. In: Paul M, editor. Occupational and Environmental Reproductive Hazards: A Guide for Clinicians. Baltimore: Williams & Wilkins; 1993. pp. 165–200.
114.
Irgens A, Kruger K, Ulstein M. The effect of male occupational exposure in infertile couples in Norway. J Occup Environ Med. 1999;41:1116–20. [PubMed: 10609232]
115.
Hjollund NH, Skotte JH, Kolstad HA, Bonde JPE. Extremely low frequency magnetic fields and fertility: a follow up study of couples planning first pregnancies. Occup Environ Med. 1999;56:253–55. [PMC free article: PMC1757722] [PubMed: 10450242]
116.
Lundsberg LS, Bracken MB, Belanger K. Occupationally related magnetic field exposure and male subfertility. Fertil Steril. 1995;63:384–91. [PubMed: 7843447]
117.
Penkov A, Tzvetkov D. Effect of vibrations on male reproductive system and function. Cent Eur J Public Health. 1999;7:149–54. [PubMed: 10499149]
118.
Egnatz DG, Ott MG, Townsend JC, Olson RD, Johns DB. DBCP and testicular effects in chemical workers: an epidemiological survey in Midland, Michigan. J Occup Med. 1980;22:727–32. [PubMed: 7441391]
119.
Slutsky M, Levin JL, Levy BS. Azoospermia and oligospermia among a large cohort of DBCP applicators in 12 countries. Int J Occup Environ Health. 1999;5:116–22. [PubMed: 10330512]
120.
Potashnik G, Ben Aderet N, Israeli R, Yanai-Inbar I, Sober I. Suppressive effect of 1,2-dibromo-3-chloropropane on human spermatogenesis. Fertil Steril. 1978;30:444–7. [PubMed: 710616]
121.
Potashnik G, Porath A. Dibromochloropropane (DBCP): a 17-year reassessment of testicular function and reproductive performance. J Occup Environ Med. 1995;37:1287–92. [PubMed: 8595498]
122.
Tielemans E, van Kooij R, te Velde ER, Burdorf A, Heederik D. Pesticide exposure and decreased fertilisation rates in vitro. Lancet. 1999;354:484–5. [PubMed: 10465178]
123.
Whorton MD, Milby TH, Stubbs HA, Avashia BH, Hull EQ. Testicular function among carbaryl-exposed exployees. J Toxicol Environ Health. 1979;5:929–41. [PubMed: 117116]
124.
Rozati R, Reddy PP, Reddanna P, Mujtaba R. Xenoesterogens and male infertility: myth or reality? Asian J Androl. 2000;2:263–9. [PubMed: 11202414]
125.
Hauser R, Altshul L, Chen Z, Ryan L, Overstreet J, Schiff I, et al. Environmental organochlorines and semen quality: results of a pilot study. Environ Health Perspect. 2002;110:229–33. [PMC free article: PMC1240761] [PubMed: 11882472]
126.
Gennart JP, Buchet JP, Roels H, Ghyselen P, Ceulemans E, Lauwerys R. Fertility of male workers exposed to cadmium, lead, or manganese. Am J Epidemiol. 1992;135:1208–19. [PubMed: 1626539]
127.
Alexander BH, Checkoway H, van Netten C, Muller CH, Ewers TG, Kaufman JD, et al. Semen quality of men employed at a lead smelter. Occup Environ Med. 1996;53:411–6. [PMC free article: PMC1128498] [PubMed: 8758037]
128.
Robins TG, Bornman MS, Ehrlich RI, Cantrell AC, Pienaar E, Vallabh J, et al. Semen quality and fertility of men employed in a South African lead acid battery plant. Am J Ind Med. 1997;32:369–76. [PubMed: 9258391]
129.
Telisman S, Cvitkovic P, Jurasovic J, Pizent A, Gavella M, Rocic B. Semen quality and reproductive endocrine function in relation to biomarkers of lead, cadmium, zinc, and copper in men. Environ Health Perspect. 2000;108:45–53. [PMC free article: PMC1637869] [PubMed: 10620523]
130.
Lancranjan I, Popescu HI, Gavanescu O, Klepsch I, Serbanescu M. Reproductive ability of workmen occupationally exposed to lead. Arch Environ Health. 1975;30:396–401. [PubMed: 1155972]
131.
Bonde JP, Joffe M, Apostoli P, Dale A, Kiss P, Spano M, et al. Sperm count and chromatin structure in men exposed to inorganic lead: lowest adverse effect levels. Occup Environ Med. 2002;59:234–42. [PMC free article: PMC1740274] [PubMed: 11934950]
132.
Coste J, Mandereau L, Pessione F, Bregu M, Faye C, Hemon D, et al. Lead-exposed workmen and fertility: a cohort study on 354 subjects. Eur J Epidemiol. 1991;7:154–8. [PubMed: 2044712]
133.
Hanf V, Forstmann A, Costea JE, Schieferstein G, Fischer I, Schweinsberg F. Mercury in urine and ejaculate in husbands of barren couples. Toxicol Lett. 1996;88:227–331. [PubMed: 8920741]
134.
Cooper TG, Neuwinger J, Bahrs S, Nieschlag E. Internal quality control of semen analysis. Fertil Steril. 1992;58:172–8. [PubMed: 1624001]
135.
Tielemans E, Burdorf A, te Velde ER, Weber RF, van Kooij RJ, Veulemans H, et al. Occupationally related exposures and reduced semen quality: a case–control study. Fertil Steril. 1999;71:690–6. [PubMed: 10202880]
136.
Lindbohm ML. Effects of occupational solvent exposure on fertility. Scand J Work Environ Health. 1999;25(Suppl 1):44–6. [PubMed: 10235409]
137.
Wennborg H, Bodin L, Vainio H, Axelsson G. Solvent use and time to pregnancy among female personnel in biomedical laboratories in Sweden. Occup Environ Med. 2001;58:225–31. [PMC free article: PMC1740116] [PubMed: 11245738]
138.
Welch LS, Schrader SM, Turner TW, Cullen MR. Effects of exposure to ethylene glycol ethers on shipyard painters: II. Male reproduction. Am J Ind Med. 1988;14:509–26. Erratum in Am J Ind Med 1989;15;239. [PubMed: 3228067]
139.
Kolstad HA, Bisanti L, Roeleveld N, Baldi R, Bonde JP, Joffe M. Time to pregnancy among male workers of the reinforced plastics industry in Denmark, Italy and the Netherlands. Scand J Work Environ Health. 2000;26:353–8. [PubMed: 10994802]
140.
Plenge-Bonig A, Karmaus W. Exposure to toluene in the printing industry is associated with subfecundity in women but not in men. Occup Environ Med. 1999;56:443–8. [PMC free article: PMC1757762] [PubMed: 10472314]
141.
Dahl JE, Sundby J, Hensten-Pettersen A, Jacobsen N. Dental workplace exposure and effect on fertility. Scand J Work Environ Health. 1999;25:285–90. [PubMed: 10450781]
142.
Knill-Jones RP, Newman BJ, Spence AA. Anaesthetic practice and pregnancy. Controlled survey of male anaesthetists in the United Kingdom. Lancet. 1975;2:807–9. [PubMed: 78166]
143.
Ahlborg G Jr, Axelsson G, Bodin L. Shift work, nitrous oxide exposure and subfertility among Swedish midwives. Int J Epidemiol. 1996;25:783–90. [PubMed: 8921457]
144.
Zielhuis G, Peelen SJM, Florack EIM, Roeleveld N. Hospital work and fecundability. Scand J Work Environ Health. 1999;25:47–8. [PubMed: 10235410]
145.
Doyle P, Roman E, Maconochie N, Davies G, Smith PG, Beral V. Primary infertility in nuclear industry employees: report from the nuclear industry family study. Occup Environ Med. 2001;58:535–9. [PMC free article: PMC1740175] [PubMed: 11452049]
146.
Bramwell RS, Davidson MJ. Visual display units and pregnancy outcome: a prospective study. J Psychosom Obstet Gynaecol. 1993;14:197–210. [PubMed: 8261029]
147.
Smith EM, Hammonds-Ehlers M, Clark MK, Kirchner HL, Fuortes L. Occupational exposures and risk of female infertility. J Occup Environ Med. 1997;39:138–47. [PubMed: 9048320]
148.
Curtis KM, Savitz DA, Weinberg CR, Arbuckle TE. The effect of pesticide exposure on time to pregnancy. Epidemiology. 1999;10:112–7. [PubMed: 10069244]
149.
Sallmen M, Anttila A, Lindbohm ML, Kyyronen P, Taskinen H, Hemminki K. Time to pregnancy among women occupationally exposed to lead. J Occup Environ Med. 1995;37:931–4. [PubMed: 8520955]
150.
Rachootin P, Olsen J. The risk of infertility and delayed conception associated with exposures in the Danish workplace. J Occup Med. 1983;25:394–402. [PubMed: 6854429]
151.
Valanis B, Vollmer W, Labuhn K, Glass A. Occupational exposure to antineoplastic agents and self-reported infertility among nurses and pharmacists. J Occup Environ Med. 1997;39:574–80. [PubMed: 9211216]
152.
Schaumburg I, Olsen J. Time to pregnancy among Danish pharmacy assistants. Scand J Work Environ Health. 1989;15:222–6. [PubMed: 2781252]
153.
Knill-Jones RP, Rodrigues LV, Moir DD, Spence AA. Anaesthetic practice and pregnancy. Controlled survey of women anaesthetists in the United Kingdom. Lancet. 1972;1:1326–8. [PubMed: 4113412]
154.
Rowland AS, Baird DD, Weinberg CR, Shore DL, Shy CM, Wilcox AJ. Reduced fertility among women employed as dental assistants exposed to high levels of nitrous oxide. N Engl J Med. 1992;327:993–7. [PubMed: 1298226]
155.
De Rosis F, Anastasio SP, Selvaggi L, Beltrame A, Moriani G. Female reproductive health in two lamp factories: effects of exposure to inorganic mercury vapour and stress factors. Br J Ind Med. 1985;42:488–94. [PMC free article: PMC1007514] [PubMed: 4015997]
156.
Rowland AS, Baird DD, Weinberg CR, Shore DL, Shy CM, Wilcox AJ. The effect of occupational exposure to mercury vapour on the fertility of female dental assistants. Occup Environ Med. 1994;51:28–34. [PMC free article: PMC1127897] [PubMed: 8124459]
157.
Taskinen HK, Kyyronen P, Sallmen M, Virtanen SV, Liukkonen TA, Huida O, et al. Reduced fertility among female wood workers exposed to formaldehyde. Am J Ind Med. 1999;36:206–12. [PubMed: 10361608]
158.
Priddy AR, Killick SR, Elstein M, Morris J, Sullivan M, Patel L, et al. The effect of prostaglandin synthetase inhibitors on human preovulatory follicular fluid prostaglandin, thromboxane, and leukotriene concentrations. J Clin Endocrinol Metab. 1990;71:235–42. [PubMed: 2115045]
159.
Killick S, Elstein M. Pharmacologic production of luteinized unruptured follicles by prostaglandin synthetase inhibitors. Fertil Steril. 1987;47:773–7. [PubMed: 3552753]
160.
Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med. 2000;160:610–9. [PubMed: 10724046]
161.
Grodstein F, Goldman MB, Ryan L, Cramer DW. Self-reported use of pharmaceuticals and primary ovulatory infertility. Epidemiology. 1993;4:151–6. [PubMed: 8452904]
162.
Bath LE, Hamish W, Wallace B, Critchley HO. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. BJOG. 2002;109:107–14. [PubMed: 11905426]
163.
Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7:535–43. [PubMed: 11727861]
164.
Van Thiel DH, Gavaler JS, Smith WI Jr, Paul G. Hypothalamic-pituitary-gonadal dysfunction in men using cimetidine. N Engl J Med. 1979;300:1012–5. [PubMed: 431595]
165.
Marmor D. The effects of sulphasalazine on male fertility. Reprod Toxicol. 1995;9:219–23. [PubMed: 7579905]
166.
Fody EP, Walker EM. Effects of drugs on the male and female reproductive systems. Ann Clin Lab Sci. 1985;15:451–8. [PubMed: 4062226]
167.
Beeley L. Drug-induced sexual dysfunction and infertility. Adverse Drug React Acute Poisoning Rev. 1984;3:23–42. [PubMed: 6148848]
168.
Shalet SM. Cytotoxic endocrinopathy: a legacy of insults. J R Soc Med. 1997;90:192–9. [PMC free article: PMC1296214] [PubMed: 9155752]
169.
French AE, Koren G. Motherisk Team. Effect of methotrexate on male fertility. Can Fam Physician. 2003;49:577–8. [PMC free article: PMC2214217] [PubMed: 12790266]
170.
Mueller BA, Daling JR, Weiss NS, Moore DE. Recreational drug use and the risk of primary infertility. Epidemiology. 1990;1:195–200. [PubMed: 2081252]
171.
Bracken MB, Eskenazi B, Sachse K, McSharry JE, Hellenbrand K, Leo-Summers L. Association of cocaine use with sperm concentration, motility, and morphology. Fertil Steril. 1990;53:315–22. [PubMed: 2298313]
172.
Knuth UA, Maniera H, Nieschlag E. Anabolic steroids and semen parameters in bodybuilders. Fertil Steril. 1989;52:1041–7. [PubMed: 2512180]
173.
Torres-Calleja J, Gonzalez-Unzaga M, DeCelis-Carrillo R, Calzada-Sanchez L, Pedron N. Effect of androgenic anabolic steroids on sperm quality and serum hormone levels in adult male bodybuilders. Life Sci. 2001;68:1769–74. [PubMed: 11270623]
174.
Rege NN, Date J, Kulkarni V, Prem AR, Punekar SV, Dahanukar SA. Effect of Y virilin on male infertility. J Postgrad Med. 1997;43:64–7. [PubMed: 10740725]
175.
Scott R, MacPherson A, Yates RW, Hussain B, Dixon J. The effect of oral selenium supplementation on human sperm motility. Br J Urol. 1998;82:76–80. [PubMed: 9698665]
176.
Bergmann J, Luft B, Boehmann S, Runnebaum B, Gerhard I. [The efficacy of the complex medication Phyto-Hypophyson L in female, hormone-related sterility. A randomized, placebo-controlled clinical double-blind study]. Forsch Komplementarmed Klass Naturheilkd. 2000;7:190–9. [German] [PubMed: 11025394]
177.
Gerhard I. Homoopathie versus konventionelle Therapie bei weiblichen Fertilitatsstorungen: Eine monozentrische, prospektive, offene und teilrandomisierte Therapievergleichsstudie. Erfahrungsheilkunde. 1999;48:527–41.
178.
Cha KY, Wirth DP, Lobo RA. Does prayer influence the success of in vitro fertilization-embryo transfer? Report of a masked, randomized trial. J Reprod Med. 2001;46:781–7. [PubMed: 11584476]
179.
Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev. 2001;(3):CD001056. [PubMed: 11686974]
180.
Expert Advisory Group Department of Health, Scottish Office Home and Health Department, Welsh Office, and Department of Health and Social Services, Northern Ireland. Folic Acid and the Prevention of Neural Tube Defects. London: HMSO; 1992.
181.
Royal Pharmaceutical Society of Great Britain, British Medical Association. British National Formulary. London: BMA and RPS; 2003.
182.
Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet. 2001;358:2069–73. [PubMed: 11755633]
183.
Wald NJ, Morris JK. Teleoanalysis: combining data from different types of study. BMJ. 2003;327:616–8. [PMC free article: PMC194099] [PubMed: 12969936]
184.
Miller CL, Miller E, Sequeira PJ, Cradock-Watson JE, Longson M, Wiseberg EC. Effect of selective vaccination on rubella susceptibility and infection in pregnancy. BMJ. 1985;291:1398–401. [PMC free article: PMC1419038] [PubMed: 3933685]
185.
Bayer SR, Turksoy RN, Emmi AM, Reindollar RH. Rubella susceptibility of an infertile population. Fertil Steril. 1991;56:145–6. [PubMed: 2065795]
186.
Fawzy M, Harrison RF. Essential pre-conceptual measures for the female partner before commencing an in vitro fertilisation programme. Ir J Med Sci. 1998;167:14–6. [PubMed: 9540291]
187.
Leader A, Taylor PJ, Daudi FA. The value of routine rubella and syphilitic serology in the infertile couple. Fertil Steril. 1984;42:140–2. [PubMed: 6724008]
188.
Ron-El R, Bracha Y, Herman A, Golan A, Soffer Y, Bukovsky I, et al. Prerequisite work-up of the couple before in-vitro fertilization. Hum Reprod. 1992;7:483–6. [PubMed: 1522189]
189.
National Health Service (NHS). Cancer Screening Programmes. About the NHS Cervical Screening Programme. NHS Screening Programme. 2003.
190.
Population Commission, United Nations. Reproductive Rights and Reproductive Health: A Concise Report. POP/623. Geneva: United Nations; 1996.
191.
The epidemiology of infertility. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1975;582:1–37. [PubMed: 814727]
192.
Rachootin P, Olsen J. Social selection in seeking medical care for reduced fecundity among women in Denmark. J Epidemiol Community Health. 1981;35:262–4. [PMC free article: PMC1052174] [PubMed: 7338701]
193.
Rachootin P, Olsen J. Prevalence and socioeconomic correlates of subfecundity and spontaneous abortion in Denmark. Int J Epidemiol. 1982;11:245–9. [PubMed: 7129738]
194.
Mosher WD. Reproductive impairments in the United States. 1965–1982. Demography. 1985;22:415–30. [PubMed: 4043453]
195.
Hirsch MB, Mosher WD. Characteristics of infertile women in the United States and their use of infertility services. Fertil Steril. 1987;47:618–25. [PubMed: 3569545]
196.
Johnson G, Roberts D, Brown R, Cox E, Evershed Z, Goutam P, et al. Infertile or childless by choice? A multipractice survey of women aged 35 and 50. BMJ. 1987;294:804–6. [PMC free article: PMC1245864] [PubMed: 3105749]
197.
Marchbanks PA, Peterson HB, Rubin GL, Wingo PA. Research on infertility: definition makes a difference. The Cancer and Steroid Hormone Study Group. Am J Epidemiol. 1989;130:259–67. [PubMed: 2750725]
198.
Martin TE. Infertility in a large Royal Air Force General Practice. J R Army Med Corps. 1989;135:68–75. [PubMed: 2788737]
199.
Weinberg CR. Infertility and the use of illicit drugs. Epidemiology. 1990;1:189–92. [PubMed: 2081250]
200.
Sundby J, Lund E. [Subfertility and infertility. A sample of Norwegian women]. Tidsskr Nor Laegeforen. 19891996–8:19–21. [Norwegian] [PubMed: 2749686]
201.
Greenhall E, Vessey M. The prevalence of subfertility: a review of the current confusion and a report of two new studies. Fertil Steril. 1990;54:978–83. [PubMed: 2245856]
202.
Templeton A, Fraser C, Thompson B. The epidemiology of infertility in Aberdeen. BMJ. 1990;301:148–52. [PMC free article: PMC1663514] [PubMed: 2390599]
203.
Templeton A, Fraser C, Thompson B. Infertility-epidemiology and referral practice. Hum Reprod. 1991;6:1391–4. [PubMed: 1770132]
204.
Ghazi HA, Spielberger C, Kallen B. Delivery outcome after infertility – a registry study. Fertil Steril. 1991;55:726–32. [PubMed: 2009996]
205.
Hogberg U, Sandstrom A, Nilsson NG. Reproductive patterns among Swedish women born 1936–1960. Acta Obstet Gynecol Scand. 1992;71:207–14. [PubMed: 1317644]
206.
Webb S, Holman D. A survey of infertility, surgical sterility and associated reproductive disability in Perth, Western Australia. Aust J Public Health. 1992;16:376–81. [PubMed: 1296786]
207.
Rowe PJ, Comhaire FH, Hargreave TB, Mellows HJ. WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple. Cambridge: Cambridge University Press; 1997.
208.
Gunnell DJ, Ewings P. Infertility prevalence, needs assessment and purchasing. J Public Health Med. 1994;16:29–35. [PubMed: 8037949]
209.
Schmidt L, Munster K, Helm P. Infertility and the seeking of infertility treatment in a representative population. Br J Obstet Gynaecol. 1995;102:978–84. [PubMed: 8652489]
210.
Schmidt L, Munster K. Infertility, involuntary infecundity, and the seeking of medical advice in industrialised countries 1970–1992: a review of concepts, measurements and results. Hum Reprod. 1995;10:1407–18. [PubMed: 7593506]
211.
The ESHRE Capri Workshop. Guidelines to the prevalence, diagnosis, treatment and management of infertility, 1996. Hum Reprod. 1996;11:1775–807.
212.
Buckett W, Bentick B. The epidemiology of infertility in a rural population. Acta Obstet Gynecol Scand. 1997;76:233–7. [PubMed: 9093137]
213.
Stephen EH, Chandra A. Use of infertility services in the United States: 1995. Fam Plann Perspect. 2000;32:132–7. [PubMed: 10894259]
214.
Page H. Estimation of the prevalence and incidence of infertility in a population: a pilot study. Fertil Steril. 1989;51:571–7. [PubMed: 2784395]
215.
Rantala M-L, Koskimies AI. Infertility in women participating in a screening program for cervical cancer in Helsinki. Acta Obstet Gynecol Scand. 1986;65:823–5. [PubMed: 3825520]
216.
Bongaarts J. Infertility after age 30: a false alarm. Fam Plann Perspect. 1982;14:75–8. [PubMed: 7095110]
217.
Cahill DJ, Wardle PG. Management of infertility. BMJ. 2002;325:28–32. [PMC free article: PMC1123548] [PubMed: 12098728]
218.
Human Fertilisation and Embryology Authority. Code of Practice. 6th ed. London: HFEA; 2004.
219.
Owens DJ, Read MW. Patients’ experience with and assessment of subfertility testing and treatment. J Reprod Med. 1984;2:7–17.
220.
Souter VL, Penney G, Hopton JL, Templeton AA. Patient satisfaction with the management of infertility. Hum Reprod. 1998;13:1831–6. [PubMed: 9740434]
221.
Bromham DR, Balmer B, Clay R, Hamer R. Disenchantment with infertility services: a survey of patients in Yorkshire. Br J Fam Plann. 1988;14:3–8.
222.
Souter VL, Penney G, Gorman DR. A survey of infertility practices in primary care in Scotland. Br J Gen Pract. 1997;47:727–8. [PMC free article: PMC1409946] [PubMed: 9519520]
223.
Ley P. Giving information to patients. In: Eiser JR, editor. Social Psychology and Behavioral Science. Chichester: John Wiley & Sons Ltd; 1982. pp. 339–73.
224.
Sabourin S, Wright J, Duchesne C, Belisle S. Are consumers of modern fertility treatments satisfied? Fertil Steril. 1991;56:1084–90. [PubMed: 1743326]
225.
Halman LJ, Abbey A, Andrews FM. Why are couples satisfied with infertility treatment? Fertil Steril. 1993;59:1046–54. [PubMed: 8486172]
226.
Sundby J, Olsen A, Schei B. Quality of care for infertility patients. An evaluation of a plan for a hospital investigation. Scand J Soc Med. 1994;22:139–44. [PubMed: 8091156]
227.
Hammarberg K, Astbury J, Baker H. Women’s experience of IVF: a follow-up study. Hum Reprod. 2001;16:374–83. [PubMed: 11157838]
228.
Kerr J, Brown C, Balen AH. The experiences of couples who have had infertility treatment in the United Kingdom: results of a survey performed in 1997. Hum Reprod. 1999;14:934–8. [PubMed: 10221223]
229.
Ellis DA, Hopkin JM, Leitch AG, Crofton J. “Doctors’ orders”: controlled trial of supplementary, written information for patients” BMJ. 1979;1:456. [PMC free article: PMC1597794] [PubMed: 427407]
230.
Laffont I, Edelmann RJ. Perceived support and counselling needs in relation to in vitro fertilization. J Psychosom Obstet Gynaecol. 1994;15:183–8. [PubMed: 7881503]
231.
National Health Service (NHS). A First Class Service: Quality in the New NHS – Summary. London: NHS; 1998.
232.
Human Fertilisation and Embryology Authority. Storage and Use of Frozen Eggs. London: HFEA; 2003.
233.
Human Fertilisation and Embryology Authority. Egg Freezing Centres. London: HFEA; 2003.
234.
Human Fertilisation and Embryology Authority. Welfare of the Child Information for GPs. London: HFEA; 2003.
235.
Human Fertilisation and Embryology Authority. About the Human Fertilisation and Embryology Authority. London: HFEA; 2003.
236.
Human Fertilisation and Embryology Authority. Embryo Storage. London: HFEA; 2003.
237.
Human Fertilisation and Embryology Authority. Embryo Research. London: HFEA; 2003.
238.
Human Fertilisation and Embryology Authority. Welfare of the Child Information for Patients. London: HFEA; 2003.
239.
Human Fertilisation and Embryology Authority. Intra-Cytoplasmic Sperm Injection (ICSI). London: HFEA; 2003.
240.
Human Fertilisation and Embryology Authority. Egg Donation. London: HFEA; 2003.
241.
Human Fertilisation and Embryology Authority. Sperm and Egg Donors and the Law. London: HFEA; 2003.
242.
Human Fertilisation and Embryology Authority. Consent to the Use and Storage of Gametes and Embryos. London: HFEA; 2003.
243.
Blenner JL. Health care providers’ treatment approaches to culturally diverse infertile clients. J Transcult Nurs. 1991;2:24–31. [PubMed: 2043292]
244.
Hirsh A. Post-coital sperm retrieval could lead to the wider approval of assisted conception by some religions. Hum Reprod. 1996;11:245–7. [PubMed: 8671202]
245.
Schenker JG. Religious views regarding treatment of infertility by assisted reproductive technologies. J Assist Reprod Genet. 1992;9:3–8. [PubMed: 1617246]
246.
Brkovich AM, Fisher WA. Psychological distress and infertility: forty years of research. J Psychosom Obstet Gynaecol. 1998;19:218–28. [PubMed: 9929848]
247.
Hjollund NH. Job strain and time to pregnancy. Scand J Work Environ Health. 1998;24:344–50. [PubMed: 9869305]
248.
Hjollund NH, Jensen TK, Bonde JP, Henriksen TB, Andersson AM, Kolstad HA, et al. Distress and reduced fertility: a follow-up study of first-pregnancy planners. Fertil Steril. 1999;72:47–53. [PubMed: 10428147]
249.
Fenster L, Waller K, Chen J, Hubbard AE, Windham GC, Elkin E, et al. Psychological stress in the workplace and menstrual function. Am J Epidemiol. 1999;149:127–34. [PubMed: 9921957]
250.
Poland ML, Giblin PT, Ager JW, Moghissi KS. Effect of stress on semen quality in semen donors. Int J Fertil. 1986;31:229–31. [PubMed: 2875966]
251.
Fenster L, Katz DF, Wyrobek AJ, Pieper C, Rempel DM, Oman D, et al. Effects of psychological stress on human semen quality. J Androl. 1997;18:194–202. [PubMed: 9154514]
252.
Benazon N, Wright J, Sabourin S. Stress, sexual satisfaction, and marital adjustment in infertile couples. J Sex Marital Ther. 1992;18:273–84. [PubMed: 1291698]
253.
Irvine S, Cawood E. Male infertility and its effect on male sexuality. Sex Marital Ther. 1996;11:273–80.
254.
Lenzi A, Lombardo F, Salacone P, Gandini L, Jannini EA. Stress, sexual dysfunctions, and male infertility. J Endocrinol Invest. 2003;26(Suppl 3):72–6. [PubMed: 12834026]
255.
Freeman EW, Boxer AS, Rickels K, Tureck R, Mastroianni L. Psychological evaluation and support in a program of in vitro fertilization and embryo transfer. Fertil Steril. 1985;43:48–53. [PubMed: 3965315]
256.
Keye WR, Deneris A, Wilson T, Sullivan J. Psychosexual response to infertility: differences between infertile men and women. Fertil Steril. 1981;36:426.
257.
Newton CR, Hearn MT, Yuzpe AA. Psychological assessment and follow-up after in vitro fertilization: assessing the impact of failure. Fertil Steril. 1990;54:879–86. [PubMed: 2226921]
258.
Downey J, Yingling S, McKinney M, Husami N, Jewelewicz R, Maidman J. Mood disorders, psychiatric symptoms, and distress in women presenting for infertility evaluation. Fertil Steril. 1989;52:425–32. [PubMed: 2776896]
259.
Wischmann T, Stammer H, Scherg H, Gerhard I, Verres R. Psychosocial characteristics of infertile couples: a study by the ‘Heidelberg Fertility Consultation Service’ Hum Reprod. 2001;16:1753–61. [PubMed: 11473978]
260.
Wright J, Allard M, Lecours A, Sabourin S. Psychosocial Distress and Infertility: A Review of Controlled Research. Int J Fertil. 1989;34:126–42. [PubMed: 2565316]
261.
Wright J, Duchesne C, Sabourin S, Bissonnette F, Benoit J, Girard Y. Psychosocial distress and infertility: men and women respond differently. Fertil Steril. 1991;55:100–8. [PubMed: 1986949]
262.
van Balen F, Trimbos-Kemper TCM. Long-term infertile couples: a study of their well-being. J Psychosom Obstet Gynaecol. 1993;14(Suppl):53–60. [PubMed: 8142990]
263.
Baram D, Tourtelot E, Muechler E, Huang KE. Psychosocial adjustment following unsuccessful in vitro fertilization. J Psychosom Obstet Gynaecol. 1988;9:181–90.
264.
Beutel M, Kupfer J, Kirchmeyer P, Kehde S, Kohn FM, Schroeder-Printzen I, et al. Treatment-related stresses and depression in couples undergoing assisted reproductive treatment by IVF or ICSI. Andrologia. 1999;31:27–35. [PubMed: 9949886]
265.
Guerra D, Llobera A, Veiga A, Barri PN. Psychiatric morbidity in couples attending a fertility service. Hum Reprod. 1998;13:1733–6. [PubMed: 9688423]
266.
Paulson JD, Haarmann BS, Salerno RL, Asmar P. An investigation of the relationship between emotional maladjustment and infertility. Fertil Steril. 1988;49:258–62. [PubMed: 3338582]
267.
Domar AD, Zuttermeister PC, Friedman R. The psychological impact of infertility: a comparison with patients with other medical conditions. J Psychosom Obstet Gynaecol. 1993;14(Suppl):45–52. [PubMed: 8142988]
268.
Lalos A, Lalos O, Jacobsson L, von Schoultz B. The psychosocial impact of infertility two years after completed surgical treatment. Acta Obstet Gynecol Scand. 1985;64:599–604. [PubMed: 4082934]
269.
Domar AD, Clapp DE. The impact of group psychological interventions on distress in infertile women. Health Psychol. 2000;19:568–75. [PubMed: 11129360]
270.
Domar AD, Clapp DE. Impact of group psychological interventions on pregnancy rates in infertile women. Fertil Steril. 2000;73:805–11. [PubMed: 10731544]
271.
Eugster A, Vingerhoets AJ. Psychological aspects of in vitro fertilization: a review. Soc Sci Med. 1999 Mar;48:575–89. [PubMed: 10080360]
272.
Connolly KJ, Edelmann RJ, Bartlett H, Cooke ID, Lenton E, Pike S. An evaluation of counselling for couples undergoing treatment for in-vitro fertilization. Hum Reprod. 1993;8:1332–8. [PubMed: 8408538]
273.
Daniluk JC. Infertility: intrapersonal and interpersonal impact. Fertil Steril. 1988;49:982–90. [PubMed: 3371493]
274.
Child. The National Infertility Support Network. Treatment quality survey report. [Internal report compiled 2000, unpublished.]
275.
Hernon M, Harris CP, Elstein M, Russell CA, Seif MW. Review of the organized support network for infertility patients in licensed units in the UK. Hum Reprod. 1995;10:960–4. [PubMed: 7650151]
276.
Boivin J, Scanlan LC, Walker SM. Why are infertile patients not using psychosocial counselling? Hum Reprod. 1999;14:1384–91. [PubMed: 10325300]
277.
Boivin J. Is there too much emphasis on psychosocial counseling for infertile patients? J Assist Reprod Genet. 1997;14:184–6. [PMC free article: PMC3454700] [PubMed: 9130063]
278.
McLeod J. An Introduction to Counselling. Buckingham: Open University Press; 1994.
279.
Overton D. Why counselling is not sought in deteriorating relationships: the effect of denial. British Journal of Guidance and Counselling. 994;22:405–16.
280.
Cudmore L. The impact of infertility on the couple relationship. In: Burnell A, Reich D, Sawbridge P, editors. Advances in Adoption Series: Infertility and Adoption. London: Tavistock Matital Studies Institute; 1992. pp. 15–22.
281.
Grilli R, Minozzi S, Tinazzi A, Labianca R, Sheldon TA, Liberati A. Do specialists do it better? The impact of specialization on the processes and outcomes of care for cancer patients. Ann Oncol. 1998;9:365–74. [PubMed: 9636826]
282.
Hearn J, Higginson IJ. Do specialist palliative care teams improve outcomes for cancer patients? A systematic literature review. Palliat Med. 1998;12:317–32. [PubMed: 9924595]
283.
Harrold LR, Field TS, Gurwitz JH. Knowledge, patterns of care, and outcomes of care for generalists and specialists. J Gen Intern Med. 1999;14:499–511. [PMC free article: PMC1496728] [PubMed: 10491236]
284.
Watson AJ, Gupta JK, O’Donovan P, Dalton ME, Lilford RJ. The results of tubal surgery in the treatment of infertility in two nonspecialist hospitals. Br J Obstet Gynaecol. 1990;97:561–8. [PubMed: 2202431]
285.
World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm–Cervical Mucus Interaction. Cambridge: Cambridge University Press; 2000.
286.
Opsahl MS, Dixon NG, Robins ER, Cunningham DS. Single vs. multiple semen specimens in screening for male infertility factors. A comparison. J Reprod Med. 1996;41:313–5. [PubMed: 8725754]
287.
Rowe PJ, Comhaire FH, Hargreave TB, Mahmoud AM. WHO Manual for the Standardized Investigation, Diagnosis and Management of the Infertile Male. Cambridge: Cambridge University Press; 2000.
288.
British Andrology Society Education Sub-committee. Seminal Fluid Analysis and Anti-sperm Antibody Testing. Standard Operating Procedures – Laboratory Manual. 1997. [Accessed 21 November 2002]. [www​.repromed.org.uk/bas​/bas2000/Publications/labmanual.html]
289.
MacLeod J. Human seminal cytology as a sensitive indicator of the germinal epithelium. Int J Fertil. 1964;9:281–95. [PubMed: 14145790]
290.
Helmerhorst FM, Finken MJ, Erwich JJ. Antisperm antibodies: detection assays for antisperm antibodies: what do they test? Hum Reprod. 1999;14:1669–71. [PubMed: 10402364]
291.
Mahmoud A, Comhaire F. Antisperm antibodies: use of the mixed agglutination reaction (MAR) test using latex beads. Hum Reprod. 2000;15:231–3. [PubMed: 10655287]
292.
Helmerhorst FM, Erwich JJ. Antisperm antibodies: comment on the use of the MAR test using latex beads. Hum Reprod. 2000;15:233. [PubMed: 10655288]
293.
Bronson R. Detection of antisperm antibodies: an argument against therapeutic nihilism. Hum Reprod. 1999;14:1671–3. [PubMed: 10402365]
294.
The ESHRE Capri Workshop Group. Male sterility and subfertility: guidelines for management. Hum Reprod. 1994;9:1260–4. [PubMed: 7962430]
295.
Bonde JP, Ernst E, Jensen TK, Hjollund NH, Kolstad H, Henriksen TB, et al. Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet. 1998;352:1172–7. [PubMed: 9777833]
296.
Comhaire FH, de Kretser D, Farley TMM. Towards more objectivity in the management of male infertility. The need for a standardized approach. Int J Androl. 1987;10:1–2.
297.
Nieschlag E, Behre HM. Andrology: Male Reproductive Health and Dysfunction. Heidelberg: Springer; 1997.
298.
Farley TMM, Belsey FH. The prevalence and aetiology of infertility; Proceedings of the African Population Conference; 7–12 November 1988; Dakar, Senegal. Liege: International Union for the Scientific Study of Population; 1988. pp. 2.1.15–30.
299.
Kamischke A, Nieschlag E. Treatment of retrograde ejaculation and anejaculation. Hum Reprod Update. 1999;5:448–74. [PubMed: 10582783]
300.
Witt MA, Grantmyre JE. Ejaculatory failure. World J Urol. 1993;11:89–95. [PubMed: 8343800]
301.
Perera ND, Hill JT. Erectile and ejaculatory failure after transurethral prostatectomy. Ceylon Med J. 1998;43:74–7. [PubMed: 9704545]
302.
Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992;340:17–8. [PubMed: 1351601]
303.
The influence of varicocele on parameters of fertility in a large group of men presenting to infertility clinics. World Health Organization. Fertil Steril. 1992;57:1289–93. [PubMed: 1601152]
304.
Zini A, Buckspan M, Berardinucci D, Jarvi K. The influence of clinical and subclinical varicocele on testicular volume. Fertil Steril. 1997;68:671–4. [PubMed: 9341609]
305.
Zorgniotti AW, MacLeod J. Studies in temperature, human semen quality, and varicocele. Fertil Steril. 1973;24:854–63. [PubMed: 4742006]
306.
Collins JA. Diagnostic Assessment of the Infertile Female Partner. Curr Probl Obstet Gynecol Fertil. 1988;11:6–42.
307.
Hull MG, Savage PE, Bromham DR, Ismail AA, Morris AF. The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle (“ovulation”) derived from treated and untreated conception cycles. Fertil Steril. 1982;37:355–60. [PubMed: 7060786]
308.
Abdulla U, Diver MJ, Hipkin LJ, Davis JC. Plasma progesterone levels as an index of ovulation. Br J Obstet Gynaecol. 1983;90:543–8. [PubMed: 6860600]
309.
Wathen NC, Perry L, Lilford RJ, Chard T. Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. BMJ. 1984;288:7–9. [PMC free article: PMC1444184] [PubMed: 6418326]
310.
Hull MG. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol. 1987;1:235–45. [PubMed: 3140583]
311.
Homburg R. Should patients with polycystic ovarian syndrome be treated with metformin? A note of cautious optimism. Hum Reprod. 2002;17:853–6. [PubMed: 11925372]
312.
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7. [PubMed: 14688154]
313.
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25. [PubMed: 14711538]
314.
Balen AH, Laven JSE, Tan SL, Dewailly D. The ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod. 2003;9:505–14. [PubMed: 14714587]
315.
Vanrell JA, Balasch J. Prolactin in the evaluation of luteal phase in infertility. Fertil Steril. 1983;39:30–3. [PubMed: 6848391]
316.
Laufer MR, Floor AE, Parsons KE, Kuntz KM, Barbieri RL, Friedman AJ. Evaluation of hormonal testing in the screening for in vitro fertilization (IVF) of women with tubal factor infertility. J Assist Reprod Genet. 1995;12:93–6. [PubMed: 7670280]
317.
Varkopoulou K, Dericks-Tan JS, Taubert HD. [The diagnostic value of routine prolactin determination in sterility patients]. Zentralbl Gynakol. 1993;115:167–70. [German] [PubMed: 8503235]
318.
Glazener CM, Kelly NJ, Hull MG. Prolactin measurement in the investigation of infertility in women with a normal menstrual cycle. Br J Obstet Gynaecol. 1987;94:535–8. [PubMed: 3620401]
319.
Stratford GA, Barth JH, Rutherford AJ, Balen AH. Plasma prolactin measurement is not indicated in women in the routine investigation of uncomplicated infertility. Hum Fertil (Camb). 1999;2:70–1. [PubMed: 11844330]
320.
Suliman AM, Smith TP, Gibney J, McKenna TJ. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clin Chem. 2003;49:1504–9. [PubMed: 12928232]
321.
Fahie-Wilson M. In hyperprolactinemia, testing for macroprolactin is essential. Clin Chem. 2003;49:1434–6. [PubMed: 12928222]
322.
Strachan MWJ, Teoh WL, Don-Wauchope AC, Seth J, Stoddart M, Beckett GJ. Clinical and radiological features of patients with macroprolactinaemia. Clin Endocrinol (Oxf). 2003;59:339–46. [PubMed: 12919157]
323.
Faddy MJ, Gosden RG. A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod. 1996;11:1484–6. [PubMed: 8671489]
324.
Sharara FI, Scott RT Jr, Seifer DB. The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol. 1998;179:804–12. [PubMed: 9757994]
325.
Scott RT Jr, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril. 1995;63:1–11. [PubMed: 7805895]
326.
Scott RT, Leonardi MR, Hofmann GE, Illions EH, Neal GS, Navot D. A prospective evaluation of clomiphene citrate challenge test screening of the general infertility population. Obstet Gynecol. 1993;82:539–44. [PubMed: 8377979]
327.
Scott RT, Opsahl MS, Leonardi MR, Neall GS, Illions EH, Navot D. Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age. Hum Reprod. 1995;10:1706–10. [PubMed: 8582965]
328.
Navot D, Rosenwaks Z, Margalioth EJ. Prognostic assessment of female fecundity. Lancet. 1987;2:645–7. [PubMed: 2887939]
329.
Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989;51:651–4. [PubMed: 2494082]
330.
Loumaye E, Billion JM, Mine JM, Psalti I, Pensis M, Thomas K. Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril. 1990;53:295–301. [PubMed: 2105246]
331.
Tanbo T, Dale PO, Lunde O, Norman N, Abyholm T. Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels. Fertil Steril. 1992;57:819–24. [PubMed: 1555694]
332.
Hofmann GE, Sosnowski J, Scott RT, Thie J. Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility center population. Fertil Steril. 1996;66:49–53. [PubMed: 8752610]
333.
Levi AJ, Raynault MF, Bergh PA, Drews MR, Miller BT, Scott RT Jr. Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril. 2001;76:666–9. [PubMed: 11591396]
334.
Sharif K, Elgendy M, Lashen H, Afnan M. Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome. Br J Obstet Gynaecol. 1998;105:107–12. [PubMed: 9442172]
335.
Chuang CC, Chen CD, Chao KH, Chen SU, Ho HN, Yang YS. Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization. Fertil Steril. 2003;79:63–8. [PubMed: 12524065]
336.
Lawson R, El Toukhy T, Kassab A, Taylor A, Braude P, Parsons J, et al. Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod. 2003;18:527–33. [PubMed: 12615819]
337.
Danforth DR, Arbogast LK, Mroueh J, Kim MH, Kennard EA, Seifer DB, et al. Dimeric inhibin: a direct marker of ovarian aging. Fertil Steril. 1998;70:119–23. [PubMed: 9660432]
338.
Hofmann GE, Danforth DR, Seifer DB. Inhibin-B: the physiologic basis of the clomifene citrate challenge test for ovarian reserve screening. Fertil Steril. 1998;69:474–7. [PubMed: 9531880]
339.
Corson SL, Gutmann J, Batzer FR, Wallace H, Klein N, Soules MR. Inhibin-B as a test of ovarian reserve for infertile women. Hum Reprod. 1999;14:2818–21. [PubMed: 10548629]
340.
Hall JE, Welt CK, Cramer DW. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod. 1999;14:409–15. [PubMed: 10099988]
341.
Gulekli B, Bulbul Y, Onvural A, Yorukoglu K, Posaci C, Demir N, et al. Accuracy of ovarian reserve tests. Hum Reprod. 1999;14:2822–6. [PubMed: 10548630]
342.
Damario MA, Davis OK, Rosenwaks Z. The role of maternal age in the assisted reproductive technologies. Reprod Med Rev. 1999;7:41–60.
343.
Akande EO, Anderson DC. Role of sex-hormone-binding globulin in hormonal changes and amenorrhoea in thyrotoxic women. Br J Obstet Gynaecol. 1975;82:557–61. [PubMed: 50080]
344.
Akande EO, Hockaday TD. Plasma concentration of gonadotrophins, oestrogens and progesterone in thyrotoxic women. Br J Obstet Gynaecol. 1975;82:541–51. [PubMed: 1170874]
345.
Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977;7:481–93. [PubMed: 598014]
346.
Conway DI, Glazener CM, Kelly N, Hull MG. Routine measurement of thyroid hormones and FSH in infertility not worthwhile. Lancet. 1985;1:977–8. [PubMed: 2859426]
347.
Strickland DM, Whitted WA, Wians FH Jr. Screening infertile women for subclinical hypothyroidism. Am J Obstet Gynecol. 1990;163:262–3. [PubMed: 2375364]
348.
Shalev E, Eliyahu S, Ziv M, Ben Ami M. Routine thyroid function tests in infertile women: are they necessary? Am J Obstet Gynecol. 1994;171:1191–2. [PubMed: 7977517]
349.
Stratford GA, Barth JH, Rutherford AJ, Balen AH. Value of thyroid function tests in routine screening of women investigated for infertility. Hum Fertil (Cambs). 2000;3:203–6. [PubMed: 11844379]
350.
Jones GS. The luteal phase defect. Fertil Steril. 1976;27:351–6. [PubMed: 1269800]
351.
Balasch J, Creus M, Marquez M, Burzaco I, Vanrell JA. The significance of luteal phase deficiency on fertility: a diagnostic and therapeutic approach. Hum Reprod. 1986;1:145–7. [PubMed: 3114310]
352.
Li TC, Cooke ID. Evaluation of the luteal phase. Hum Reprod. 1991;6:484–99. [PubMed: 1918297]
353.
Peters AJ, Lloyd RP, Coulam CB. Prevalence of out-of-phase endometrial biopsy specimens. Am J Obstet Gynecol. 1992;166:1738–45. [PubMed: 1615982]
354.
Karamardian LM, Grimes DA. Luteal phase deficiency: effect of treatment on pregnancy rates. Am J Obstet Gynecol. 1992;167:1391–8. [PubMed: 1344880]
355.
Balasch J, Fabregues F, Creus M, Vanrell JA. The usefulness of endometrial biopsy for luteal phase evaluation in infertility. Hum Reprod. 1992;7:973–7. [PubMed: 1430139]
356.
Smith S, Hosid S, Scott L. Endometrial biopsy dating. Interobserver variation and its impact on clinical practice. J Reprod Med. 1995;40:1–3. [PubMed: 7722968]
357.
Macmillan S, McKenzie H, Flett G. Which women should be tested for Chlamydia trachomatis? BJOG. 2000;107:1088–93. [PubMed: 11002950]
358.
Westrom L, Wolner-Hanssen P. Pathogenesis of pelvic inflammatory disease. Genitourin Med. 1993;69:9–17. [PMC free article: PMC1195002] [PubMed: 8444495]
359.
Paavonen J, Eggert-Kruse W. Chlamydia trachomatis: impact on human reproduction. Hum Reprod Update. 1999;5:433–47. [PubMed: 10582782]
360.
Macmillan S, Templeton A. Screening for Chlamydia trachomatis in subfertile women. Hum Reprod. 1999;14:3009–12. [PubMed: 10601088]
361.
Forsey JP, Caul EO, Paul ID, Hull MG. Chlamydia trachomatis, tubal disease and the incidence of symptomatic and asymptomatic infection following hysterosalpingography. Hum Reprod. 1990;5:444–7. [PubMed: 2113932]
362.
Land JA, Gijsen AP, Evers JLH, Bruggeman CA. Chlamydia trachomatis in subfertile women undergoing uterine instrumentation: screen or treat? Hum Reprod. 2002;17:525–7. [PubMed: 11870096]
363.
Chlamydial STD treatment. Bandolier. 1996;(28):28–4.
364.
Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996;334:1362–6. [PubMed: 8614421]
365.
Expert Advisory Group. Chlamydia trachomatis – Summary and Conclusions of CMO’s Expert Advisory Group. London: Department of Health; 1998.
366.
Skulnick M, Chua R, Simor AE, Low DE, Khosid HE, Fraser S, et al. Use of the polymerase chain reaction for the detection of Chlamydia trachomatis from endocervical and urine specimens in an asymptomatic low-prevalence population of women. Diagn Microbiol Infect Dis. 1994;20:195–201. [PubMed: 7705032]
367.
Schachter J, Moncada J, Whidden R, Shaw H, Bolan G, Burczak JD, et al. Noninvasive tests for diagnosis of Chlamydia trachomatis infection: application of ligase chain reaction to first-catch urine specimens of women. J Infect Dis. 1995;172:1411–4. [PubMed: 7594691]
368.
Ridgway GL, Mumtaz G, Robinson AJ, Franchini M, Carder C, Burczak J, et al. Comparison of the ligase chain reaction with cell culture for the diagnosis of Chlamydia trachomatis infection in women. J Clin Pathol. 1996;49:116–9. [PMC free article: PMC500342] [PubMed: 8655675]
369.
Greendale GA, Haas ST, Holbrook K, Walsh B, Schachter J, Phillips RS. The relationship of Chlamydia trachomatis infection and male infertility. Am J Public Health. 1993;83:996–1001. [PMC free article: PMC1694769] [PubMed: 8328623]
370.
Sulak PJ, Letterie GS, Coddington CC, Hayslip CC, Woodward JE, Klein TA. Histology of proximal tubal occlusion. Fertil Steril. 1987;48:437–40. [PubMed: 2957237]
371.
Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril. 1985;43:351–2. [PubMed: 3979573]
372.
Rock JA. The revised American Fertility Society classification of endometriosis: reproducibility of scoring. ZOLADEX Endometriosis Study Group. Fertil Steril. 1995;63:1108–10. [PubMed: 7720925]
373.
Guzick DS, Silliman NP, Adamson GD, Buttram VC Jr, Canis M, Malinak LR, et al. Prediction of pregnancy in infertile women based on the American Society for Reproductive Medicine’s revised classification of endometriosis. Fertil Steril. 1997;67:822–9. [PubMed: 9130885]
374.
Belisle S, Collins JA, Burrows EA, Willan AR. The value of laparoscopy among infertile womenwith tubal patency. J Soc Obstet Gynaecol Can. 1996;18:326–36.
375.
Swart P, Mol BW, van der Veen F, van Beurden M, Redekop WK, Bossuyt PM. The accuracy of hysterosalpingography in the diagnosis of tubal pathology: a meta-analysis. Fertil Steril. 1995;64:486–91. [PubMed: 7641899]
376.
Opsahl MS, Miller B, Klein TA. The predictive value of hysterosalpingography for tubal and peritoneal infertility factors. Fertil Steril. 1993;60:444–8. [PubMed: 8375524]
377.
Mol BW, Swart P, Bossuyt PM, van Beurden M, van der Veen F. Reproducibility of the interpretation of hysterosalpingography in the diagnosis of tubal pathology. Hum Reprod. 1996;11:1204–8. [PubMed: 8671424]
378.
Glatstein IZ, Sleeper LA, Lavy Y, Simon A, Adoni A, Palti Z, et al. Observer variability in the diagnosis and management of the hysterosalpingogram. Fertil Steril. 1997;67:233–7. [PubMed: 9022595]
379.
Mol BW, Collins JA, Burrows EA, van der Veen F, Bossuyt PM. Comparison of hysterosalpingography and laparoscopy in predicting fertility outcome. Hum Reprod. 1999;14:1237–42. [PubMed: 10325270]
380.
Mol BW, Dijkman B, Wertheim P, Lijmer J, van der Veen F, Bossuyt PM. The accuracy of serum chlamydial antibodies in the diagnosis of tubal pathology: a meta-analysis. Fertil Steril. 1997;67:1031–7. [PubMed: 9176440]
381.
Eggert-Kruse W, Rohr G, Demirakca T, Rusu R, Naher H, Petzoldt D, et al. Chlamydial serology in 1303 asymptomatic subfertile couples. Hum Reprod. 1997;12:1464–75. [PubMed: 9262279]
382.
Land JA, Evers JL, Goossens VJ. How to use Chlamydia antibody testing in subfertility patients. Hum Reprod. 1998;13:1094–8. [PubMed: 9619578]
383.
Johnson NP, Taylor K, Nadgir AA, Chinn DJ, Taylor PJ. Can diagnostic laparoscopy be avoided in routine investigation for infertility? BJOG. 2000;107:174–8. [PubMed: 10688500]
384.
Akande VA, Jenkins JM. What is the prognostic value of chlamydia serology for pregnancy and live birth rates? Abstract no. 185. J Reprod Fertil Abstract Ser. 2000;(5):68–9.
385.
Akande VA, Jenkins JM. The relationship of tubal pelvic damage (TPD) and chlamydia serology to severity of disease and functional potential for pregnancy. Hum Fertil. 2001;4:15.
386.
Dijkman AB, Mol BWJ, van der Veen F, Bossuyt PM, Hogerzeil HV. Can hysterosalpingocontrast-sonography replace hysterosalpingography in the assessment of tubal subfertility? Eur J Radiol. 2000;35:44–8. [PubMed: 10930765]
387.
Ayida G, Kennedy S, Barlow D, Chamberlain P. A comparison of patient tolerance of hysterosalpingo-contrast sonography (HyCoSy) with Echovist-200 and X-ray hysterosalpingography for outpatient investigation of infertile women. Ultrasound Obstet Gynecol. 1996;7:201–4. [PubMed: 8705414]
388.
Boudghene FP, Bazot M, Robert Y, Perrot N, Rocourt N, Antoine JM, et al. Assessment of fallopian tube patency by HyCoSy: comparison of a positive contrast agent with saline solution. Ultrasound Obstet Gynecol. 2001;18:525–30. [PubMed: 11844177]
389.
Watrelot A, Dreyfus JM, Andine JP. Evaluation of the performance of fertiloscopy in 160 consecutive infertile patients with no obvious pathology. Hum Reprod. 1999;14:707–11. [PubMed: 10221700]
390.
Gordts S, Watrelot A, Campo R, Brosens I. Risk and outcome of bowel injury during transvaginal pelvic endoscopy. Fertil Steril. 2001;76:1238–41. [PubMed: 11730757]
391.
Kerin J, Daykhovsky L, Grundfest W, Surrey E. Falloposcopy. A microendoscopic transvaginal technique for diagnosing and treating endotubal disease incorporating guide wire cannulation and direct balloon tuboplasty. J Reprod Med. 1990;35:606–12. [PubMed: 2359058]
392.
Dechaud H, Daures JP, Hedon B. Prospective evaluation of falloposcopy. Hum Reprod. 1998;13:1815–8. [PubMed: 9740431]
393.
Downing BG, Wood C. Predictive value of falloscopy: 200 case study. References en Gynecologie Obstetrique. 1995;3:156–62.
394.
Lundberg S, Rasmussen C, Berg AA, Lindblom B. Falloposcopy in conjunction with laparoscopy: possibilities and limitations. Hum Reprod. 1998;13:1490–2. [PubMed: 9688378]
395.
Rimbach S, Bastert G, Wallwiener D. Technical results of falloposcopy for infertility diagnosis in a large multicentre study. Hum Reprod. 2001;16:925–30. [PubMed: 11331639]
396.
Johnson N, Vandekerckhove P, Watson A, Lilford R, Harada T, Hughes E. Tubal flushing for subfertility. Cochrane Database Syst Rev. 2002;(3):CD003718. [PubMed: 12137708]
397.
Trout SW, Kemmann E. Fallopian sperm perfusion versus intrauterine insemination: a randomized controlled trial and metaanalysis of the literature. Fertil Steril. 1999;71:881–5. [PubMed: 10231050]
398.
Wallach EE. The uterine factor in infertility. Fertil Steril. 1972;23:138–58. [PubMed: 4551503]
399.
Golan A, Eilat E, Ron-El R, Herman A, Soffer Y, Bukovsky I. Hysteroscopy is superior to hysterosalpingography in infertility investigation. Acta Obstet Gynecol Scand. 1996;75:654–6. [PubMed: 8822660]
400.
Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate? Hum Reprod. 2002;17:1424–30. [PubMed: 12042254]
401.
Hart R. A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception. Hum Reprod. 2001;16:2411–7. [PubMed: 11679530]
402.
Stovall DW, Parrish SB, Van Voorhis BJ, Hahn SJ, Sparks AET, Syrop CH. Uterine leiomyomas reduce the efficacy of assisted reproduction cycles: results of a matched follow-up study. Hum Reprod. 1998;13:192–7. [PubMed: 9512256]
403.
Frederick JL, Paulson RJ, Sauer MV. Routine use of vaginal ultrasonography in the preoperative evaluation of gynecologic patients. An adjunct to resident education. J Reprod Med. 1991;36:779–82. [PubMed: 1765955]
404.
Nezhat C, Santolaya J, Nezhat FR. Comparison of transvaginal sonography and bimanual pelvic examination in patients with laparoscopically confirmed endometriosis. J Am Assoc Gynecol Laparosc. 1994;1:127–30. [PubMed: 9050474]
405.
Reuss ML, Kolton S, Tharakan T. Transvaginal ultrasonography in gynecologic office practice: assessment in 663 premenopausal women. Am J Obstet Gynecol. 1996;175:1189–94. [PubMed: 8942486]
406.
Eimers JM, te Velde ER, Gerritse R, van Kooy RJ, Kremer J, Habbema JD. The validity of the postcoital test for estimating the probability of conceiving. Am J Obstet Gynecol. 1994;171:65–70. [PubMed: 8030736]
407.
Cohlen BJ, te Velde ER, Habbema JD. Postcoital testing. Postcoital test should be performed as routine infertility test. BMJ. 1999;318:1008–9. [PubMed: 10336278]
408.
Hull MG, Evers JL. Postcoital testing. Criterion for positive test was not given. BMJ. 1999;318:1007–9. [PMC free article: PMC1115385] [PubMed: 10195980]
409.
Hull MGR, Evers JLH, Hendry WF, Cohlen BJ, te Velde ER, Habbema JDF, et al. Postcoital testing. BMJ. 1999;318:1007–9.
410.
Balasch J. Investigation of the infertile couple in the era of assisted reproductive technology: a time for reappraisal. Hum Reprod. 2000;15:2251–7. [PubMed: 11056115]
411.
Oei SG, Helmerhorst FM, Keirse MJ. Routine postcoital testing is unnecessary. Hum Reprod. 2001;16:1051–3. [PubMed: 11331659]
412.
Glazener CM, Ford WC, Hull MG. The prognostic power of the post-coital test for natural conception depends on duration of infertility. Hum Reprod. 2000;15:1953–7. [PubMed: 10966993]
413.
Oei SG, Helmerhorst FM, Keirse MJ. When is the post-coital test normal? A critical appraisal. Hum Reprod. 1995;10:1711–4. [PubMed: 8582966]
414.
Oei SG, Helmerhorst FM, Bloemenkamp KW, Hollants FA, Meerpoel DE, Keirse MJ. Effectiveness of the postcoital test: randomised controlled trial. BMJ. 1998;317:502–5. [PMC free article: PMC28641] [PubMed: 9712594]
415.
Wolff H, Anderson DJ. Immunohistologic characterization and quantitation of leukocyte subpopulations in human semen. Fertil Steril. 1988;49:497–504. [PubMed: 3342902]
416.
Barratt CLR, Kessopoulou LA, Tomlinson MJ, Cooke ID. The functional significance of leucocytes in human reproduction. Reprod Med Rev. 1991;1:115–29.
417.
Conner P, Fried G. Hyperprolactinemia; etiology, diagnosis and treatment alternatives. Acta Obstet Gynecol Scand. 1998;77:249–62. [PubMed: 9539269]
418.
Cates W, Farley TM, Rowe PJ. Worldwide patterns of infertility: is Africa different? Lancet. 1985;1:596. [PubMed: 2863605]
419.
Collins JA, Burrows EA, Wilan AR. The prognosis for live birth among untreated infertile couples. Fertil Steril. 1995;64:22–8. [PubMed: 7789569]
420.
Snick HK, Snick TS, Evers JL, Collins JA. The spontaneous pregnancy prognosis in untreated subfertile couples: the Walcheren primary care study. Hum Reprod. 1997;12:1582–8. [PubMed: 9262301]
421.
Collins JA, Rowe TC. Age of the female partner is a prognostic factor in prolonged unexplained infertility: a multicenter study. Fertil Steril. 1989;52:15–20. [PubMed: 2526029]
422.
Collins JA, Crosignani PG. Unexplained infertility: a review of diagnosis, prognosis, treatment efficacy and management. Int J Gynaecol Obstet. 1992;39:267–75. [PubMed: 1361459]
423.
Eimers JM, te Velde ER, Gerritse R, Vogelzang ET, Looman CW, Habbema JD. The prediction of the chance to conceive in subfertile couples. Fertil Steril. 1994;61:44–52. [PubMed: 8293843]
424.
Wichmann L, Isola J, Tuohimaa P. Prognostic variables in predicting pregnancy. A prospective follow up study of 907 couples with an infertility problem. Hum Reprod. 1994;9:1102–8. [PubMed: 7962383]
425.
Lenton EA, Weston GA, Cooke ID. Long-term follow-up of the apparently normal couple with a complaint of infertility. Fertil Steril. 1977;28:913–9. [PubMed: 892041]
426.
Collins JA, Milner RA, Rowe TC. The effect of treatment on pregnancy among couples with unexplained infertility. Int J Fertil. 1991;36:140–1. 145–52. [PubMed: 1678368]
427.
MacLeod J, Pazianos A, Ray B. The restoration of human spermatogenesis and of the reproductive tract with urinary gonadotropins following hypophysectomy. Fertil Steril. 1966;17:7–23. [PubMed: 5901014]
428.
Mancini RE, Seiguer AC, Lloret AP. Effect of gonadotropins on the recovery of spermatogenesis in hypophysectomized patients. J Clin Endocrinol Metab. 1969;29:467–78. [PubMed: 5779244]
429.
Finkel DM, Phillips JL, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med. 1985;313:651–5. [PubMed: 3927163]
430.
Burris AS, Clark RV, Vantman DJ, Sherins RJ. A low sperm concentration does not preclude fertility in men with isolated hypogonadotropic hypogonadism after gonadotropin therapy. Fertil Steril. 1988;50:343–7. [PubMed: 3135208]
431.
Burgues S, Calderon MD. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism. Hum Reprod. 1997;12:980–6. [PubMed: 9194651]
432.
Liu L, Banks SM, Barnes KM, Sherins RJ. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1988;67:1140–5. [PubMed: 3142911]
433.
Schopohl J, Mehltretter G, von Zumbusch R, Eversmann T, von Werder K. Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic hypogonadism. Fertil Steril. 1991;56:1143–50. [PubMed: 1743335]
434.
Buchter D, Behre HM, Kliesch S, Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol. 1998;139:298–303. [PubMed: 9758439]
435.
Kamischke A. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod. 1998;13:596–603. [PubMed: 9572419]
436.
Matorras R, Perez C, Corcostegui B, Pijoan JI, Ramon O, Delgado P, et al. Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband’s spermatozoa: a randomized study. Hum Reprod. 1997;12:24–8. [PubMed: 9043896]
437.
Vandekerckhove P, Lilford R, Hughes E. The medical treatment of idiopathic oligo- and/or asthenospermia: anti-oestrogens (clomifene or tamoxifen) versus placebo or no treatment. Cochrane Database Syst Rev. 1996. [no longer available]
438.
Khan KS, Daya S, Jadad A. The importance of quality of primary studies in producing unbiased systematic reviews. Arch Intern Med. 1996;156:661–6. [PubMed: 8629879]
439.
Vandekerckhove P, Lilford R, Hughes E. The medical treatment of idiopathic oligo/asthenospermia: androgens (mesterolone or testosterone) versus placebo or no treatment. Androgens for oligospermia. Cochrane Database Syst Rev. 1996. [no longer available]. [PubMed: 10796496]
440.
Vandekerckhove P, Lilford R, Vail A, Hughes E. Kinin-enhancing drugs for unexplained subfertility in men. Cochrane Database Syst Rev. 2000;(2):CD000153. [PubMed: 10796695]
441.
Yamamoto M. The lack of effectiveness of kallikrein in the treatment of idiopathic oligozoospermia: a double-blind, randomized, placebo-controlled study. Japanese Journal of Fertility and Sterility. 1996;41:1–6.
442.
Vandekerckhove P, Lilford R, Hughes E. Bromocriptine for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev. 2000;(2):CD000152. [PubMed: 10796498]
443.
Kessopoulou E, Powers HJ, Sharma KK, Pearson MJ, Russell JM, Cooke ID, et al. A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril. 1995;64:825–31. [PubMed: 7672157]
444.
Suleiman SA, Ali ME, Zaki ZM, el Malik EM, Nasr MA. Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl. 1996;17:530–7. [PubMed: 8957697]
445.
Rolf C, Cooper TG, Yeung CH, Nieschlag E. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod. 1999;14:1028–33. [PubMed: 10221237]
446.
Lenzi A, Culasso F, Gandini L, Lombardo F, Dondero F. Placebo-controlled, double-blind, crossover trial of glutathione therapy in male infertility. Hum Reprod. 1993;8:1657–62. [PubMed: 8300824]
447.
Yamamoto M, Hibi H, Miyake K. Comparison of the effectiveness of placebo and alpha-blocker therapy for the treatment of idiopathic oligozoospermia. Fertil Steril. 1995;63:396–400. [PubMed: 7843449]
448.
Yamamoto M, Hibi H, Miyake K. New treatment of idiopathic severe oligozoospermia with mast cell blocker: results of a single-blind study. Fertil Steril. 1995;64:1221–3. [PubMed: 7589684]
449.
Haas GG Jr, Manganiello P. A double-blind, placebo-controlled study of the use of methylprednisolone in infertile men with sperm-associated immunoglobulins. Fertil Steril. 1987;47:295–301. [PubMed: 3545909]
450.
Bals-Pratsch M, Doren M, Karbowski B, Schneider HP, Nieschlag E. Cyclic corticosteroid immunosuppression is unsuccessful in the treatment of sperm antibody-related male infertility: a controlled study. Hum Reprod. 1992;7:99–104. [PubMed: 1551969]
451.
Lahteenmaki A, Rasanen M, Hovatta O. Low-dose prednisolone does not improve the outcome of in-vitro fertilization in male immunological infertility. Hum Reprod. 1995;10:3124–9. [PubMed: 8822427]
452.
Hendry WF, Hughes L. Comparison of prednisolone and placebo in subfertile men with antibodies to spermatozoa. Lancet. 1990;335:85–8. [PubMed: 1967425]
453.
Omu AE, al-Qattan N. Effect of low dose continuous corticosteroid therapy in men with antisperm antibodies on spermatozoal quality and conception rate. Eur J Obstet Gynecol Reprod Biol. 1996;69:129–34. [PubMed: 8902446]
454.
Katz M, Newill R. Steroid treatment for infertility associated with antisperm antibodies. Lancet. 1980;1:1306. [PubMed: 6104116]
455.
Shulman JF, Shulman S. Methylprednisolone treatment of immunologic infertility in male. Fertil Steril. 1982;38:591–9. [PubMed: 7128845]
456.
Hendry WF. Bilateral aseptic necrosis of femoral heads following intermittent high-dose steroid therapy. Fertil Steril. 1982;38:120. [PubMed: 7095162]
457.
Branigan EF, Muller CH. Efficacy of treatment and recurrence rate of leukocytospermia in infertile men with prostatitis. Fertil Steril. 1994;62:580–4. [PubMed: 7520396]
458.
Meirow D, Schenker JG. Appraisal of gamete intrafallopian transfer. Eur J Obstet Gynecol Reprod Biol. 1995;58:59–65. [PubMed: 7758647]
459.
Yanushpolsky EH, Politch JA, Hill JA, Anderson DJ. Antibiotic therapy and leukocytospermia: a prospective, randomized, controlled study. Fertil Steril. 1995;63:142–7. [PubMed: 7805903]
460.
Erel CT, Senturk LM, Demir F, Irez T, Ertungealp E. Antibiotic therapy in men with leukocytospermia. Int J Fertil Womens Med. 1997;42:206–10. [PubMed: 9222805]
461.
Comhaire FH, Rowe PJ, Farley TM. The effect of doxycycline in infertile couples with male accessory gland infection: a double blind prospective study. Int J Androl. 1986;9:91–8. [PubMed: 3539821]
462.
Vicari E. Effectiveness and limits of antimicrobial treatment on seminal leukocyte concentration and related reactive oxygen species production in patients with male accessory gland infection. Hum Reprod. 2000;15:2536–44. [PubMed: 11098023]
463.
Harrison RF, De Louvois J, Blades M, Hurley R. Doxycycline treatment and human infertility. Lancet. 1975;1:605–7. [PubMed: 47949]
464.
Micic S. Kallikrein and antibiotics in the treatment of infertile men with genital tract infections. Andrologia. 1988;20:55–9. [PubMed: 3369709]
465.
Hendry WF, Levison DA, Parkinson MC, Parslow JM, Royle MG. Testicular obstruction: clinicopathological studies. Ann R Coll Surg Engl. 1990;72:396–407. [PMC free article: PMC2499292] [PubMed: 2241062]
466.
Pryor JP, Hendry WF. Ejaculatory duct obstruction in subfertile males: analysis of 87 patients. Fertil Steril. 1991;56:725–30. [PubMed: 1915949]
467.
Turek PJ, Magana JO, Lipshultz LI. Semen parameters before and after transurethral surgery for ejaculatory duct obstruction. J Urol. 1996;155:1291–3. [PubMed: 8632556]
468.
Evers JL, Collins JA. Assessment of efficacy of varicocele repair for male subfertility. Lancet. 2003;361:1849–52. [PubMed: 12788571]
469.
Evers JL, Collins JA, Vandekerckhove P. Surgery or embolisation for varicocele in subfertile men. Cochrane Database Syst Rev. 2001;(1):CD000479. [PubMed: 11279693]
470.
Madgar I, Weissenberg R, Lunenfeld B, Karasik A, Goldwasser B. Controlled trial of high spermatic vein ligation for varicocele in infertile men. Fertil Steril. 1995;63:120–4. [PubMed: 7805900]
471.
Nieschlag E, Hertle L, Fischedick A, Abshagen K, Behre HM. Update on treatment of varicocele: counselling as effective as occlusion of the vena spermatica. Hum Reprod. 1998;13:2147–50. [PubMed: 9756286]
472.
Hargreave TB. Varicocele: overview and commentary on the results of the World Health Organisation [sic] varicocele trial. In: Waites GMH, Frick J, Baker GWH, editors. Current Advances in Andrology; Proceedings of the VIth International Congress of Andrology; 25–29 May 1997; Salzburg, Austria. Bologna: Monduzzi Editore; 1997. pp. 31–44.
473.
Glezerman M. Treatment of varicocele for male infertility. Acta Obstet Gynecol Scand. 1997;76(167):Suppl:2. Abstract no. SES3.1.
474.
Comhaire F. Clinical andrology: from evidence-base to ethics. The ‘E’ quintet in clinical andrology. Hum Reprod. 2000;15:2067–71. [PubMed: 11006174]
475.
Templeton A. Varicocele and infertility. Lancet. 2003;361:1838–9. [PubMed: 12788564]
476.
Unravelling the efficacy of varicocele repair. Lancet. 2003;361:1835.
477.
Ohl DA, Sonksen J. Electroejaculation versus vibratory stimulation in spinal cord injured men: sperm quality and patient preference. J Urol. 1997;157:2147–9. [PubMed: 9146603]
478.
Hovav Y, Almagor M, Yaffe H. Comparison of semen quality obtained by electroejaculation and spontaneous ejaculation in men suffering from ejaculation disorder. Hum Reprod. 2002;17:3170–2. [PubMed: 12456619]
479.
Schatte EC, Orejuela FJ, Lipshultz LI, Kim ED, Lamb DJ. Treatment of infertility due to anejaculation in the male with electroejaculation and intracytoplasmic sperm injection. J Urol. 2000;163:1717–20. [PubMed: 10799167]
480.
Nikolettos N, al Hasani S, Baukloh V, Schopper B, Demirel LC, Baban N, et al. The outcome of intracytoplasmic sperm injection in patients with retrograde ejaculation. Hum Reprod. 1999;14:2293–6. [PubMed: 10469698]
481.
Kiekens C, Spiessens C, Duyck F, Vandenweghe D, Coucke W, Vanderschueren D. Pregnancy after electroejaculation in combination with intracytoplasmic sperm injection in a patient with idiopathic anejaculation. Fertil Steril. 1996;66:834–6. [PubMed: 8893695]
482.
Hovav Y, Yaffe H, Zentner B, Dan-Goor M, Almagor M. The use of ICSI with fresh and cryopreserved electroejaculates from psychogenic anejaculatory men. Hum Reprod. 2002;17:390–2. [PubMed: 11821284]
483.
Watkins W, Bourne H, Nieto F, Gronow M, Baker G. Testicular aspiration of sperm for intracytoplasmic sperm injection: a novel treatment for ejaculatory failure on the day of oocyte retrieval. Fertil Steril. 1996;66:660–1. [PubMed: 8816635]
484.
Burls A, Gold L, Clark W. Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction. Br J Gen Pract. 2001;51:1004–12. [PMC free article: PMC1314170] [PubMed: 11766850]
485.
Hughes E, Collins J, Vandekerckhove P. Clomifene citrate for ovulation induction in women with oligo-amenorrhoea. Cochrane Database Syst Rev. 2000;(2):CD000056. [PubMed: 10796477]
486.
Boostanfar R. A prospective randomized trial comparing clomifene citrate with tamoxifen citrate for ovulation induction. Fertil Steril. 2001;75:1024–6. [PubMed: 11334921]
487.
Gerhard I, Runnebaum B. Comparison between tamoxifen and clomifene therapy in women with anovulation. Arch Gynecol. 1979;227:279–88. [PubMed: 518130]
488.
Buvat J, Buvat-Herbaut M, Marcolin G, Ardaens-Boulier K. Antiestrogens as treatment of female and male infertilities. Horm Res. 1987;28:219–29. [PubMed: 3331375]
489.
Messinis IE, Nillius SJ. Comparison between tamoxifen and clomifene for induction of ovulation. Acta Obstet Gynecol Scand. 1982;61:377–9. [PubMed: 7148414]
490.
Suginami H. A clomifene citrate and tamoxifen citrate combination therapy: a novel therapy for ovulation induction. Fertil Steril. 1993;59:976–9. [PubMed: 8486198]
491.
Taymor ML. The use and misuse of ovulation-inducing drugs. Infertil Reprod Med Clin North Am. 1990;1:165–86.
492.
The ESHRE Capri Workshop. European Society for Human Reproduction and Embryology. Female infertility: treatment options for complicated cases. Hum Reprod. 1997;12:1191–6. [PubMed: 9222000]
493.
Gysler M, March CM, Mishell DR Jr, Bailey EJ. A decade’s experience with an individualized clomifene treatment regimen including its effect on the postcoital test. Fertil Steril. 1982;37:161–7. [PubMed: 7060766]
494.
Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE. Metformin increases the ovulatory rate and pregnancy rate from clomifene citrate in patients with polycystic ovary syndrome who are resistant to clomifene citrate alone. Fertil Steril. 2001;75:310–5. [PubMed: 11172832]
495.
Kousta E, White DM, Franks S. Modern use of clomifene citrate in induction of ovulation. Hum Reprod Update. 1997;3:359–65. [PubMed: 9459281]
496.
Milsom SR, Gibson G, Buckingham K, Gunn AJ. Factors associated with pregnancy or miscarriage after clomifene therapy in WHO Group II anovulatory women. Aust N Z J Obstet Gynaecol. 2002;42:170–5. [PubMed: 12069145]
497.
Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod. 1995;10:2705–12. [PubMed: 8567797]
498.
Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod. 1998;13:1502–5. [PubMed: 9688382]
499.
Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 1992;36:105–11. [PubMed: 1559293]
500.
Huber-Buchholz MM, Carey DG, Norman RJ. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab. 1999;84:1470–4. [PubMed: 10199797]
501.
Hammond MG, Halme JK, Talbert LM. Factors affecting the pregnancy rate in clomifene citrate induction of ovulation. Obstet Gynecol. 1983;62:196–202. [PubMed: 6866363]
502.
Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med. 1994;331:771–6. [PubMed: 8065405]
503.
Hughes E, Collins J, Vandekerckhove P. Clomifene citrate for unexplained subfertility in women. Cochrane Database Syst Rev. 2000;(2):CD000057. Update in: Cochrane Database Syst Rev 2000;(3):CD000057. [PubMed: 10796478]
504.
Fujii S, Fukui A, Fukushi Y, Kagiya A, Sato S, Saito Y. The effects of clomifene citrate on normally ovulatory women. Fertil Steril. 1997;68:997–9. [PubMed: 9418686]
505.
Lord JM, Flight IH, Norman RJ. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev. 2003;(3):CD003053. [PubMed: 12917943]
506.
Costello MF, Eden JA. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril. 2003;79:1–13. [PubMed: 12524053]
507.
Harborne L, Fleming R, Lyall H, Norman J, Sattar N. Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet. 2003;361:1894–901. [PubMed: 12788588]
508.
Farquhar C, Vandekerckhove P, Arnot M, Lilford R. Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev. 2000;(2):CD001122. Update in: Cochrane Database Syst Rev 2001;(4):CD001122. [PubMed: 10796746]
509.
El Saeed M, Ezzat R, Hasan M, Elhelw B, Aboulmaaty Z, Aboulghar M. High incidence of pelvic adhesions detected by second-look laparoscopy after laparoscopic ovarian drilling. Middle East Fertility Society Journal. 2000;5:519–25.
510.
Amer SAK, Li TC, Cooke ID. Laparoscopic ovarian diathermy in women with polycystic ovarian syndrome: a retrospective study on the influence of the amount of energy used on the outcome. Hum Reprod. 2002;17:1046–51. [PubMed: 11925403]
511.
Muenstermann U. Long-term GnRH analogue treatment is equivalent to laparoscopic laser diathermy in polycystic ovarian syndrome patients with severe ovarian dysfunction. Hum Reprod. 2000;15:2526–30. [PubMed: 11098021]
512.
Shoham Z, Balen A, Patel A, Jacobs HS. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril. 1991;56:1048–53. [PubMed: 1743320]
513.
Nugent D, Vandekerckhove P, Hughes E, Arnot M, Lilford R. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev. 2000;(4):CD000410. [PubMed: 11034687]
514.
Bayram N, van Wely M, van Der Veen F. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev. 2001;(2):CD002121. [PubMed: 11406034]
515.
Daya S, Gunby J, Hughes EG, Collins JA, Sagle MA. Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis. Fertil Steril. 1995;64:347–54. [PubMed: 7615113]
516.
Agrawal R, Holmes J, Jacobs HS. Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis. Fertil Steril. 2000;73:338–43. [PubMed: 10685540]
517.
Daya S, Gunby J. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles. Cochrane Database Syst Rev. 2000;(4):CD002810. [PubMed: 11034767]
518.
Al-Inany H, Aboulghar M, Mansour R, Serour G. Meta-analysis of recombinant versus urinary-derived FSH: an update. Hum Reprod. 2003;18:305–13. [PubMed: 12571166]
519.
Larizgoitia L, Estrada MD, Garcia-Altes A. Some Data on the Efficacy and Efficiency of Recombinant-FSH Related to FSH of Urinary Origin. Barcelona: Catalan Agency for Health Technology Assessment and Research; 2000. Recombinant-FSH as Ddjuvant in Assisted Reproduction. BR02/2000.
520.
Van Wely M, Westergaard LG, Bossuyt PM, Van der Veen F. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. Cochrane Database Syst Rev. 2003;(1):CD003973. [PubMed: 12535497]
521.
Al Inany H, Aboulghar M, Mansour R, Serour G. Meta-analysis of recombinant versus urinary-derived FSH: an update. Hum Reprod. 2003;18:1. [PubMed: 12571166]
522.
Ferraretti AP, Gianaroli L, Magli MC, Feliciani E, Gergolet M, Fortini D. Does recombinant FSH increase embryo viability in poor responder patients? 15th Annual Meeting of the ESHRE, 1999, Tours, France. Abstract no. P-256. Hum Reprod. 1999;14(Abstract Book 1):279.
523.
Jansen CA, van Os HC, Out HJ, Coelingh Bennink HJ. A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients. Hum Reprod. 1998;13:2995–9. [PubMed: 9853844]
524.
Strehler E, Abt M, El Danasouri I, De Santo M, Sterzik K. Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome. Fertil Steril. 2001;75:332–6. [PubMed: 11172835]
525.
Serhal P, Phophong P, Ranieri DM. Comparison between HMG and recombinant-FSH for ovarian stimulation in patients undergoing IVF. Hum Reprod. 2000;15:143.
526.
Manassiev NA, Davies WAR, Leonard T, Pavlovich B, Philips A, Tenekedjiev K. Initial results from the comparison of recombinant FSH and urinary FSH in an IVF programme; 13th Annual Meeting of the ESHRE; Hum Reprod; 22–25 June 1997; Edinburgh, Scotland. 1997. pp. 526–6. Abstract no. P-256.
527.
O’Dea L. A randomised comparative multicentre clinical trial of recombinant and urinary human FSH in in vitro fertilisation and embryo transfer (IV-FET). Abstract no. O-106. Fertil Steril. 1993;60(Suppl):S50–1.
528.
Machado MG, Borges de Souza MC, Oliveira JBA, Henriques CA, Mancebo ACA. Highly purified gonadatropin and recombinant gonadotropin: study in IVF cycles. Gynecol Endocrinol. 1999;13(Suppl 13):Abstract no. FC-51.
529.
Nardo LG, Bellanca SA, Messina K, Nardo F. Efficacy of recombinant follicle stimulating hormone versus urinary follicle stimulating hormone in in-vitro fertilization: a prospective, randomized, assessor-blind study. Italian Journal of Gynaecology and Obstetrics. 2000;12:44–53.
530.
Kilani Z, Dakkak A, Ghunaim S, Cognigni GE, Tabarelli C, Parmegiani L, et al. A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes. Hum Reprod. 2003;18:1194–9. [PubMed: 12773445]
531.
Alvino H, Norman RJ, Matthews CD. Recombinant human follicle stimulating hormone (Gonal-F, Serono) compared to urinary follicle stimulating hormone (Metrodin) in IVF cycles: a randomised control study; Abstracts of Fertility Society of Australia/Australian Gynaecological Endoscopy Society Annual Meeting; 12–25 November, 1995; FSA; p. 46.
532.
Berger E, Chabloz P, De Quay N, Sann A, Walton S, Germond M, Birkhauser M. An open, randomized, group-comparative bicentre study comparing recombinant FSH Follitropinum 150 IU and highly purified urinary FSH 225 IU as a fixed dose regimen in IVF/ICSI treatment; 15th Annual Meeting of the ESHRE; Hum Reprod; 1999; Tours, France. 1999. pp. 61–2. Abstract no. O-112.
533.
Bergh C, Howles CM, Borg K, Hamberger L, Josefsson B, Nilsson L, et al. Recombinant human follicle stimulating hormone (rhFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod. 1997;12:2133–9. [PubMed: 9402268]
534.
Dickey RP, Thornton M, Nichols J, Marshall DC, Fein SH, Nardi RV. Comparison of the efficacy and safety of a highly purified human follicle-stimulating hormone (Bravelle) and recombinant follitropin-beta for in vitro fertilization: a prospective, randomized study. Fertil Steril. 2002;77:1202–8. [PubMed: 12057729]
535.
The European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone. Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial. Fertil Steril. 2002;78:520–8. [PubMed: 12215327]
536.
Franco JG Jr, Baruffi RL, Coelho J, Mauri AL, Petersen CG, Garbellini E. A prospective and randomized study of ovarian stimulation for ICSI with recombinant FSH versus highly purified urinary FSH. Gynecol Endocrinol. 2000;14:5–10. [PubMed: 10813100]
537.
Frydman R, Howles CM, Truong F. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists. Hum Reprod. 2000;15:520–5. [PubMed: 10686190]
538.
Germond M, De Palma R, Senn A, Inaudi P, Dessole S, De Grandi P. Recombinant versus highly purified urinary FSH to induce ovulation induction and pregnancies in women over 35 years of age in an IVF/ICSI programme; Abstracts of the 16th Annual Meeting of the ESHRE; Hum Reprod; 2000; Bologna, Italy. 2000. pp. 46–7. Absatract no. O-118.
539.
Ghosh S, Chattopadhyay R, Goswami S, Chakravarty BN. Recombinant FSH versus highly purified urinary FSH – our experience; Abstracts of, 11th World Congress of In Vitro Fertilization and Human Reproductive Genetics; Sydney, Australia. 9–14 May, 1999; p. 264.
540.
Gordon UD, Harrison RF, Fawzy M, Hennelly B, Gordon AC. A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome. Fertil Steril. 2001;75:324–31. [PubMed: 11172834]
541.
Hedon B, Out HJ, Hugues JN, Camier B, Cohen J, Lopes P, et al. Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a prospective, randomized, assessor-blind, multicentre trial. Hum Reprod. 1995;10:3102–6. [PubMed: 8822422]
542.
Hoomans EH, Andersen AN, Loft A, Leerentveld RA, van Kamp AA, Zech H. A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon® and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP®) in a fixed-dose regimen in women undergoing ovarian stimulation. Hum Reprod. 1999;14:2442–7. [PubMed: 10527965]
543.
Kornilov NV, Shlykova SA, Loginova JA, Tomas C, Ashorn RG. Comparison of four different gonadotropins for ovarian stimulation in IVF treatment; Abstracts of, 11th World Congress of In Vitro Fertilization and Human Reproductive Genetics; Sydney, Australia. 9–14 May, 1999; pp. 379–83.
544.
Ng EH, Lau EY, Yeung WS, Ho PC. HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial. Hum Reprod. 2001;16:319–25. [PubMed: 11157827]
545.
Lenton E, Soltan A, Hewitt J, Thomson A, Davies W, Ashraf N, et al. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP). Hum Reprod. 2000;15:1021–7. [PubMed: 10783345]
546.
Out HJ, Mannaerts BM, Driessen SG, Bennink HJ. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum Reprod. 1995;10:2534–40. [PubMed: 8567765]
547.
Loumaye E, Beltrami V, Galazka A, Hansson C, Howles C, Dupont F, et al. Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Fertil Steril. 1995;63:77–86. [PubMed: 7805928]
548.
Schats R, De Sutter P, Bassil S, Kremer JAM, Tournaye H, Donnez J. Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH. Hum Reprod. 2000;15:1691–7. [PubMed: 10920087]
549.
Westergaard HB, Erb K. Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study. Fertil Steril. 2001;76:543–9. [PubMed: 11532479]
550.
Platteau P, Laurent E, Albano C, Osmanagaoglu K, Vernaeve V, Tournaye H, et al. An open, randomized single-centre study to compare the efficacy and convenience of follitropin administered by a pen device with follitropin administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI. Hum Reprod. 2003;18:1204. [PubMed: 12773446]
551.
Daya S, Gunby J. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction. Hum Reprod. 1999;14:2207–15. [PubMed: 10469682]
552.
Daya S, Ledger W, Auray JP, Duru G, Silverberg K, Wikland M, et al. Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK. Hum Reprod. 2001;16:2563–9. [PubMed: 11726575]
553.
Sykes D, Out HJ, Palmer SJ, van Loon J. The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments. Hum Reprod. 2001;16:2557–62. [PubMed: 11726574]
554.
Lloyd A, Kennedy R, Hutchinson J, Sawyer W. Economic evaluation of highly purified menotropin compared with recombinant follicle stimulating hormone in assisted reproduction. Fertil Steril. 2003;80:1108–13. [PubMed: 14607557]
555.
Hughes E, Collins J, Vandekerckhove P. Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomifene-resistant polycystic ovarian syndrome. Cochrane Database Syst Rev. 2000;(2):CD000097. [PubMed: 10796488]
556.
Vegetti W. Ovarian stimulation with low-dose pure follicle-stimulating hormone in polycystic ovarian syndrome anovulatory patients: effect of long-term pretreatment with gonadotrophin-releasing hormone analogue. Gynecol Obstet Invest. 1998;45:186–9. [PubMed: 9565144]
557.
Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van de KP, Collins JA. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril. 1992;58:888–96. [PubMed: 1426372]
558.
Daya S. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. Cochrane Database Syst Rev. 2000;(2):CD001299. [PubMed: 10796763]
559.
Albuquerque LE, Saconato H, Maciel MC. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles. Cochrane Database Syst Rev. 2002;(3):CD002808. [PubMed: 12137658]
560.
Wong JM, Forrest KA, Snabes MC, Zhao SZ, Gersh GE, Kennedy SH. Efficacy of nafarelin in assisted reproductive technology: a meta-analysis. Hum Reprod Update. 2001;7:92–101. [PubMed: 11212082]
561.
Al-Inany H, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev. 2001;(4):CD001750. [PubMed: 11687120]
562.
Ludwig M, Katalinic A, Diedrich K. Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis. Arch Gynecol Obstet. 2001;265:175–82. [PubMed: 11789740]
563.
Roulier R, Chabert-Orsini V, Sitri MC, Barry B. Utilisation des antagonistes de la LHRH (cetrotide 3mg) en pratique courante dans une population non selectionee: etude prospective, randomisee, comparative versus agonistes retard de la GnRH. 2001.
564.
Hohmann FP, Macklon NS, Fauser BCJM. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab. 2003;88:166–73. [PubMed: 12519847]
565.
Fiedler K, Krusmann G, von Hertwig I, Schleyer M, Wurfel W. Comparison of Clomid/FSH/HMG stimulation for IVF with and without GnRH antagonists; Abstracts of the 17th Annual Meeting of the ESHRE; Hum Reprod; 2001; Lausanne, Switzerland. 2001. pp. 72–3. Abstract no. O-177.
566.
Check JH, Choe JK, Nazari A, Davies E, Kiefer D. A prospective study to evaluate whether gonadotrophin releasing hormone (GnRH) antagonists have an adverse effect on embryo implantation. Abstract no. P-188. Fertil Steril. 2002;78(Suppl 3):S178.
567.
Abae M. Prospective randomized trial of two mild ovarian stimulation protocols with recombinant FSH in combination with ganerelix acetate or low dose leuprolide acetates. Preliminary results. Hum Reprod. 2002;17:S117.
568.
Norbryhn GA, Feinman M, Kolb B, Nelson J, Wilcox J, Batzofin J. Nursing perspective of a comparative randomized study of Lupron/Follistim versus Follistim/Antagon in IVF. Abstract no. P-141. Fertil Steril. 2002;78(Suppl 3):S163.
569.
Homburg R. Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial. Hum Reprod. 1995;10:2550–3. [PubMed: 8567768]
570.
Jacobs HS. Growth hormone and ovulation: is there an indication for treatment of infertile women with growth hormone? Horm Res. 1992;38:14–21. [PubMed: 1295808]
571.
Balen AH, Braat DD, West C, Patel A, Jacobs HS. Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients. Hum Reprod. 1994;9:1563–70. [PubMed: 7989523]
572.
Braat DD, Schoemaker R, Schoemaker J. Life table analysis of fecundity in intravenously gonadotropin- releasing hormone-treated patients with normogonadotropic and hypogonadotropic amenorrhea. Fertil Steril. 1991;55:266–71. [PubMed: 1991525]
573.
Filicori M, Flamigni C, Dellai P, Cognigni G, Michelacci L, Arnone R, et al. Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles. J Clin Endocrinol Metab. 1994;79:1215–20. [PubMed: 7962297]
574.
Bayram N, van Wely M, Vandekerckhove P, Lilford R, van Der Veen F. Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev. 2000;(2):CD000412. [PubMed: 10796718]
575.
Martin KA, Hall JE, Adams JM, Crowley WF Jr. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab. 1993;77:125–9. [PubMed: 8325934]
576.
Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med. 1994;331:904–9. [PubMed: 7915824]
577.
Pascal-Vigneron V, Weryha G, Bosc M, Leclere J. [Hyperprolactinemic amenorrhea:treatment with cabergoline versus bromocriptine. Results of a national multicenter randomized double-blind study]. Presse Med. 1995;24:753–7. [French] [PubMed: 7784413]
578.
Hughes E, Collins J, Vandekerckhove P. Bromocriptine for unexplained subfertility in women. Cochrane Database Syst Rev. 2000;(2):CD000044. [PubMed: 10796473]
579.
Hardiman P, Thomas M, Osgood V, Vlassopoulou V, Ginsburg J. Are estrogen assays essential for monitoring gonadotropin stimulant therapy? Gynecol Endocrinol. 1990;4:261–9. [PubMed: 2127985]
580.
Shoham Z, Di Carlo C, Patel A, Conway GS, Jacobs HS. Is it possible to run a successful ovulation induction program based solely on ultrasound monitoring? The importance of endometrial measurements. Fertil Steril. 1991;56:836–41. [PubMed: 1936315]
581.
Haning RV Jr, Austin CW, Kuzma DL, Shapiro SS, Zweibel WJ. Ultrasound evaluation of estrogen monitoring for induction of ovulation with menotropins. Fertil Steril. 1982;37:627–32. [PubMed: 6804275]
582.
Blankstein J, Shalev J, Saadon T, Kukia EE, Rabinovici J, Pariente C, et al. Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles. Fertil Steril. 1987;47:597–602. [PubMed: 3106098]
583.
Confino E, Binor Z, Molo MW, Rawlins R, Balos R, Mullaney K, et al. Sonographically monitored ovarian stimulation for assisted reproduction: a prospective, blind study. J Reprod Med. 1996;41:7–10. [PubMed: 8855069]
584.
Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril. 1978;30:255–68. [PubMed: 361440]
585.
Navot D, Relou A, Birkenfeld A, Rabinowitz R, Brzezinski A, Margalioth EJ. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol. 1988;159:210–5. [PubMed: 3134814]
586.
Smitz J, Camus M, Devroey P, Erard P, Wisanto A, Van Steirteghem AC. Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. Hum Reprod. 1990;5:933–7. [PubMed: 2150522]
587.
Asch RH, Li HP, Balmaceda JP, Weckstein LN, Stone SC. Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. Hum Reprod. 1991;6:1395–9. [PubMed: 1770133]
588.
Roest J, van Heusden AM, Mous H, Zeilmaker GH, Verhoeff A. The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years. Fertil Steril. 1996;66:969–73. [PubMed: 8941063]
589.
Nygren KG, Andersen AN. Assisted reproductive technology in Europe, 1999. Results generated from European registers by ESHRE. Hum Reprod. 2002;17:3260–74. [PubMed: 12456634]
590.
Evans MI, Kramer RL, Yaron Y, Drugan A, Johnson MP. What are the ethical and technical problems associated with multifetal pregnancy reduction? Clin Obstet Gynecol. 1998;41:46–54. [PubMed: 9504223]
591.
Evans MI, Wapner R, Carpenter R, Goldberg J, Timor-Tritsch IE, Ayoub MA, et al. International collaboration on multifetal pregnancy reduction (MFPR): dramatically improved outcomes with increased experience. Am J Obstet Gynecol. 1999;180(1 Suppl 2):S28.
592.
Petterson B, Nelson KB, Watson L, Stanley F. Twins, triplets, and cerebral palsy in births in Western Australia in the 1980s. BMJ. 1993;307:1239–43. [PMC free article: PMC1679356] [PubMed: 8281055]
593.
Callahan TL, Hall JE, Ettner SL, Christiansen CL, Greene MF, Crowley WF Jr. The economic impact of multiple-gestation pregnancies and the contribution of assisted-reproduction techniques to their incidence. N Engl J Med. 1994;331:244–9. [PubMed: 8015572]
594.
Mugford M, Henderson J. Resource implications of multiple births. In: Ward HR, Whittle M, editors. Multiple Pregnancy. London: RCOG Press; 1995. pp. 334–45.
595.
Garel M, Salobir C, Blondel B. Psychological consequences of having triplets: a 4-year follow-up study. Fertil Steril. 1997;67:1162–5. [PubMed: 9176462]
596.
Olivennes F, Kadhel P, Rufat P, Fanchin R, Fernandez H, Frydman R. Perinatal outcome of twin pregnancies obtained after in vitro fertilization: comparison with twin pregnancies obtained spontaneously or after ovarian stimulation. Fertil Steril. 1996;66:105–9. [PubMed: 8752619]
597.
Agustsson T, Geirsson RT, Mires G. Obstetric outcome of natural and assisted conception twin pregnancies is similar. Acta Obstet Gynecol Scand. 1997;76:45–9. [PubMed: 9033243]
598.
Hartshorne GM, Lilford RJ. Different perspectives of patients and health care professionals on the potential benefits and risks of blastocyst culture and multiple embryo transfer. Hum Reprod. 2002;17:1023–30. [PubMed: 11925400]
599.
Ryan GL, Zhang S, Dokras A, Van Voorhis BJ. The desire of infertility patients for multiple gestations – do they know the risks? Fertil Steril. 2002;78(Suppl 1):S67.
600.
Hamilton M, Brown C, Ledger W. Infertility treatment in the United Kingdom in 2002: a survey of patients’ views. [Unpublished].
601.
Goldfarb J, Kinzer DJ, Boyle M, Kurit D. Attitudes of in vitro fertilization and intrauterine insemination couples toward multiple gestation pregnancy and multifetal pregnancy reduction. Fertil Steril. 1996;65:815–20. [PubMed: 8654645]
602.
Gleicher N, Campbell DP, Chan CL, Karande V, Rao R, Balin M, et al. The desire for multiple births in couples with infertility problems contradicts present practice patterns. Hum Reprod. 1995;10:1079–84. [PubMed: 7657745]
603.
The ESHRE Task Force on Ethics and Law. Ethical issues related to multiple pregnancies in medically assisted procreation. Hum Reprod. 2003;18:1976–9. [PubMed: 12923160]
604.
Venn A, Lumley J. Clomifene citrate and pregnancy outcome. Aust N Z J Obstet Gynaecol. 1994;34:56–66. [PubMed: 8053878]
605.
Dunn A, Macfarlane A. Recent trends in the incidence of multiple births and associated mortality in England and Wales. Arch Dis Child Fetal Neonatal Ed. 1996;75:F10–9. [PMC free article: PMC1061144] [PubMed: 8795350]
606.
MMWR. Morbidity and mortality weekly report: entry into prenatal care – United States, 1989–1997. JAMA. 2000;283:2924–5. [PubMed: 10896525]
607.
Wang CF, Gemzell C. The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease. Fertil Steril. 1980;33:479–86. [PubMed: 6768596]
608.
Levene MI, Wild J, Steer P. Higher multiple births and the modern management of infertility in Britain. The British Association of Perinatal Medicine. Br J Obstet Gynaecol. 1992;99:607–13. [PubMed: 1525105]
609.
Quinn MJ, Babb P. Cancer trends in England and Wales. 1950–1999. Health Stat Q. 2000;8:5–19.
610.
Artini PG, Fasciani A, Cela V, Battaglia C, de Micheroux AA, D’Ambrogio G, et al. Fertility drugs and ovarian cancer. Gynecol Endocrinol. 1997;11:59–68. [PubMed: 9086341]
611.
Nugent D, Salha O, Balen AH, Rutherford AJ. Ovarian neoplasia and subfertility treatments. Br J Obstet Gynaecol. 1998;105:584–91. [PubMed: 9647147]
612.
Glud E, Kjaer SK, Troisi R, Brinton LA. Fertility drugs and ovarian cancer. Epidemiol Rev. 1998;20:237–57. [PubMed: 9919441]
613.
Duckitt K, Templeton AA. Cancer in women with infertility. Curr Opin Obstet Gynecol. 1998;10:199–203. [PubMed: 9619342]
614.
Klip H, Burger CW, Kenemans P, van Leeuwen FE. Cancer risk associated with subfertility and ovulation induction: a review. Cancer Causes Control. 2000;11:319–44. [PubMed: 10843444]
615.
Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case–control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol. 1992;136:1184–203. [PubMed: 1476141]
616.
Casagrande JT, Louie EW, Pike MC, Roy S, Ross RK, Henderson BE. “Incessant ovulation” and ovarian cancer” Lancet. 1979;2:170–3. [PubMed: 89281]
617.
Nasca PC, Greenwald P, Chorost S, Richart R, Caputo T. An epidemiologic case–control study of ovarian cancer and reproductive factors. Am J Epidemiol. 1984;119:705–13. [PubMed: 6539067]
618.
Hildreth NG, Kelsey JL, LiVolsi VA, Fischer DB, Holford TR, Mostow ED, et al. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol. 1981;114:398–405. [PubMed: 7304575]
619.
Joly DJ, Lilienfeld AM, Diamond EL, Bross ID. An epidemiologic study of the relationship of reproductive experience to cancer of the ovary. Am J Epidemiol. 1974;99:190–209. [PubMed: 4814690]
620.
McGowan L, Parent L, Lednar W, Norris HJ. The woman at risk for developing ovarian cancer. Gynecol Oncol. 1979;7:325–44. [PubMed: 447120]
621.
Doyle P, Maconochie N, Beral V, Swerdlow AJ, Tan SL. Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod. 2002;17:2209–13. [PubMed: 12151460]
622.
Rosen B, Irvine J, Ritvo P, Shapiro H, Stewart D, Reynolds K, et al. The feasibility of assessing women’s perceptions of the risks and benefits of fertility drug therapy in relation to ovarian cancer risk. Fertil Steril. 1997;68:90–4. [PubMed: 9207590]
623.
Houmard BS, Seifer DB. Infertility treatment and informed consent: current practices of reproductive endocrinologists. Obstet Gynecol. 1999;93:252–7. [PubMed: 9932565]
624.
Shushan A, Laufer N. Fertility drugs and ovarian cancer: what are the practical implications of the ongoing debate? Fertil Steril. 2000;74:8–9. [PubMed: 10899489]
625.
Shaked GM, Shaked Y, Kariv-Inbal Z, Halimi M, Avraham I, Gabizon R. A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases. J Biol Chem. 2001;276:31479–82. [PubMed: 11423531]
626.
Marana R, Muzii L, Paielli FV, Lucci FM, Dell’Acquia S, Mancuso S. Proximal tubal obstruction: are we overdiagnosing and overtreating? Gynaecol Endosc. 1992;1:101.
627.
Gillett WR, Clarke RH, Herbison GP. First and subsequent pregnancies after tubal microsurgery: evaluation of the fertility index. Fertil Steril. 1997;68:1033–42. [PubMed: 9418693]
628.
Patton PE, Williams TJ, Coulam CB. Microsurgical reconstruction of the proximal oviduct. Fertil Steril. 1987;47:35–9. [PubMed: 3792574]
629.
Marana R, Quagliarello J. Proximal tubal occlusion: microsurgery versus IVF – a review. Int J Fertil. 1988;33:338–40. [PubMed: 2904421]
630.
Wu CH, Gocial B. A pelvic scoring system for infertility surgery. Int J Fertil. 1988;33:341–6. [PubMed: 2904422]
631.
Winston RM, Margara RA. Microsurgical salpingostomy is not an obsolete procedure. Br J Obstet Gynaecol. 1991;98:637–42. [PubMed: 1832011]
632.
Filippini F, Darai E, Benifla JL, Renolleau C, Sebban E, Vlastos G, et al. [Distal tubal surgery: a critical review of 104 laparoscopic distal tuboplasty]. J Gynecol Obstet Biol Reprod (Paris). 1996;25:471–8. [French] [PubMed: 8926348]
633.
Donnez J, Casanas-Roux F. Prognostic factors of fimbrial microsurgery. Fertil Steril. 1986;46:200–4. [PubMed: 3732526]
634.
Tomazevic T, Ribic-Pucelj M. Microsurgery and in vitro fertilization/embryo transfer for infertility resulting from distal tubal lesions. J Reprod Med. 1991;36:527–30. [PubMed: 1941789]
635.
Oelsner G, Sivan E, Goldenberg M, Carp H, Admon D, Mashiach S. Should lysis of adhesions be performed when in-vitro fertilization and embryo transfer are available? Hum Reprod. 1994;9:2339–41. [PubMed: 7714154]
636.
Marana R, Quagliarello J. Distal tubal occlusion: microsurgery versus in vitro fertilization – a review. Int J Fertil. 1988;33:107–15. [PubMed: 2898447]
637.
Singhal V, Li TC, Cooke ID. An analysis of factors influencing the outcome of 232 consecutive tubal microsurgery cases. Br J Obstet Gynaecol. 1991;98:628–36. [PubMed: 1883785]
638.
Watson A, Vandekerckhove P, Lilford R. Techniques for pelvic surgery in subfertility. Cochrane Database Syst Rev. 2000;(2):CD000221. [PubMed: 10796702]
639.
Johnson NP, Watson A. Postoperative procedures for improving fertility following pelvic reproductive surgery. Cochrane Database Syst Rev. 2000;(2):CD001897. [PubMed: 10796835]
640.
Winston RML. Tubal surgery or in vitro fertilization (IVF)? J Assist Reprod Genet. 1992;9:309–11. [PubMed: 1472805]
641.
Gomel V, Taylor PJ. In vitro fertilization versus reconstructive tubal surgery. J Assist Reprod Genet. 1992;9:306–9. [PubMed: 1472804]
642.
Barri PN. Cost-benefit analysis between IVF and tubal surgery. References en Gynecologie Obstetrique. 1995;3:231–3.
643.
Posaci C, Camus M, Osmanagaoglu K, Devroey P. Tubal surgery in the era of assisted reproductive technology: clinical options. Hum Reprod. 1999;14(Suppl 1):120–36. [PubMed: 10573029]
644.
Larsson B. Late results of salpingostomy combined with salpingolysis and ovariolysis by electromicrosurgery in 54 women. Fertil Steril. 1982;37:156–60. [PubMed: 7060765]
645.
Canis M, Mage G, Pouly JL, Manhes H, Wattiez A, Bruhat MA. Laparoscopic distal tuboplasty: report of 87 cases and a 4-year experience. Fertil Steril. 1991;56:616–21. [PubMed: 1833244]
646.
Marana R, Rizzi M, Muzii L, Catalano GF, Caruana P, Mancuso S. Correlation between the American Fertility Society classifications of adnexal adhesions and distal tubal occlusion, salpingoscopy, and reproductive outcome in tubal surgery. Fertil Steril. 1995;64:924–9. [PubMed: 7589635]
647.
Woolcott R, Fisher S, Thomas J, Kable W. A randomized, prospective, controlled study of laparoscopic dye studies and selective salpingography as diagnostic tests of fallopian tube patency. Fertil Steril. 1999;72:879–84. [PubMed: 10560993]
648.
Honore GM, Holden AE, Schenken RS. Pathophysiology and management of proximal tubal blockage. Fertil Steril. 1999;71:785–95. [PubMed: 10231034]
649.
Thurmond AS. Pregnancies after selective salpingography and tubal recanalization. Radiology. 1994;190:11–3. [PubMed: 8259385]
650.
Flood JT, Grow DR. Transcervical tubal cannulation: a review. Obstet Gynecol Surv. 1993;48:768–76. [PubMed: 8278140]
651.
Buttram VC Jr, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36:433–45. [PubMed: 7026295]
652.
Verkauf BS. Myomectomy for fertility enhancement and preservation. Fertil Steril. 1992;58:1–15. [PubMed: 1623990]
653.
Pritts EA. Fibroids and infertility: a systematic review of the evidence. Obstet Gynecol Surv. 2001;56:483–91. [PubMed: 11496160]
654.
Bulletti C, de Ziegler D, Polli V, Flamigni C. The role of leiomyomas in infertility. J Am Assoc Gynecol Laparosc. 1999;6:441–5. [PubMed: 10548702]
655.
Seracchioli R, Rossi S, Govoni F, Rossi E, Venturoli S, Bulletti C, et al. Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod. 2000;15:2663–8. [PubMed: 11098042]
656.
Ashton D, Amin HK, Richart RM, Neuwirth RS. The incidence of asymptomatic uterine anomalies in women undergoing transcervical tubal sterilization. Obstet Gynecol. 1988;72:28–30. [PubMed: 3380507]
657.
Simon C, Martinez L, Pardo F, Tortajada M, Pellicer A. Mullerian defects in women with normal reproductive outcome. Fertil Steril. 1991;56:1192–3. [PubMed: 1743344]
658.
Heinonen PK, Saarikoski S, Pystynen P. Reproductive performance of women with uterine anomalies. An evaluation of 182 cases. Acta Obstet Gynecol Scand. 1982;61:157–62. [PubMed: 7113692]
659.
Acien P. Reproductive performance of women with uterine malformations. Hum Reprod. 1993;8:122–6. [PubMed: 8458914]
660.
Raga F, Bauset C, Remohi J, Bonilla-Musoles F, Simon C, Pellicer A. Reproductive impact of congenital Mullerian anomalies. Hum Reprod. 1997;12:2277–81. [PubMed: 9402295]
661.
Heinonen PK. Reproductive performance of women with uterine anomalies after abdominal or hysteroscopic metroplasty or no surgical treatment. J Am Assoc Gynecol Laparosc. 1997;4:311–7. [PubMed: 9154779]
662.
Grimbizis G, Camus M, Clasen K, Tournaye H, De Munck L, Devroey P. Hysteroscopic septum resection in patients with recurrent abortions or infertility. Hum Reprod. 1998;13:1188–93. [PubMed: 9647545]
663.
Homer HA, Li TC, Cooke ID. The septate uterus: a review of management and reproductive outcome. Fertil Steril. 2000;73:1–14. [PubMed: 10632403]
664.
Malik E, Berg C, Sterzik K, Stoz F, Rossmanith WG. Reproductive outcome of 32 patients with primary or secondary infertility and uterine pathology. Arch Gynecol Obstet. 2000;264:24–6. [PubMed: 10985614]
665.
Pabuccu R, Atay V, Orhon E, Urman B, Ergun A. Hysteroscopic treatment of intrauterine adhesions is safe and effective in the restoration of normal menstruation and fertility. Fertil Steril. 1997;68:1141–3. [PubMed: 9418714]
666.
Hughes E, Fedorkow D, Collins J, Vandekerckhove P. Ovulation suppression for endometriosis. Cochrane Database Syst Rev. 2000;(2):CD000155. Update in: Cochrane Database Syst Rev 2003;(3):CD000155. [PubMed: 10796697]
667.
Harrison RF, Barry-Kinsella C. Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study. Fertil Steril. 2000;74:24–30. [PubMed: 10899492]
668.
Hughes EG, Fedorkow DM, Collins JA. A quantitative overview of controlled trials in endometriosis-associated infertility. Fertil Steril. 1993;59:963–70. [PubMed: 8486196]
669.
Adamson GD, Pasta DJ. Surgical treatment of endometriosis-associated infertility: meta-analysis compared with survival analysis. Am J Obstet Gynecol. 1994;171:1488–504. Erratum appears in Am J Obstet Gynecol 1995;172:1937. [PubMed: 7802058]
670.
Hughes E, Tiffin G, Vandekerckhove P. Danazol for unexplained infertilty. Cochrane Database Syst Rev. 2000;(2):CD000069. [PubMed: 10796484]
671.
Jacobson TZ, Barlow DH, Koninckx PR, Olive D, Farquhar C. Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev. 2002;(4):CD001398. [PubMed: 12519555]
672.
Marcoux S, Maheux R, Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis. N Engl J Med. 1997;337:217–22. [PubMed: 9227926]
673.
Paulson JD, Asmar P, Saffan DS. Mild and moderate endometriosis. Comparison of treatment modalities for infertile couples. J Reprod Med. 1991;36:151–5. [PubMed: 1827652]
674.
Chapron C, Querleu D, Bruhat MA, Madelenat P, Fernandez H, Pierre F, et al. Surgical complications of diagnostic and operative gynaecological laparoscopy: a series of 29,966 cases. Hum Reprod. 1998;13:867–72. [PubMed: 9619539]
675.
Beretta P, Franchi M, Ghezzi F, Busacca M, Zupi E, Bolis P. Randomized clinical trial of two laparoscopic treatments of endometriomas: cystectomy versus drainage and coagulation. Fertil Steril. 1998;70:1176–80. [PubMed: 9848316]
676.
Adamson GD, Hurd SJ, Pasta DJ, Rodriguez BD. Laparoscopic endometriosis treatment: is it better? Fertil Steril. 1993;59:35–44. [PubMed: 8419220]
677.
Fayez JA, Collazo LM. Comparison between laparotomy and operative laparoscopy in the treatment of moderate and severe stages of endometriosis. Int J Fertil. 1990;35:272–9. [PubMed: 1980662]
678.
Crosignani PG, Vercellini P, Biffignandi F, Costantini W, Cortesi I, Imparato E. Laparoscopy versus laparotomy in conservative surgical treatment for severe endometriosis. Fertil Steril. 1996;66:706–11. [PubMed: 8893671]
679.
Busacca M, Fedele L, Bianchi S, Candiani M, Agnoli B, Raffaelli R, et al. Surgical treatment of recurrent endometriosis: laparotomy versus laparoscopy. Hum Reprod. 1998;13:2271–4. [PubMed: 9756309]
680.
Vercellini P, Crosignani PG, Fadini R, Radici E, Belloni C, Sismondi P. A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol. 1999;106:672–7. [PubMed: 10428523]
681.
Busacca M, Somigliana E, Bianchi S, De Marinis S, Calia C, Candiani M, et al. Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III–IV: a randomized controlled trial. Hum Reprod. 2001;16:2399–402. [PubMed: 11679528]
682.
Bianchi S, Busacca M, Agnoli B, Candiani M, Calia C, Vignali M. Effects of 3 month therapy with danazol after laparoscopic surgery for stage III/IV endometriosis: a randomized study. Hum Reprod. 1999;14:1335–7. [PubMed: 10325289]
683.
Parazzini F, Fedele L, Busacca M, Falsetti L, Pellegrini S, Venturini PL, et al. Postsurgical medical treatment of advanced endometriosis: results of a randomized clinical trial. Am J Obstet Gynecol. 1994;171:1205–7. [PubMed: 7977520]
684.
Ford WC, Mathur RS, Hull MG. Intrauterine insemination: is it an effective treatment for male factor infertility? Baillieres Clin Obstet Gynaecol. 1997;11:691–710. [PubMed: 9692011]
685.
Cohlen BJ, Vandekerckhove P, te Velde ER, Habbema JD. Timed intercourse versus intra-uterine insemination with or without ovarian hyperstimulation for subfertility in men. Cochrane Database Syst Rev. 2000;(2):CD000360. [PubMed: 10796711]
686.
Goverde AJ, McDonnell J, Vermeiden JP, Schats R, Rutten FF, Schoemaker J. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet. 2000;355:13–8. [PubMed: 10615885]
687.
Zreik TG, Garcia-Velasco JA, Habboosh MS, Olive DL, Arici A. Prospective, randomized, crossover study to evaluate the benefit of human chorionic gonadotropin-timed versus urinary luteinizing hormone-timed intrauterine inseminations in clomifene citrate-stimulated treatment cycles. Fertil Steril. 1999;71:1070–4. [PubMed: 10360912]
688.
Guzick DS, Carson SA, Coutifaris C, Overstreet JW, Factor-Litvak P, Steinkampf MP, et al. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network. N Engl J Med. 1999;340:177–83. [PubMed: 9895397]
689.
Deaton JL, Gibson M, Blackmer KM, Nakajima ST, Badger GJ, Brumsted JR. A randomized, controlled trial of clomifene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis. Fertil Steril. 1990;54:1083–8. [PubMed: 2245833]
690.
Zeyneloglu HB, Arici A, Olive DL, Duleba AJ. Comparison of intrauterine insemination with timed intercourse in superovulated cycles with gonadotropins: a meta-analysis. Fertil Steril. 1998;69:486–91. [PubMed: 9531883]
691.
Hughes EG. The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: a metaanalysis. Hum Reprod. 1997;12:1865–72. [PubMed: 9363697]
692.
Subspeciality Trainees in Reproductive Medicine and Surgery. A multicentre analysis of 1580 cycles of superovulation with intrauterine insemination: what is the impact on multiple pregnancy rates? [Unpublished data].
693.
Athaullah N, Proctor M, Johnson NP. Oral versus injectable ovulation induction agents for unexplained subfertility. Cochrane Database Syst Rev. 2002;(3):CD003052. [PMC free article: PMC6494519] [PubMed: 12137671]
694.
Sengoku K. The clinical efficacy of low-dose step-up follicle stimulating hormone administration for treatment of unexplained infertility. Hum Reprod. 1999;14:349–53. [PubMed: 10099977]
695.
Hughes EG, Collins JA, Gunby J. A randomized controlled trial of three low-dose gonadotrophin protocols for unexplained infertility. Hum Reprod. 1998;13:1527–31. [PubMed: 9688386]
696.
Sengoku K, Tamate K, Takaoka Y, Morishita N, Ishikawa M. A randomized prospective study of gonadotrophin with or without gonadotrophin-releasing hormone agonist for treatment of unexplained infertility. Hum Reprod. 1994;9:1043–7. [PubMed: 7962373]
697.
Pandian Z, Bhattacharya S, Nikolaou D, Vale L, Templeton A. In vitro fertilisation for unexplained subfertility. Cochrane Database Syst Rev. 2002;(2):CD003357. [PubMed: 12076476]
698.
Tummon IS, Asher LJ, Martin JS, Tulandi T. Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis. Fertil Steril. 1997;68:8–12. [PubMed: 9207576]
699.
Fedele L, Bianchi S, Marchini M, Villa L, Brioschi D, Parazzini F. Superovulation with human menopausal gonadotropins in the treatment of infertility associated with minimal or mild endometriosis: a controlled randomized study. Fertil Steril. 1992;58:28–31. [PubMed: 1624019]
700.
Nulsen JC, Walsh S, Dumez S, Metzger DA. A randomized and longitudinal study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertility. Obstet Gynecol. 1993;82:780–6. [PubMed: 8414326]
701.
Cantineau AE, Heineman MJ, Cohlen BJ. Single versus double intrauterine insemination (IUI) in stimulated cycles for subfertile couples. Cochrane Database Syst Rev. 2003;(1):CD003854. [PubMed: 12535490]
702.
Kahn JA, Sunde A, von DV, Sordal T, Molne K. Intrauterine insemination. Ann N Y Acad Sci. 1991;626:452–60. [PubMed: 1905511]
703.
Ricci G, Nucera G, Pozzobon C, Boscolo R, Giolo E, Guaschino S. A simple method for fallopian tube sperm perfusion using a blocking device in the treatment of unexplained infertility. Fertil Steril. 2001;76:1242–8. [PubMed: 11730758]
704.
El Sadek MM, Amer MK, Abdel-Malak G. Questioning the efficacy of fallopian tube sperm perfusion. Hum Reprod. 1998;13:3053–6. [PubMed: 9853855]
705.
Soliman EM, Salit ME, Ebrashy AN, Sheiba MA, Attia AM. A randomized prospective comparison between intrauterine insemination and two methods of fallopian tube sperm perfusion. Middle East Fertility Society Journal. 1999;4:162–8.
706.
Petrou S. Economic consequences of preterm birth and low birthweight. BJOG. 2003;110(Suppl 20):17–23. [PubMed: 12763106]
707.
Zayed F, Lenton EA, Cooke ID. Comparison between stimulated in-vitro fertilization and stimulated intrauterine insemination for the treatment of unexplained and mild male factor infertility. Hum Reprod. 1997;12:2408–13. [PubMed: 9436674]
708.
Van Voorhis BJ, Sparks AE, Allen BD, Stovall DW, Syrop CH, Chapler FK. Cost-effectiveness of infertility treatments: a cohort study. Fertil Steril. 1997;67:830–6. [PubMed: 9130886]
709.
Goverde AJ, McDonnell J, Vermeiden JP, Schats R, Rutten FF, Schoemaker J. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet. 2000;355:13–8. [PubMed: 10615885]
710.
Guzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP, et al. Efficacy of treatment for unexplained infertility. Fertil Steril. 1998;70:207–13. [PubMed: 9696208]
711.
Human Fertilisation and Embryology Authority. The Patients’ Guide to IVF Clinics Provisional Data 2002. London: HFEA; 2002.
712.
Hughes EG, Beecroft ML, Wilkie V, Burville L, Claman P, Tummon I, et al. A multi-centre randomized trial of expectant management vs in-vitro fertilization in women with fallopian tube patency: the EMVI trial; 48th Annual Meeting of the Canadian Fertility & Andrology Society; 25–28 September 2002; Charlevoix, Canada.
713.
Jarrell JF, Labelle R, Goeree R, Milner R, Collins J. In vitro fertilization and embryo transfer: a randomized controlled trial. Online J Curr Clin Trials 1993;Doc No 73. [PubMed: 8306010]
714.
Soliman S, Daya S, Collins J, Jarrell J. A randomized trial of in vitro fertilization versus conventional treatment for infertility. Fertil Steril. 1993;59:1239–44. [PubMed: 8495772]
715.
Vardon D, Burban C, Collomb J, Stolla V, Erny R. [Spontaneous pregnancies in couples after failed or successful in vitro fertilization]. J Gynecol Obstet Biol Reprod (Paris). 1995;24:811–5. [French] [PubMed: 8636613]
716.
Templeton A, Morris JK. In vitro fertilisation: factors affecting outcome. In: Templeton A, Cooke I, O’Brien PMS, editors. Evidence-based Fertility Treatment. London: RCOG; 1998. pp. 265–73.
717.
Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril. 2002;77:1148–55. [PubMed: 12057720]
718.
Dlugi AM, Loy RA, Dieterle S, Bayer SR, Seibel MM. The effect of endometriomas on in vitro fertilization outcome. J In Vitro Fert Embryo Transf. 1989;6:338–41. [PubMed: 2517506]
719.
Olivennes F, Feldberg D, Liu H-C, Cohen J, Moy F, Rosenwaks Z. Endometriosis: a stage by stage analysis – the role of in vitro fertilization. Fertil Steril. 1995;64:392–8. [PubMed: 7615119]
720.
Isaacs JD Jr, Hines RS, Sopelak VM, Cowan BD. Clinical assisted reproduction: ovarian endometriomas do not adversely affect pregnancy success following treatment with in vitro fertilization. J Assist Reprod Genet. 1997;14:551–3. [PMC free article: PMC3454734] [PubMed: 9447452]
721.
Tinkanen H, Kujansuu E. In vitro fertilization in patients with ovarian endometriomas. Acta Obstet Gynecol Scand. 2000;79:119–22. [PubMed: 10696959]
722.
Jansen RPS. Relative infertility: modeling clinical paradoxes. Fertil Steril. 1993;59:1041–5. [PubMed: 8486171]
723.
Templeton A, Morris JK, Parslow W. Factors that affect outcome of in-vitro fertilisation treatment. Lancet. 1996;348:1402–6. [PubMed: 8937279]
724.
Dor J, Seidman DS, Ben Shlomo I, Levran D, Ben Rafael Z, Mashiach S. Cumulative pregnancy rate following in-vitro fertilization: the significance of age and infertility aetiology. Hum Reprod. 1996;11:428. [PubMed: 8671236]
725.
Prietl G, Engelberts U, Maslanka M, van der Ven HH, Krebs D. Cumulative rates of conception following conventional in vitro fertilization as a function of patient age and diagnosis: results of the Bonn IVF programme. Geburtshilfe und Frauenheilkunde. 1998;58:433–9.
726.
Tan SL, Royston P, Campbell S, Jacobs HS, Betts J, Mason B, et al. Cumulative conception and livebirth rates after in-vitro fertilisation. Lancet. 1992;339:1390–4. [PubMed: 1350813]
727.
Williams RS, Kipersztok S, Hills D, Dattilo M. A novel, simplified and cost effective protocol for superovulation and intrauterine insemination. J Fla Med Assoc. 1997;84:316–9. [PubMed: 9260436]
728.
Nuojua-Huttunen S, Tuomivaara L, Juntunen K, Tomas C, Martikainen H. Long gonadotrophin releasing hormone agonist/human menopausal gonadotrophin protocol for ovarian stimulation in intrauterine insemination treatment. Eur J Obstet Gynecol Reprod Biol. 1997;74:83–7. [PubMed: 9243209]
729.
Dourron NE, Keye WR Jr. A cost-effective approach to the evaluation and management of the couple with unexplained infertility. Infertil Reprod Med Clin North Am. 1997;8:689–701.
730.
Strandell A. The influence of hydrosalpinx on IVF and embryo transfer: a review. Hum Reprod Update. 2000;6:387–95. [PubMed: 10972525]
731.
Camus E, Poncelet C, Goffinet F, Wainer B, Merlet F, Nisand I, et al. Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum Reprod. 1999;14:1243–9. [PubMed: 10325271]
732.
Strandell A, Waldenstrom U, Nilsson L, Hamberger L. Hydrosalpinx reduces in-vitro fertilization/embryo transfer pregnancy rates. Hum Reprod. 1994;9:861–3. [PubMed: 7929732]
733.
Katz E, Akman MA, Damewood MD, Garcia JE. Deleterious effect of the presence of hydrosalpinx on implantation and pregnancy rates with in vitro fertilization. Fertil Steril. 1996;66:122–5. [PubMed: 8752622]
734.
Johnson NP, Mak W, Sowter MC. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev. 2001;(3):CD002125. [PubMed: 11687014]
735.
Kondo I, Suganuma N, Ando T, Asada Y, Furuhashi M, Tomoda Y. Clinical factors for successful cryopreserved-thawed embryo transfer. J Assist Reprod Genet. 1996;13:201–6. [PubMed: 8852879]
736.
Schalkoff ME, Oskowitz SP, Powers RD. A multifactorial analysis of the pregnancy outcome in a successful embryo cryopreservation program. Fertil Steril. 1993;59:1070–4. [PubMed: 8486176]
737.
Queenan JT Jr, Veeck LL, Seltman HJ, Muasher SJ. Transfer of cryopreserved-thawed pre-embryos in a natural cycle or a programmed cycle with exogenous hormonal replacement yields similar pregnancy results. Fertil Steril. 1994;62:545–50. [PubMed: 8062950]
738.
[FIVNAT evaluation of frozen embryo transfers from 1987 to 1994]. Contracept Fertil Sex. 1996;24:700–5. [French] [PubMed: 8998522]
739.
Karlstrom PO, Bergh T, Forsberg AS, Sandkvist U, Wikland M. Prognostic factors for the success rate of embryo freezing. Hum Reprod. 1997;12:1263–6. [PubMed: 9222014]
740.
Toner JP, Veeck LL, Acosta AA, Muasher SJ. Predictive value of pregnancy during original in vitro fertilization cycle on implantation and pregnancy in subsequent cryothaw cycles. Fertil Steril. 1991;56:505–8. [PubMed: 1894029]
741.
Wang XJ, Ledger W, Payne D, Jeffrey R, Matthews CD. The contribution of embryo cryopreservation to in-vitro fertilization/gamete intra-fallopian transfer: 8 years experience. Hum Reprod. 1994;9:103–9. [PubMed: 8195330]
742.
Human Fertilisation and Embryology Authority. Human Fertilisation and Embryology Authority Eighth Annual Report and Accounts. London: HFEA; 1999.
743.
Human Fertilisation and Embryology Authority. Human Fertilisation and Embryology Authority Eleventh Annual Report and Accounts. London: HFEA; 2002.
744.
Hull MG, Fleming CF, Hughes AO, McDermott A. The age-related decline in female fecundity: a quantitative controlled study ofimplanting capacity and survival of individual embryos after in vitro fertilization. Fertil Steril. 1996;65:783–90. [PubMed: 8654639]
745.
Bopp BL, Alper MM, Thompson IE, Mortola J. Success rates with gamete intrafallopian transfer and in vitro fertilization in women of advanced maternal age. Fertil Steril. 1995;63:1278–83. [PubMed: 7750601]
746.
Minaretzis D, Harris D, Alper MM, Mortola JF, Berger MJ, Power D. Multivariate analysis of factors predictive of successful live births in in vitro fertilization (IVF) suggests strategies to improve IVF outcome. J Assist Reprod Genet. 1998;15:365–71. [PMC free article: PMC3455016] [PubMed: 9673880]
747.
Roseboom TJ, Vermeiden JP, Schoute E, Lens JW, Schats R. The probability of pregnancy after embryo transfer is affected by the age of the patient, cause of infertility, number of embryos transferred and the average morphology score, as revealed by multiple logistic regression analysis. Hum Reprod. 1995;10:3035–41. [PubMed: 8747067]
748.
Kahn JA, von During V, Sunde A, Sordal T, Molne K. The efficacy and efficiency of an in-vitro fertilization programme including embryo cryopreservation: a cohort study. Hum Reprod. 1993;8:247–52. [PubMed: 8473429]
749.
Horne G, Critchlow JD, Newman MC, Edozien L, Matson PL, Lieberman BA. A prospective evaluation of cryopreservation strategies in a two-embryo transfer programme. Hum Reprod. 1997;12:542–7. [PubMed: 9130756]
750.
Wennerholm UB, Bergh C, Hamberger L, Westlander G, Wikland M, Wood M. Obstetric outcome of pregnancies following ICSI, classified according to sperm origin and quality. Hum Reprod. 2000;15:1189–94. [PubMed: 10783376]
751.
Wada I, Macnamee MC, Wick K, Bradfield JM, Brinsden PR. Birth characteristics and perinatal outcome of babies conceived from cryopreserved embryos. Hum Reprod. 1994;9:543–6. [PubMed: 8006149]
752.
Wennerholm UB, Albertsson-Wikland K, Bergh C, Hamberger L, Niklasson A, Nilsson L, et al. Postnatal growth and health in children born after cryopreservation as embryos. Lancet. 1998;351:1085–90. [PubMed: 9660577]
753.
Lass A, Croucher C, Duffy S, Dawson K, Margara R, Winston RML. One thousand initiated cycles of in vitro fertilization in women > or = 40 years of age. Fertil Steril. 1998;70:1030–4. [PubMed: 9848290]
754.
Cordeiro I, Calhaz-Jorge C, Barata M, Leal F, Proenca H, Coelho AM. [The effect of the woman’s age, the rate of cleavage and embryo quality on obtaining a pregnancy by in-vitro fertilization]. Acta Med Port. 1995;8:145–50. [Portuguese] [PubMed: 7484241]
755.
Preutthipan S, Amso N, Curtis P, Shaw RW. Effect of maternal age on clinical outcome in women undergoing in vitro fertilization and embryo transfer (IVF-ET). J Med Assoc Thai. 1996;79:347–52. [PubMed: 8855607]
756.
Segal S, Casper RF. The response to ovarian hyperstimulation and in-vitro fertilization in women older than 35 years. Hum Reprod. 1990;5:255–7. [PubMed: 2112553]
757.
Kenny DT. The impact of maternal age on clinical pregnancy and spontaneous abortion in women undergoing in vitro fertilization and gamete intra-fallopian transfer. Aust N Z J Obstet Gynaecol. 1994;34:443–8. [PubMed: 7848237]
758.
Padilla SL, Garcia JE. Effect of maternal age and number of in vitro fertilization procedures on pregnancy outcome. Fertil Steril. 1989;52:270–3. [PubMed: 2753174]
759.
Widra EA, Gindoff PR, Smotrich DB, Stillman RJ. Achieving multiple-order embryo transfer identifies women over 40 years of age with improved in vitro fertilization outcome. Fertil Steril. 1996;65:103–8. [PubMed: 8557122]
760.
Legro RS, Shackleford DP, Moessner JM, Gnatuk CL, Dodson WC. ART in women 40 and over. Is the cost worth it? J Reprod Med. 1997;42:76–82. [PubMed: 9058341]
761.
Al-Shawaf T, Nolan A, Guirgis R, Harper J, Santis M, Craft I. The influence of ovarian response on gamete intra-fallopian transfer outcome in older women. Hum Reprod. 1992;7:1106–10. [PubMed: 1383263]
762.
Harrison KL, Breen TM, Hennessey JF, Hynes MJ, Keeping JD, Kilvert GT, et al. Patient age and success in a human IVF programme. Aust N Z J Obstet Gynaecol. 1989;29:326–8. [PubMed: 2619682]
763.
Croucher CA, Lass A, Margara R, Winston RM. Predictive value of the results of a first in-vitro fertilization cycle on the outcome of subsequent cycles. Hum Reprod. 1998;13:403–8. [PubMed: 9557847]
764.
Parneix I, Jayot S, Verdaguer S, Discamps G, Audebert A, Emperaire JC. [Age and fertility: contribution of endometrial cocultures]. Contracept Fertil Sex. 1995;23:667–9. [French] [PubMed: 8520646]
765.
al Hasani S, Ludwig M, Gagsteiger F, Kupker W, Sturm R, Yilmaz A, et al. Comparison of cryopreservation of supernumerary pronuclear human oocytes obtained after intracytoplasmic sperm injection (ICSI) and after conventional in-vitro fertilization. Hum Reprod. 1996;11:604–7. [PubMed: 8671276]
766.
Hoover L, Baker A, Check JH, Lurie D, Summers D. Clinical outcome of cryopreserved human pronuclear stage embryos resulting from intracytoplasmic sperm injection. Fertil Steril. 1997;67:621–4. [PubMed: 9093183]
767.
Kowalik A, Palermo GD, Barmat L, Veeck L, Rimarachin J, Rosenwaks Z. Comparison of clinical outcome after cryopreservation of embryos obtained from intracytoplasmic sperm injection and in-vitro fertilization. Hum Reprod. 1998;13:2848–51. [PubMed: 9804244]
768.
Check JH, Choe JK, Nazari A, Fox F, Swenson K. Fresh embryo transfer is more effective than frozen for donor oocyte recipients but not for donors. Hum Reprod. 2001;16:1403–8. [PubMed: 11425820]
769.
Chandra A, Stephen EH. Impaired fecundity in the United States: 1982–1995. Fam Plann Perspect. 1998;30:34–42. [PubMed: 9494814]
770.
Toner JP, Flood JT. Fertility after the age of 40. Obstet Gynecol Clin North Am. 1993;20:261–72. [PubMed: 8367130]
771.
Yie SM, Collins JA, Daya S, Hughes E, Sagle M, Younglai EV. Polyploidy and failed fertilization in in-vitro fertilization are related to patient’s age and gamete quality. Hum Reprod. 1996;11:614–7. [PubMed: 8671278]
772.
Ashkenazi J, Orvieto R, Gold-Deutch R, Feldberg D, Dicker D, Voliovitch I, et al. The impact of woman’s age and sperm parameters on fertilization rates in IVF cycles. Eur J Obstet Gynecol Reprod Biol. 1996;66:155–9. [PubMed: 8735739]
773.
Tucker MJ, Morton PC, Wright G, Ingargiola PE, Jones AE, Sweitzer CL. Factors affecting success with intracytoplasmic sperm injection. Reprod Fertil Dev. 1995;7:229–36. [PubMed: 7480841]
774.
van Kooij RJ, Looman CW, Habbema JD, Dorland M, te Velde ER. Age-dependent decrease in embryo implantation rate after in vitro fertilization. Fertil Steril. 1996;66:769–75. [PubMed: 8893683]
775.
Arthur ID, Anthony FW, Masson GM, Thomas EJ. The selection criteria on an IVF program can remove the association between maternal age and implantation. Acta Obstet Gynecol Scand. 1994;73:562–6. [PubMed: 8079607]
776.
Janny L, Menezo YJ. Maternal age effect on early human embryonic development and blastocyst formation. Mol Reprod Dev. 1996;45:31–7. [PubMed: 8873066]
777.
Alrayyes S, Fakih H, Khan I. Effect of age and cycle responsiveness in patients undergoing intracytoplasmic sperm injection. Fertil Steril. 1997;68:123–7. [PubMed: 9207596]
778.
Rufat P, Roulier R, Belaisch-Allart J, Bachelot A, de Mouzon J. Variation in IVF success factors according to the rank of attempts. Contracept Fertil Sex. 1994;22:282–6.
779.
de Mouzon J, Rossin-Amar B, Bachelot A, Renon C, Devecchi A. [FIVNAT. Influence of attempt rank in in vitro fertilization]. Contracept Fertil Sex. 1998;26:466–72. [French] [PubMed: 9810115]
780.
Mardesic T, Muller P, Zetova L, Mikova M. [Factors affecting the results of in vitro fertilization – I. The effect of age]. Ceska Gynekol. 1994;59:259–61. [Czech] [PubMed: 7865019]
781.
Dawood MY. In vitro fertilization, gamete intrafallopian transfer, and superovulation with intrauterine insemination: efficacy and potential health hazards on babies delivered. Am J Obstet Gynecol. 1996;174:1208–17. [PubMed: 8623848]
782.
Tuppin P, Blondel B, Kaminski M. Trends in multiple deliveries and infertility treatments in France. Br J Obstet Gynaecol. 1993;100:383–5. [PubMed: 8494841]
783.
Cohen J. How to avoid multiple pregnancies in assisted reproduction. Hum Reprod. 1998;13(Suppl 3):197–214. [PubMed: 9755424]
784.
Human Fertilisation and Embryology Authority. HFEA reduces maximum number of embryos transferred in single IVF treatment from three to two. Press Release 8 August 2001.
785.
Prevention of twin pregnancies after IVF/ICSI by single embryo transfer. ESHRE Campus Course Report. Hum Reprod. 2001;16:790–800. [PubMed: 11278236]
786.
Templeton A, Morris JK. Reducing the risk of multiple births by transfer of two embryos after in vitro fertilization. N Engl J Med. 1998;339:573–7. [PubMed: 9718375]
787.
Engmann L, Maconochie N, Tan SL, Bekir J. Trends in the incidence of births and multiple births and the factors that determine the probability of multiple birth after IVF treatment. Hum Reprod. 2001;16:2598–605. [PubMed: 11726581]
788.
Gerris J, De Neubourg D, Mangelschots K, Van Royen E, Van de Meerssche M, Valkenburg M. Prevention of twin pregnancy after in-vitro fertilization or intracytoplasmic sperm injection based on strict embryo criteria: a prospective randomized clinical trial. Hum Reprod. 1999;14:2581–7. [PubMed: 10527991]
789.
Lukassen HG, Braat DDM, Zielhuis GA, Adang EM, Kremer JAM. 2×1 versus 1×2, a randomized study. Abstract no. O-005. Hum Reprod. 2002;17(Suppl 1):S2.
790.
Martikainen H, Tiitinen A, Tomas C, Tapanainen J, Orava M, Tuomivaara L, et al. One versus two embryo transfer after IVF and ICSI: a randomized study. Hum Reprod. 2001;16:1900–3. [PubMed: 11527895]
791.
Staessen C, Janssenswillen C, Van den Abbeel E, Devroey P, Van Steirteghem AC. Avoidance of triplet pregnancies by elective transfer of two good quality embryos. Hum Reprod. 1993;8:1650–3. [PubMed: 8300822]
792.
Vauthier-Brouzes D, Lefebvre G, Lesourd S, Gonzales J, Darbois Y. How many embryos should be transferred in in vitro fertilization? A prospective randomized study. Fertil Steril. 1994;62:339–42. [PubMed: 8034082]
793.
Goldfarb JM, Austin C, Lisbona H, Peskin B, Clapp M. Cost-effectiveness of in vitro fertilization. Obstet Gynecol. 1996;87:18–21. [PubMed: 8532258]
794.
Liao XH, de Caestecker L, Gemmell J, Lees A, McIlwaine G, Yates R. The neonatal consequences and neonatal cost of reducing the number of embryos transferred following IVF. Scott Med J. 1997;42:76–8. [PubMed: 9351120]
795.
Wolner-Hanssen P, Rydhstroem H. Cost-effectiveness analysis of in-vitro fertilization: estimated costs per successful pregnancy after transfer of one or two embryos. Hum Reprod. 1998;13:88–94. [PubMed: 9512235]
796.
Kovacs GT, MacLachlan V, Brehny S. What is the probability of conception for couples entering an IVF program? Aust N Z J Obstet Gynaecol. 2001;41:207–9. [PubMed: 11453274]
797.
Meldrum DR, Silverberg KM, Bustillo M, Stokes L. Success rate with repeated cycles of in vitro fertilization-embryo transfer. Fertil Steril. 1998;69:1005–9. [PubMed: 9627284]
798.
Templeton A. Infertility-epidemiology, aetiology and effective management. Health Bull (Edinb). 1995;53:294–8. [PubMed: 7490200]
799.
Bachelot A, Pouly JL, Renon C, Devecchi A, de Mouzon J. In vitro fertilization results after an IVF pregnancy. Contracept Fertil Sex. 1997;25:507–10.
800.
Klonoff-Cohen H, Lam-Kruglick P, Gonzalez C. Effects of maternal and paternal alcohol consumption on the success rates of in vitro fertilization and gamete intrafallopian transfer. Fertil Steril. 2003;79:330–9. [PubMed: 12568842]
801.
Klonoff-Cohen H, Natarajan L, Marrs R, Yee B. Effects of female and male smoking on success rates of IVF and gamete intra-fallopian transfer. Hum Reprod. 2001;16:1382–90. [PubMed: 11425817]
802.
Feichtinger W, Papalambrou K, Poehl M, Krischker U, Neumann K. Smoking and in vitro fertilization: a meta-analysis. J Assist Reprod Genet. 1997;14:596–9. [PMC free article: PMC3454733] [PubMed: 9447461]
803.
Hughes EG, Yeo J, Claman P, Young Lai EV, Sagle MA, Daya S, et al. Cigarette smoking and the outcomes of in vitro fertilization: measurement of effect size and levels of action. Fertil Steril. 1994;62:807–14. [PubMed: 7926092]
804.
Joesbury KA, Edirisinghe WR, Phillips MR, Yovich JL. Evidence that male smoking affects the likelihood of a pregnancy following IVF treatment: application of the modified cumulative embryo score. Hum Reprod. 1998;13:1506–13. [PubMed: 9688383]
805.
Zitzmann M, Rolf C, Nordhoff V, Schrader G, Rickert-Fohring M, Gassner P, et al. Male smokers have a decreased success rate for in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril. 2003;79(Suppl 3):1550–4. [PubMed: 12801558]
806.
Klonoff-Cohen H, Bleha J, Lam-Kruglick P. A prospective study of the effects of female and male caffeine consumption on the reproductive endpoints of IVF and gamete intra-fallopian transfer. Hum Reprod. 2002;17:1746–54. [PubMed: 12093834]
807.
Fedorcsak P, Storeng R, Dale PO, Tanbo T, Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand. 2000;79:43–8. [PubMed: 10646815]
808.
Loveland JB, McClamrock HD, Malinow AM, Sharara FI. Increased body mass index has a deleterious effect on in vitro fertilization outcome. J Assist Reprod Genet. 2001;18:382–6. [PMC free article: PMC3455823] [PubMed: 11499322]
809.
Wittemer C, Ohl J, Bailly M, Bettahar-Lebugle K, Nisand I. Does body mass index of infertile women have an impact on IVF procedure and outcome? J Assist Reprod Genet. 2000;17:547–52. [PMC free article: PMC3455453] [PubMed: 11209534]
810.
Nichols JE, Crane MM, Higdon HL, Miller PB, Boone WR. Extremes of body mass index reduce in vitro fertilization pregnancy rates. Fertil Steril. 2003;79:645–7. [PubMed: 12620460]
811.
Granberg M, Wikland M, Nilsson L, Hamberger L. Couples’ willingness to pay for IVF/ET. Acta Obstet Gynecol Scand. 1995;74:199–202. [PubMed: 7900524]
812.
Murdoch AP, Harris M. Gamete intrafallopian transfer (GIFT) compared with intrauterine insemination in the treatment of unexplained infertility. Br J Obstet Gynaecol. 1991;98:1107–11. [PubMed: 1760422]
813.
Wessels PH, Cronje HS, Oosthuizen AP, Trumpelmann MD, Grobler S, Hamlett DK. Cost-effectiveness of gamete intrafallopian transfer in comparison with induction of ovulation with gonadotropins in the treatment of female infertility: a clinical trial. Fertil Steril. 1992;57:163–7. [PubMed: 1730312]
814.
Hogerzeil HV, Spiekerman JCM, de Vries JWA, de Schepper G. A randomized trial between GIFT and ovarian stimulation for the treatment of unexplained infertility and failed artificial insemination by donor. Hum Reprod. 1992;7:1235–9. [PubMed: 1479004]
815.
Leeton J, Rogers P, Caro C, Healy D, Yates C. A controlled study between the use of gamete intrafallopian transfer (GIFT) and in vitro fertilization and embryo transfer in the management of idiopathic and male infertility. Fertil Steril. 1987;48:605–7. [PubMed: 2958366]
816.
Habana AE, Palter SF. Is tubal embryo transfer of any value? A meta-analysis and comparison with the Society for Assisted Reproductive Technology database. Fertil Steril. 2001;76:286–93. [PubMed: 11476774]
817.
Rombauts L, Dear M, Breheny S, Healy DL. Cumulative pregnancy and live birth rates after gamete intra-fallopian transfer. Hum Reprod. 1997;12:1338–42. [PubMed: 9222027]
818.
Assisted reproductive technology in the United States: 1997 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril. 2000;74:641–53. [PubMed: 11020500]
819.
Abusheikha N, Akagbosu F, Marcus S, Lass A, Cousins C, Brinsden P. Viral screening and assisted conception treatment – the Bourn Hall experience. J Assist Reprod Genet. 1999;16:337–9. [PMC free article: PMC3455533] [PubMed: 10394532]
820.
Passos EP, Silveira TR, Salazar CC, Facin AC, Souza CA, Guerin YL, et al. Hepatitis C virus infection and assisted reproduction. Hum Reprod. 2002;17:2085–8. [PubMed: 12151441]
821.
Levy R, Tardy JC, Bourlet T, Cordonier H, Mion F, Lornage J, et al. Transmission risk of hepatitis C virus in assisted reproductive techniques. Hum Reprod. 2000;15:810–6. [PubMed: 10739825]
822.
Tedder RS, Zuckerman MA, Goldstone AH, Hawkins AE, Fielding A, Briggs EM, et al. Hepatitis B transmission from contaminated cryopreservation tank. Lancet. 1995;346:137–40. [PubMed: 7603227]
823.
Letur-Konirsch H, Collin G, Sifer C, Devaux A, Kuttenn F, Madelenat P, et al. Safety of cryopreservation straws for human gametes or embryos: a study with human immunodeficiency virus-1 under cryopreservation conditions. Hum Reprod. 2003;18:140–4. [PubMed: 12525455]
824.
Bielanski A, Nadin-Davis S, Sapp T, Lutze-Wallace C. Viral contamination of embryos cryopreserved in liquid nitrogen. Cryobiology. 2000;40:110–6. [PubMed: 10788310]
825.
Gilling-Smith C, Almeida P. HIV, hepatitis B and hepatitis C and infertility: reducing risk. Hum Fertil (Camb). 2003;6:106–12. [PubMed: 12960441]
826.
Minkoff H, Santoro N. Ethical considerations in the treatment of infertility in women with human immunodeficiency virus infection. N Engl J Med. 2000;342:1748–50. [PubMed: 10841881]
827.
Gilling-Smith C, Smith JR, Semprini AE. HIV and infertility: time to treat. There’s no justification for denying treatment to parents who are HIV positive. BMJ. 2001;322:566–7. [PMC free article: PMC1119773] [PubMed: 11238138]
828.
Semprini AE, Levi-Setti P, Bozzo M, Ravizza M, Taglioretti A, Sulpizio P, et al. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet. 1992;340:1317–9. [PubMed: 1360037]
829.
Semprini AE, Levi-Setti P, Ravizza M, Pardi G. Assisted conception to reduce the risk of male-to-female sexual transfer of HIV in serodiscordant couples: an update; Scientific papers presented at the 52nd ASRM Annual Meeting; Fertil Steril; Boston, USA. 1996; 1996. p. S65. [abstract] Abstract no. O-129.
830.
Pasquier C, Daudin M, Righi L, Berges L, Thauvin L, Berrebi A, et al. Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children. AIDS. 2000;14:2093–9. [PubMed: 11061649]
831.
Meseguer M, Garrido N, Gimeno C, Remohi J, Simon C, Pellicer A. Comparison of polymerase chain reaction-dependent methods for determining the presence of human immunodeficiency virus and hepatitis C virus in washed sperm. Fertil Steril. 2002;78:1199–202. [PubMed: 12477512]
832.
Marina S, Marina F, Alcolea R, Exposito R, Huguet J, Nadal J, et al. Human immunodeficiency virus type 1 – serodiscordant couples can bear healthy children after undergoing intrauterine insemination. Fertil Steril. 1998;70:35–9. [PubMed: 9660417]
833.
Gilling-Smith C. HIV prevention. Assisted reproduction in HIV-discordant couples. AIDS Read. 2000;10:581–7. [PubMed: 11068804]
834.
Chrystie IL, Mullen JE, Braude PR, Rowell P, Williams E, Elkington N, et al. Assisted conception in HIV discordant couples: evaluation of semen processing techniques in reducing HIV viral load. J Reprod Immunol. 1998;41:301–6. [PubMed: 10213318]
835.
Weigel M, Beichert M, Gentili M, Melchert F. Assisted reproduction of HIV-negative women with ‘washed’ spermatozoa of HIV-positive partners – a safe procedure or merely a risk reduction method; Abstracts of the 16th Annual Meeting of the ESHRE, 2000; Hum Reprod; Bologna, Italy. 2000; 2000. pp. 41–2. Abstract no. O-106.
836.
Pelinck MJ, Hoek A, Simons AH, Heineman MJ. Efficacy of natural cycle IVF: a review of the literature. Hum Reprod Update. 2002;8:129–39. [PubMed: 12099628]
837.
MacDougall MJ, Tan SL, Hall V, Balen A, Mason BA, Jacobs HS. Comparison of natural with clomiphene citrate-stimulated cycles in in vitro fertilization: a prospective, randomized trial. Fertil Steril. 1994;61:1052–7. [PubMed: 8194616]
838.
Ingerslev HJ, Hojgaard A, Hindkjaer J, Kesmodel U. A randomized study comparing IVF in the unstimulated cycle with IVF following clomiphene citrate. Hum Reprod. 2001;16:696–702. [PubMed: 11278221]
839.
Levy MJ, Gindoff PH. The efficacy of natural versus stimulated cycle IVF-ET. Fertil Steril. 1991;56(Suppl):S15–6.
840.
Sathanandan M, Macnamee MC, Rainsbury P, Wick K, Brinsden P, Edwards RG. Replacement of frozen-thawed embryos in artificial and natural cycles: a prospective semi-randomized study. Hum Reprod. 1991;6:685–7. [PubMed: 1939549]
841.
Muasher SJ, Kruithoff C, Simonetti S, Oehninger S, Acosta AA, Jones GS. Controlled preparation of the endometrium with exogenous steroids for the transfer of frozen-thawed pre-embryos in patients with anovulatory or irregular cycles. Hum Reprod. 1991;6:443–5. [PubMed: 1955555]
842.
Wada I, Matson PL, Troup SA, Hughes S, Buck P, Lieberman BA. Outcome of treatment subsequent to the elective cryopreservation of all embryos from women at risk of the ovarian hyperstimulation syndrome. Hum Reprod. 1992;7:962–6. [PubMed: 1430136]
843.
Pattinson HA, Greene CA, Fleetham J, Anderson-Sykes SJ. Exogenous control of the cycle simplifies thawed embryo transfer and results in a pregnancy rate similar to that for natural cycles. Fertil Steril. 1992;58:627–9. [PubMed: 1306053]
844.
Al-Shawaf T, Yang D, Al-Magid Y, Seaton A, Iketubosin F, Craft I. Ultrasonic monitoring during replacement of frozen/thawed embryos in natural and hormone replacement cycles. Hum Reprod. 1993;8:2068–74. [PubMed: 8150904]
845.
Tanos V, Friedler S, Zajicek G, Neiger M, Lewin A, Schenker JG. The impact of endometrial preparation on implantation following cryopreserved-thawed-embryo transfer. Gynecol Obstet Invest. 1996;41:227–31. [PubMed: 8793490]
846.
Dor J, Rudak E, Davidson A, Levran D, Ben Rafael Z, Mashiach S. Endocrine and biological factors influencing implantation of human embryos following cryopreservation. Gynecol Endocrinol. 1991;5:203–11. [PubMed: 1776506]
847.
Simon A, Hurwitz A, Zentner BS, Bdolah Y, Laufer N. Transfer of frozen-thawed embryos in artificially prepared cycles with and without prior gonadotrophin-releasing hormone agonist suppression: a prospective randomized study. Hum Reprod. 1998;13:2712–7. [PubMed: 9804219]
848.
Gorgy A, Taranissi M. Defining and predicting the poor responder! Fertil Steril. 2001;75:226–7. [PubMed: 11229332]
849.
Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update. 2003;9:61–76. [PubMed: 12638782]
850.
Kotarba D, Kotarba J, Hughes E. Growth hormone for in vitro fertilization. Cochrane Database Syst Rev. 2000;(2):CD000099. Update in: Cochrane Database Syst Rev 2003;(3):CD000099. [PubMed: 10796692]
851.
Suikkari A, MacLachlan V, Koistinen R, Seppala M, Healy D. Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertil Steril. 1996;65:800–5. [PubMed: 8654642]
852.
Howles CM, Loumaye E, Germond M, Yates R, Brinsden P, Healy D, et al. Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization? Hum Reprod. 1999;14:1939–43. [PubMed: 10438403]
853.
Rinehart JS. Randomized prospective trial comparing the addition of growth hormone for the induction of ovulation of “poor responders” in IVF; Abstracts from ASRM/CFAS. Conjoint Annual Meeting; Fertil Steril; 25–30 September 1999; Toronto, Canada. 1999. pp. S91–2. Abstract no. P-006.
854.
The European Recombinant Human Chorionic Gonadotrophin Study Group. Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment – recombinant HCG versus urinary HCG. Hum Reprod. 2000;15:1446–51. [PubMed: 10875887]
855.
Chang P, Kenley S, Burns T, Denton G, Currie K, DeVane G, et al. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertil Steril. 2001;76:67–74. [PubMed: 11438321]
856.
Fleming R. Monitoring during gonadotrophin-releasing hormone antagonist protocols. Hum Fertil (Camb). 2002;5:G24–7. [PubMed: 11939157]
857.
Golan A, Herman A, Soffer Y, Bukovsky I, Ron-El R. Ultrasonic control without hormone determination for ovulation induction in in-vitro fertilization/embryo transfer with gonadotrophin-releasing hormone analogue and human menopausal gonadotrophin. Hum Reprod. 1994;9:1631–3. [PubMed: 7836512]
858.
Lass A. Monitoring of in vitro fertilization-embryo transfer cycles by ultrasound versus by ultrasound and hormonal levels: a prospective, multicenter, randomized study. Fertil Steril. 2003;80:80–5. [PubMed: 12849805]
859.
Murad NM. Ultrasound or ultrasound and hormonal determinations for in vitro fertilization monitoring. Int J Gynaecol Obstet. 1998;63:271–6. [PubMed: 9989897]
860.
MacDougall MJ, Tan SL, Jacobs HS. In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod. 1992;7:597–600. [PubMed: 1639974]
861.
Whelan JG 3rd, Vlahos NF. The ovarian hyperstimulation syndrome. Fertil Steril. 2000;73:883–96. [PubMed: 10785212]
862.
Jenkins J, Mathur R. Royal College of Obstetricians and Gynaecologists Personal Assessment in Continuing Education: Reviews, Questions and Answers. Vol. 3. London: RCOG Press; 2003. Ovarian hyperstimulation syndrome PACE Review no 98/06; pp. 7–9.
863.
Fluker MR, Hooper WM, Yuzpe AA. Withholding gonadotropins (“coasting”) to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles. Fertil Steril. 1999;71:294–301. [PubMed: 9988401]
864.
D’Angelo A, Amso N. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev. 2002;(3):CD002811. [PubMed: 12137659]
865.
D’Angelo A, Amso N. Embryo freezing for preventing Ovarian Hyperstimulation Syndrome. Cochrane Database Syst Rev. 2002;(2):CD002806. [PubMed: 12076453]
866.
Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril. 1994;61:1068–76. [PubMed: 8194619]
867.
Ludwig M, Diedrich K. Evaluation of an optimal luteal phase support protocol in IVF. Acta Obstet Gynecol Scand. 2001;80:452–66. [PubMed: 11328224]
868.
Aboulghar M, Evers JH, Al-Inany H. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome. Cochrane Database Syst Rev. 2000;(2):CD001302. Update in: Cochrane Database Syst Rev 2002;(2):CD001302. [PubMed: 10796765]
869.
Ben Chetrit A, Eldar-Geva T, Gal M, Huerta M, Mimon T, Algur N, et al. The questionable use of albumin for the prevention of ovarian hyperstimulation syndrome in an IVF programme: a randomized placebo-controlled trial. Hum Reprod. 2001;16:1880–4. [PubMed: 11527892]
870.
Kissler S, Neidhardt B, Siebzehnrubl E, Schmitt H, Tschaikowsky K, Wildt L. The detrimental role of colloidal volume substitutes in severe ovarian hyperstimulation syndrome: a case report. Eur J Obstet Gynecol Reprod Biol. 2001;99:131–4. [PubMed: 11604204]
871.
Coskun S, Jaroudi KA, Hollanders JM, Atared AM, Roca GL. Recovery and maturation of immature oocytes in patients at risk for ovarian hyperstimulation syndrome. J Assist Reprod Genet. 1998;15:372–7. [PMC free article: PMC3455015] [PubMed: 9673881]
872.
Shoham Z, Schacter M, Loumaye E, Weissman A, Macnamee M, Insler V. The luteinizing hormone surge – the final stage in ovulation induction: modern aspects of ovulation triggering. Fertil Steril. 1995;64:237–51. [PubMed: 7615097]
873.
Ludwig M, Felberbaum RE, Devroey P, Albano C, Riethmuller-Winzen H, Schuler A, et al. Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction. Arch Gynecol Obstet. 2000;264:29–32. [PubMed: 10985616]
874.
Fluker M, Grifo J, Leader A, Levy M, Meldrum D, Muasher SJ, et al. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril. 2001;75:38–45. [PubMed: 11163814]
875.
Rimington MR, Walker SM, Shaw RW. The use of laparoscopic ovarian electrocautery in preventing cancellation of in-vitro fertilization treatment cycles due to risk of ovarian hyperstimulation syndrome in women with polycystic ovaries. Hum Reprod. 1997;12:1443–7. [PubMed: 9262275]
876.
Academy of Medical Royal Colleges. Implementing and Ensuring Safe Sedation Practice for Healthcare Procedures in Adults Report of an Intercollegiate Working Party Chaired by the Royal College of Anaesthetists. London: AOMRC; 2001.
877.
Trout SW, Vallerand AH, Kemmann E. Conscious sedation for in vitro fertilization. Fertil Steril. 1998;69:799–808. [PubMed: 9591482]
878.
Ng EHY, Chui DKC, Tang OS, Ho PC. Paracervical block with and without conscious sedation: a comparison of the pain levels during egg collection and the postoperative side effects. Fertil Steril. 2001;75:711–7. [PubMed: 11287024]
879.
Ng EH, Miao B, Ho PC. Anxiolytic premedication reduces preoperative anxiety and pain during oocyte retrieval. A randomized double-blinded placebo-controlled trial. Hum Reprod. 2002;17:1233–8. [PubMed: 11980744]
880.
Bhattacharya S, MacLennan F, Hamilton MP, Templeton A. How effective is patient-controlled analgesia? A randomized comparison of two protocols for pain relief during oocyte recovery. Hum Reprod. 1997;12:1440–2. [PubMed: 9262274]
881.
Thompson N, Murray S, MacLennan F, Ross JA, Tunstall ME, Hamilton MP, et al. A randomised controlled trial of intravenous versus inhalational analgesia during outpatient oocyte recovery. Anaesthesia. 2000;55:770–3. [PubMed: 10947691]
882.
Lok IH, Chan MTV, Chan DLW, Cheung LP, Haines CJ, Yuen PM. A prospective randomized trial comparing patient-controlled sedation using propofol and alfentanil and physician-administered sedation using diazepam and pethidine during transvaginal ultrasound-guided oocyte retrieval. Hum Reprod. 2002;17:2101–6. [PubMed: 12151444]
883.
Ben-Shlomo I, Moskovich R, Katz Y, Shalev E. Midazolam/ketamine sedative combination compared with fentanyl/propofol/isoflurane anaesthesia for oocyte retrieval. Hum Reprod. 1999;14:1757–9. [PubMed: 10402383]
884.
Casati A, Valentini G, Zangrillo A, Senatore R, Mello A, Airaghi B, et al. Anaesthesia for ultrasound guided oocyte retrieval: midazolam/remifentanil versus propofol/fentanyl regimens. Eur J Anaesthesiol. 1999;16:773–8. [PubMed: 10713871]
885.
Ben-Shlomo I, Moskovich R, Golan J, Eyali V, Tabak A, Shalev E. The effect of propofol anaesthesia on oocyte fertilization and early embryo quality. Hum Reprod. 2000;15:2197–9. [PubMed: 11006198]
886.
Hammadeh ME, Wilhelm W, Huppert A, Rosenbaum P, Schmidt W. Effects of general anaesthesia vs. sedation on fertilization, cleavage and pregnancy rates in an IVF program. Arch Gynecol Obstet. 1999;263:56–9. [PubMed: 10728631]
887.
Botta G, D’Angelo A, D’Ari G, Merlino G, Chapman M, Grudzinskas G. Epidural anesthesia in an in vitro fertilization and embryo transfer program. J Assist Reprod Genet. 1995;12:187–90. [PubMed: 8520183]
888.
Gonen O, Shulman A, Ghetler Y, Shapiro A, Judeiken R, Beyth Y, et al. The impact of different types of anesthesia on in vitro fertilization – embryo transfer treatment outcome. J Assist Reprod Genet. 1995;12:678–82. [PubMed: 8624422]
889.
Kim WO, Kil HK, Koh SO, Kim JI. Effects of general and locoregional anesthesia on reproductive outcome for in vitro fertilization: a meta-analysis. J Korean Med Sci. 2000;15:68–72. [PMC free article: PMC3054583] [PubMed: 10719812]
890.
Bokhari A, Pollard BJ. Anaesthesia for assisted conception: a survey of UK practice. Eur J Anaesthesiol. 1999;16:225–30. [PubMed: 10234491]
891.
Elkington NM, Kehoe J, Acharya U. Intravenous sedation in assisted conception units: a UK survey. Hum Fertil (Camb). 2003;6:74–6. [PubMed: 12869788]
892.
Elkington NM, Kehoe J, Acharya U. Recommendations for good practice for sedation in assisted conception. Hum Fertil (Camb). 2003;6:77–80. [PubMed: 12869789]
893.
Haines CJ, Emes AL, O’Shea RT, Weiss TJ. Choice of needle for ovum pickup. J In Vitro Fert Embryo Transf. 1989;6:111–2. [PubMed: 2723504]
894.
Kingsland CR, Taylor CT, Aziz N, Bickerton N. Is follicular flushing necessary for oocyte retrieval? A randomized trial. Hum Reprod. 1991;6:382–3. [PubMed: 1955546]
895.
Tan SL, Waterstone J, Wren M, Parsons J. A prospective randomized study comparing aspiration only with aspiration and flushing for transvaginal ultrasound-directed oocyte recovery. Fertil Steril. 1992;58:356–60. [PubMed: 1633902]
896.
Gorgy A, Meniru GI, Bates S, Craft IL. Percutaneous epididymal sperm aspiration and testicular sperm aspiration for intracytoplasmic sperm injection under local anesthesia. Assist Reprod Rev. 1998;8:79–93.
897.
Lumerman JH, Mellinger BC. Office-based diagnostic percutaneous testis biopsy. Minim Invasive Ther Allied Technol. 1998;7:275–80.
898.
Meniru GI, Gorgy A, Batha S, Clarke RJ, Podsiadly BT, Craft IL. Studies of percutaneous epididymal sperm aspiration (PESA) and intracytoplasmic sperm injection. Hum Reprod Update. 1998;4:57–71. [PubMed: 9622413]
899.
Van Perperstraten AM, Proctor ML, Phillipson G, Johnson NP. Techniques for surgical retrieval of sperm prior to ICSI for azoospermia. Cochrane Database Syst Rev. 2001;(4):CD002807. [PubMed: 11687162]
900.
Devroey P, Silber S, Nagy Z, Liu J, Tournaye H, Joris H, et al. Ongoing pregnancies and birth after intracytoplasmic sperm injection with frozen-thawed epididymal spermatozoa. Hum Reprod. 1995;10:903–6. [PubMed: 7650140]
901.
Silber SJ, Nagy Z, Liu J, Tournaye H, Lissens W, Ferec C, et al. The use of epididymal and testicular spermatozoa for intracytoplasmic sperm injection: the genetic implications for male infertility. Hum Reprod. 1995;10:2031–43. [PubMed: 8567837]
902.
Lisek EW, Levine LA. Percutaneous technique for aspiration of sperm from the epididymis and testicle. Tech Urol. 1997;3:81–5. [PubMed: 9297767]
903.
Friedler S, Raziel A, Strassburger D, Soffer Y, Komarovsky D, Ron-El R. Testicular sperm retrieval by percutaneous fine needle sperm aspiration compared with testicular sperm extraction by open biopsy in men with non-obstructive azoospermia. Hum Reprod. 1997;12:1488–93. [PubMed: 9262283]
904.
Hauser R, Botchan A, Amit A, Ben Yosef D, Gamzu R, Paz G, et al. Multiple testicular sampling in non-obstructive azoospermia – is it necessary? Hum Reprod. 1998;13:3081–5. [PubMed: 9853860]
905.
Ezeh UI, Moore HD, Cooke ID. A prospective study of multiple needle biopsies versus a single open biopsy for testicular sperm extraction in men with non-obstructive azoospermia. Hum Reprod. 1998;13:3075–80. [PubMed: 9853859]
906.
Turek PJ, Cha I, Ljung BM. Systematic fine-needle aspiration of the testis: correlation to biopsy and results of organ “mapping” for mature sperm in azoospermic men. Urology. 1997;49:743–8. [PubMed: 9145981]
907.
Ostad M, Liotta D, Ye Z, Schlegel PN. Testicular sperm extraction for nonobstructive azoospermia: results of a multibiopsy approach with optimized tissue dispersion. Urology. 1998;52:692–6. [PubMed: 9763095]
908.
Nagy ZP, Verheyen G, Tournaye H, Devroey P, Van Steirteghem AC. An improved treatment procedure for testicular biopsy specimens offers more efficient sperm recovery: case series. Fertil Steril. 1997;68:376–9. [PubMed: 9240275]
909.
Crabbe E, Verheyen G, Silber S, Tournaye H, Van de Velde H, Goossens A, et al. Enzymatic digestion of testicular tissue may rescue the intracytoplasmic sperm injection cycle in some patients with non-obstructive azoospermia. Hum Reprod. 1998;13:2791–6. [PubMed: 9804232]
910.
Schlegel PN. Testicular sperm extraction: microdissection improves sperm yield with minimal tissue excision. Hum Reprod. 1999;14:131–5. [PubMed: 10374109]
911.
Schlegel PN, Palermo GD, Goldstein M, Menendez S, Zaninovic N, Veeck LL, et al. Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia. Urology. 1997;49:435–40. [PubMed: 9123710]
912.
Hauser R, Temple-Smith PD, Southwick GJ, de Kretser D. Fertility in cases of hypergonadotropic azoospermia. Fertil Steril. 1995;63:631–6. [PubMed: 7851598]
913.
Martin-du-Pan RC, Bischof P. Increased follicle stimulating hormone in infertile men. Is increased plasma FSH always due to damaged germinal epithelium? Hum Reprod. 1995;10:1940–5. [PubMed: 8567817]
914.
Chen CS, Chu SH, Lai YM, Wang ML, Chan PR. Reconsideration of testicular biopsy and follicle-stimulating hormone measurement in the era of intracytoplasmic sperm injection for non-obstructive azoospermia? Hum Reprod. 1996;11:2176–9. [PubMed: 8943525]
915.
Kahraman S, Ozgur S, Alatas C, Aksoy S, Tasdemir M, Nuhoglu A, et al. Fertility with testicular sperm extraction and intracytoplasmic sperm injection in non-obstructive azoospermic men. Hum Reprod. 1996;11:756–60. [PubMed: 8671323]
916.
Silber SJ, Van Steirteghem AC, Liu J, Nagy Z, Tournaye H, Devroey P. High fertilization and pregnancy rate after intracytoplasmic sperm injection with spermatozoa obtained from testicle biopsy. Hum Reprod. 1995;10:148–52. [PubMed: 7745045]
917.
Jezek D, Knuth UA, Schulze W. Successful testicular sperm extraction (TESE) in spite of high serum follicle stimulating hormone and azoospermia: correlation between testicular morphology, TESE results, semen analysis and serum hormone values in 103 infertile men. Hum Reprod. 1998;13:1230–4. [PubMed: 9647552]
918.
Bettocchi C, Parkinson MC, Ralph DJ, Pryor JP. Clinical aspects associated with Sertoli-cell-only histology. Br J Urol. 1998;82:534–7. [PubMed: 9806183]
919.
Su LM, Palermo GD, Goldstein M, Veeck LL, Rosenwaks Z, Schlegel PN. Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia: testicular histology can predict success of sperm retrieval. J Urol. 1999;161:112–6. [PubMed: 10037381]
920.
Craft IL, Khalifa Y, Boulos A, Pelekanos M, Foster C, Tsirigotis M. Factors influencing the outcome of in-vitro fertilization with percutaneous aspirated epididymal spermatozoa and intracytoplasmic sperm injection in azoospermic men. Hum Reprod. 1995;10:1791–4. [PubMed: 8582981]
921.
Wurfel W, Krusmann G, Fiedler K, von Hertwig I, Schleyer M, Bohm I, et al. [Intracytoplasmic injection (ICSI) of cryopreserved testicular spermatozoa (Cryo-TESE): a retrospective study of the first 250 treatment cycles]. Zentralbl Gynakol. 1998;120:386–90. [German] [PubMed: 9757545]
922.
Parikh FR, Kamat SA, Arawandekar DR, Nadkarni SG, Chibber PJ, Soonawalla FP, et al. Successful pregnancy following microsurgical epididymal sperm aspiration and intracytoplasmic sperm injection. Indian J Urol. 1996;13:26–30.
923.
Meniru GI, Gorgy A, Podsiadly BT, Craft IL. Results of percutaneous epididymal sperm aspiration and intracytoplasmic sperm injection in two major groups of patients with obstructive azoospermia. Hum Reprod. 1997;12:2443–6. [PubMed: 9436681]
924.
Belker AM, Sherins RJ, Dennison-Lagos L, Thorsell LP, Schulman JD. Percutaneous testicular sperm aspiration: a convenient and effective office procedure to retrieve sperm for in vitro fertilization with intracytoplasmic sperm injection. J Urol. 1998;160:2058–62. [PubMed: 9817323]
925.
Devroey P, Liu J, Nagy Z, Goossens A, Tournaye H, Camus M, et al. Pregnancies after testicular sperm extraction and intracytoplasmic sperm injection in non-obstructive azoospermia. Hum Reprod. 1995;10:1457–60. [PubMed: 7593514]
926.
Tournaye H, Liu J, Nagy PZ, Camus M, Goossens A, Silber S, et al. Correlation between testicular histology and outcome after intracytoplasmic sperm injection using testicular spermatozoa. Hum Reprod. 1996;11:127–32. [PubMed: 8671174]
927.
Wurfel W, Krusmann G, Fiedler K, von Hertwig I, Schleyer M, Bohm I, et al. [Zur intrazytoplasmatischen injektion (ICSI) von spermatozoen aus dem nebenhoden (MESA) und dem hoden (TESE): eine retrospektive analyse von uber 500 behandlungszyklen]. Geburtshilfe Frauenheilkd. 1998;58:426–32. [German]
928.
Bispink L, Schroter D, Schroeder-Printzen I, Schalk T, Weidner W, Gehring WG, et al. [Intracytoplasmatic spermatozoa injection with surgically obtained spermatozoa – new paths in treatment of sterility]. Geburtshilfe Frauenheilkd. 1997;57:62–5. [German]
929.
Ubaldi F, Liu J, Nagy Z, Tournaye H, Camus M, Van Steirteghem A, et al. Indications for and results of intracytoplasmic sperm injection (ICSI). Int J Androl. 1995;18(Suppl 2):88–90. [PubMed: 8719867]
930.
Hovatta O, Moilanen J, von Smitten K, Reima I. Testicular needle biopsy, open biopsy, epididymal aspiration and intracytoplasmic sperm injection in obstructive azoospermia. Hum Reprod. 1995;10:2595–9. [PubMed: 8567777]
931.
Dohle GR, Ramos L, Pieters MH, Braat DD, Weber RF. Surgical sperm retrieval and intracytoplasmic sperm injection as treatment of obstructive azoospermia. Hum Reprod. 1998;13:620–3. [PubMed: 9572422]
932.
Son IP, Hong JY, Lee YS, Park YS, Jun JH, Lee HJ, et al. Efficacy of microsurgical epididymal sperm aspiration (MESA) and intracytoplasmic sperm injection (ICSI) in obstructive azoospermia. J Assist Reprod Genet. 1996;13:69–72. [PubMed: 8825171]
933.
Aboulghar MA, Mansour RT, Serour GI, Fahmy I, Kamal A, Tawab NA, et al. Fertilization and pregnancy rates after intracytoplasmic sperm injection using ejaculate semen and surgically retrieved sperm. Fertil Steril. 1997;68:108–11. [PubMed: 9207593]
934.
Kahraman S, Ozgur S, Alatas C, Aksoy S, Balaban B, Evrenkaya T, et al. High implantation and pregnancy rates with testicular sperm extraction and intracytoplasmic sperm injection in obstructive and non-obstructive azoospermia. Hum Reprod. 1996;11:673–6. [PubMed: 8671290]
935.
Mansour RT, Kamal A, Fahmy I, Tawab N, Serour GI, Aboulghar MAA. Intracytoplasmic sperm injection in obstructive and non-obstructive azoospermia. Hum Reprod. 1997;12:1974–9. [PubMed: 9363716]
936.
Kamal A, Fahmy I, Mansour R, Aboulghar M, Serour G, Tawab N, et al. Cryopreservation reduces the motility and viability of surgically retrieved spermatozoa but does not affect the outcome of ICSI. Middle East Fertility Society Journal. 1998;3:178–84.
937.
Oates RD, Mulhall J, Burgess C, Cunningham D, Carson R. Fertilization and pregnancy using intentionally cryopreserved testicular tissue as the sperm source for intracytoplasmic sperm injection in 10 men with non-obstructive azoospermia. Hum Reprod. 1997;12:734–9. [PubMed: 9159434]
938.
Tournaye H, Merdad T, Silber S, Joris H, Verheyen G, Devroey P, et al. No differences in outcome after intracytoplasmic sperm injection with fresh or with frozen-thawed epididymal spermatozoa. Hum Reprod. 1999;14:90–5. [PubMed: 10374101]
939.
De Croo I, Van der Elst J, Everaert K, De Sutter P, Dhont M. Fertilization, pregnancy and embryo implantation rates after ICSI in cases of obstructive and non-destructive azoospermia. Hum Reprod. 2000;15(18):1383–8. [PubMed: 10831574]
940.
Friedler S, Raziel A, Soffer Y, Strassburger D, Komarovsky D, Ron-El R. Intracytoplasmic injection of fresh and cryopreserved testicular spermatozoa in patients with nonobstructive azoospermia – a comparative study. Fertil Steril. 1997;68:892–7. [PubMed: 9389822]
941.
Letterie GS. Assisted hatching: rationale, technique, and clinical outcomes. Assist Reprod Rev. 1998;8:116–25.
942.
Edi-Osagie EC, Hooper L, Seif MW. The impact of assisted hatching on live birth rates and outcomes of assisted conception: a systematic review. Hum Reprod. 2003;18:1828–35. [PubMed: 12923134]
943.
Slotnick RN, Ortega JE. Monoamniotic twinning and zona manipulation: a survey of U. S. IVF centers correlating zona manipulation procedures and high-risk twinning frequency. J Assist Reprod Genet. 1996;13:381–5. [PubMed: 8739052]
944.
Skupski DW, Streltzoff J, Hutson JM, Rosenwaks Z, Cohen J, Chervenak FA. Early diagnosis of conjoined twins in triplet pregnancy after in vitro fertilization and assisted hatching. J Ultrasound Med. 1995;14:611–5. [PubMed: 7474060]
945.
Coroleu B, Carreras O, Veiga A, Martell A, Martinez F, Belil I, et al. Embryo transfer under ultrasound guidance improves pregnancy rates after in-vitro fertilization. Hum Reprod. 2000;15:616–20. [PubMed: 10686207]
946.
Tang OS, Ng EHY, So WWKS, Ho PC. Ultrasound-guided embryo transfer: a prospective randomized controlled trial. Hum Reprod. 2001;16:2310–5. [PubMed: 11679510]
947.
Matorras R, Urquijo E, Mendoza R, Corcostegui B, Exposito A, Rodriguez-Escudero FJ. Ultrasound-guided embryo transfer improves pregnancy rates and increases the frequency of easy transfers. Hum Reprod. 2002;17:1762–6. [PubMed: 12093836]
948.
Garcia-Velasco JA, Isaza V, Martinez-Salazar J, Landazabal A, Requena A, Remohi J, et al. Transabdominal ultrasound-guided embryo transfer does not increase pregnancy rates in oocyte recipients. Fertil Steril. 2002;78:534–9. [PubMed: 12215329]
949.
Prapas Y, Prapas N, Hatziparasidou A, Prapa S, Nijs M, Vanderzwalmen P, et al. The echoguide embryo transfer maximizes the IVF results. Acta Eur Fertil. 1995;26:113–5. [PubMed: 9098471]
950.
Kan AK, Abdalla HI, Gafar AH, Nappi L, Ogunyemi BO, Thomas A, et al. Embryo transfer: ultrasound-guided versus clinical touch. Hum Reprod. 1999;14:1259–61. [PubMed: 10325274]
951.
Hurley VA, Osborn JC, Leoni MA, Leeton J. Ultrasound-guided embryo transfer: a controlled trial. Fertil Steril. 1991;55:559–62. [PubMed: 2001757]
952.
Sallam HN, Agameya AF, Rahman AF, Ezzeldin F, Sallam AN. Ultrasound measurement of the uterocervical angle before embryo transfer: a prospective controlled study. Hum Reprod. 2002;17:1767–72. [PubMed: 12093837]
953.
Blake D, Proctor M, Johnson N, Olive D. Cleavage stage versus blastocyst stage embryo transfer in assisted conception. Cochrane Database Syst Rev. 2002;(2):CD002118. [PubMed: 12076439]
954.
Van der Auwera I, Debrock S, Spiessens C, Afschrift H, Bakelants E, Meuleman C, et al. A prospective randomized study: day 2 versus day 5 embryo transfer. Hum Reprod. 2002;17:1507–12. [PubMed: 12042269]
955.
Rienzi L, Ubaldi F, Iacobelli M, Ferrero S, Minasi MG, Martinez F, et al. Day 3 embryo transfer with combined evaluation at the pronuclear and cleavage stages compares favourably with day 5 blastocyst transfer. Hum Reprod. 2002;17:1852–5. [PubMed: 12093851]
956.
Utsunomiya T, Naitou T, Nagaki M. A prospective trial of blastocyst culture and transfer. Hum Reprod. 2002;17:1846–51. [PubMed: 12093850]
957.
Frattarelli JL, Leondires MP, McKeeby JL, Miller BT, Segars JH. Blastocyst transfer decreases multiple pregnancy rates in in vitro fertilization cycles: a randomized controlled trial. Fertil Steril. 2003;79:228–30. [PubMed: 12524098]
958.
Wisanto A, Janssens R, Deschacht J, Camus M, Devroey P, Van Steirteghem AC. Performance of different embryo transfer catheters in a human in vitro fertilization program. Fertil Steril. 1989;52:79–84. [PubMed: 2744191]
959.
Meriano J, Weissman A, Greenblatt EM, Ward S, Casper RF. The choice of embryo transfer catheter affects embryo implantation after IVF. Fertil Steril. 2000;74:678–82. [PubMed: 11020506]
960.
van Weering HG, Schats R, McDonnell J, Vink JM, Vermeiden JP, Hompes PG. The impact of the embryo transfer catheter on the pregnancy rate in IVF. Hum Reprod. 2002;17:666–70. [PubMed: 11870120]
961.
McDonald JA, Norman RJ. A randomized controlled trial of a soft double lumen embryo transfer catheter versus a firm single lumen catheter: significant improvements in pregnancy rates. Hum Reprod. 2002;17:1502–6. [PubMed: 12042268]
962.
Boone WR, Johnson JE, Blackhurst DM, Crane MM. Cook versus Edwards–Wallace: are there differences in flexible catheters? J Assist Reprod Genet. 2001;18:15–7. [PMC free article: PMC3455811] [PubMed: 11292989]
963.
Ghazzawi IM, al Hasani S, Karaki R, Souso S. Transfer technique and catheter choice influence the incidence of transcervical embryo expulsion and the outcome of IVF. Hum Reprod. 1999;14:677–82. [PubMed: 10221694]
964.
Al Shawaf T, Dave R, Harper J, Linehan D, Riley P, Craft I. Transfer of embryos into the uterus: how much do technical factors affect pregnancy rates? J Assist Reprod Genet. 1993;10:31–6. [PubMed: 8499676]
965.
Friedler S, Schenker JG, Herman A, Lewin A. The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: a critical review. Hum Reprod Update. 1996;2:323–35. [PubMed: 9080229]
966.
Weissman A, Gotlieb L, Casper RF. The detrimental effect of increased endometrial thickness on implantation and pregnancy rates and outcome in an in vitro fertilization program. Fertil Steril. 1999;71:147–9. [PubMed: 9935132]
967.
De Geyter C, Schmitter M, De Geyter M, Nieschlag E, Holzgreve W, Schneider HP. Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1,186 infertile women. Fertil Steril. 2000;73:106–13. [PubMed: 10632422]
968.
Yaman C, Ebner T, Sommergruber M, Polz W, Tews G. Role of three-dimensional ultrasonographic measurement of endometrium volume as a predictor of pregnancy outcome in an IVF-ET program: a preliminary study. Fertil Steril. 2000;74:797–801. [PubMed: 11020526]
969.
Bassil S. Changes in endometrial thickness, width, length and pattern in predicting pregnancy outcome during ovarian stimulation in in vitro fertilization. Ultrasound Obstet Gynecol. 2001;18:258–63. [PubMed: 11555457]
970.
Botta G, Grudzinskas G. Is a prolonged bed rest following embryo transfer useful? Hum Reprod. 1997;12:2489–92. [PubMed: 9436691]
971.
Ben Rafael Z, Ashkenazi J, Shelef M, Farhi J, Voliovitch I, Feldberg D, et al. The use of fibrin sealant in in vitro fertilization and embryo transfer. Int J Fertil Menopausal Stud. 1995;40:303–6. [PubMed: 8748919]
972.
Daya S. Efficacy of progesterone support in the luteal phase following in-vitro fertilization and embryo transfer: meta-analysis of clinical trials. Hum Reprod. 1988;3:731–4. [PubMed: 3065354]
973.
Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod. 2002;17:2287–99. [PubMed: 12202415]
974.
Levine HL. Luteal support with crinone 8% in 1827 women undergoing assisted reproductive technology (ART) procedures. Fertil Steril. 2000;74(Suppl 1):S152–3.
975.
Tarlatzis BC, Bili H. Survey on intracytoplasmic sperm injection: report from the ESHRE ICSI Task Force. Hum Reprod. 1998;13(Suppl 1):165–77. [PubMed: 9663781]
976.
van Rumste MM, Evers JL, Farquhar CM, Blake DA. Intra-cytoplasmic sperm injection versus partial zona dissection, subzonal insemination and conventional techniques for oocyte insemination during in vitro fertilisation. Cochrane Database Syst Rev. 2000;(2):CD001301. Update in: Cochrane Database Syst Rev 2003;(2):CD001301. [PubMed: 10796764]
977.
Mortier A. Prospective controlled randomized study of conventional IVF versus ICSI in the treatment of male factor infertility with moderate teratozoospermia. Abstracts from the 16th Annual Meeting of ESHRE. Abstract no. O-152. Hum Reprod. 2000;15(Abstract book 1):61–2.
978.
Tournaye H, Verheyen G, Albano C, Camus M, Van Landuyt L, Devroey P, et al. Intracytoplasmic sperm injection versus in vitro fertilization: a randomized controlled trial and a meta-analysis of the literature. Fertil Steril. 2002;78:1030–7. [PubMed: 12413989]
979.
Nagy ZP, Liu J, Joris H, Verheyen G, Tournaye H, Camus M, et al. The result of intracytoplasmic sperm injection is not related to any of the three basic sperm parameters. Hum Reprod. 1995;10:1123–9. [PubMed: 7657751]
980.
Mansour RT, Aboulghar MA, Serour GI, Amin YM, Ramzi AM. The effect of sperm parameters on the outcome of intracytoplasmic sperm injection. Fertil Steril. 1995;64:982–6. [PubMed: 7589646]
981.
Liu J, Nagy Z, Joris H, Tournaye H, Smitz J, Camus M, et al. Analysis of 76 total fertilization failure cycles out of 2732 intracytoplasmic sperm injection cycles. Hum Reprod. 1995;10:2630–6. [PubMed: 8567783]
982.
Koci K, Lachman M, Mayer Z, Mrazek M, Jarolimkova K, Tepla O, et al. [MESA, TESA, TESE + ICSI: results of the first 50 cases]. Ceska Gynekol. 1998;63:13–9. [Czech] [PubMed: 9650375]
983.
Palermo GD, Schlegel PN, Hariprashad JJ, Ergun B, Mielnik A, Zaninovic N, et al. Fertilization and pregnancy outcome with intracytoplasmic sperm injection for azoospermic men. Hum Reprod. 1999;14:741–8. [PubMed: 10221707]
984.
Vernaeve V, Tournaye H, Osmanagaoglu K, Verheyen G, Van Steirteghem A, Devroey P. Intracytoplasmic sperm injection with testicular spermatozoa is less successful in men with nonobstructive azoospermia than in men with obstructive azoospermia. Fertil Steril. 2003;79:529–33. [PubMed: 12620435]
985.
Kastrop PM, Weima SM, van Kooij RJ, te Velde ER. Comparison between intracytoplasmic sperm injection and in-vitro fertilization (IVF) with high insemination concentration after total fertilization failure in a previous IVF attempt. Hum Reprod. 1999;14:65–9. [PubMed: 10374096]
986.
Gabrielsen A, Petersen K, Mikkelsen AL, Lindenberg S. Intracytoplasmic sperm injection does not overcome an oocyte defect in previous fertilization failure with conventional in-vitro fertilization and normal spermatozoa. Hum Reprod. 1996;11:1963–5. [PubMed: 8921072]
987.
Ziebe S, Andersen AN, Andersen AG, Mikkelsen AL, Lindenberg S. Results of intracytoplasmic sperm injection in relation to indication. Acta Obstet Gynecol Scand. 1997;76:335–9. [PubMed: 9174427]
988.
Miller KF, Falcone T, Goldberg JM, Attaran M. Previous fertilization failure with conventional in vitro fertilization is associated with poor outcome of intracytoplasmic sperm injection. Fertil Steril. 1998;69:242–5. [PubMed: 9496336]
989.
Tomas C. Low pregnancy rate is achieved in patients treated with intracytoplasmic sperm injection due to previous low or failed fertilization in in-vitro fertilization. Hum Reprod. 1998;13:65–70. [PubMed: 9512230]
990.
Oehninger S, Veeck L, Lanzendorf S, Maloney M, Toner J, Muasher S. Intracytoplasmic sperm injection: achievement of high pregnancy rates in couples with severe male factor infertility is dependent primarily uponfemale and not male factors. Fertil Steril. 1995;64:977–81. [PubMed: 7589645]
991.
Mercan R, Oehninger S, Muasher SJ, Toner JP, Mayer J Jr, Lanzendorf SE. Impact of fertilization history and semen parameters on ICSI outcome. J Assist Reprod Genet. 1998;15:39–45. [PMC free article: PMC3468197] [PubMed: 9493065]
992.
Abdelmassih R, Sollia S, Moretto M, Acosta AA. Female age is an important parameter to predict treatment outcome in intracytoplasmic sperm injection. Fertil Steril. 1996;65:573–7. [PubMed: 8774289]
993.
Friedler S, Raziel A, Strassburger D, Schachter M, Soffer Y, Ron-El R. Factors influencing the outcome of ICSI in patients with obstructive and non-obstructive azoospermia: a comparative study. Hum Reprod. 2002;17:3114–21. [PubMed: 12456610]
994.
Moomjy M, Sills ES, Rosenwaks Z, Palermo GD. Implications of complete fertilization failure after intracytoplasmic sperm injection for subsequent fertilization and reproductive outcome. Hum Reprod. 1998;13:2212–6. [PubMed: 9756298]
995.
van Rumste MM, Evers JL, Farquhar CM, Blake DA. Intra-cytoplasmic sperm injection versus partial zona dissection, subzonal insemination and conventional techniques for oocyte insemination during in vitro fertilisation. Cochrane Database Syst Rev. 2000;(2):CD001301. Update in: Cochrane Database Syst Rev 2003;(2):CD001301. [PubMed: 10796764]
996.
Bhattacharya S, Hamilton MP, Shaaban M, Khalaf Y, Seddler M, Ghobara T, et al. Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non-male-factor infertility: a randomised controlled trial. Lancet. 2001;357:2075–9. [PubMed: 11445099]
997.
Moller H, Skakkebaek NE. Risk of testicular cancer in subfertile men: case–control study. BMJ. 1999;318:559–62. [PMC free article: PMC27753] [PubMed: 10037628]
998.
Petersen PM, Giwercman A, Skakkebaek NE, Rorth M. Gonadal function in men with testicular cancer. Semin Oncol. 1998;25:224–33. [PubMed: 9562456]
999.
Rieker PP. How should a man with testicular cancer be counseled and what information is available to him? Semin Urol Oncol. 1996;14:17–23. [PubMed: 8833384]
1000.
Pryor JP. Fertility considerations in the patient with testis cancer. Curr Opin Urol. 1998;8:547–50. [PubMed: 17039075]
1001.
Rosenlund B, Sjoblom P, Tornblom M, Hultling C, Hillensjo T. In-vitro fertilization and intracytoplasmic sperm injection in the treatment of infertility after testicular cancer. Hum Reprod. 1998;13:414–8. [PubMed: 9557849]
1002.
Chandley AC. Chromosome anomalies and Y chromosome microdeletions as causal factors in male infertility. Hum Reprod. 1998;13(Suppl 1):45–50. [PubMed: 9663769]
1003.
Reijo R, Lee TY, Salo P, Alagappan R, Brown LG, Rosenberg M, et al. Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat Genet. 1995;10:383–93. [PubMed: 7670487]
1004.
Vogt PH, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, Kiesewetter F, et al. Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet. 1996;5:933–43. [PubMed: 8817327]
1005.
Jaffe T, Oates RD. Genetic abnormalities and reproductive failure. Urol Clin North Am. 1994;21:389–408. [PubMed: 8059496]
1006.
Dohle GR, Veeze HJ, Overbeek SE, van den Ouweland AM, Halley DJ, Weber RF, et al. The complex relationships between cystic fibrosis and congenital bilateral absence of the vas deferens: clinical, electrophysiological and genetic data. Hum Reprod. 1999;14:371–4. [PubMed: 10099982]
1007.
Irvine DS. Epidemiology and aetiology of male infertility. Hum Reprod. 1998;13(Suppl 1):33–44. [PubMed: 9663768]
1008.
Testart J, Gautier E, Brami C, Rolet F, Sedbon E, Thebault A. Intracytoplasmic sperm injection in infertile patients with structural chromosome abnormalities. Hum Reprod. 1996;11:2609–12. [PubMed: 9021360]
1009.
van der Ven K, Peschka B, Montag M, Lange R, Schwanitz G, van der Ven HH. Increased frequency of congenital chromosomal aberrations in female partners of couples undergoing intracytoplasmic sperm injection. Hum Reprod. 1998;13:48–54. [PubMed: 9512227]
1010.
Meschede D, Lemcke B, Exeler JR, De Geyter C, Behre HM, Nieschlag E, et al. Chromosome abnormalities in 447 couples undergoing intracytoplasmic sperm injection – prevalence, types, sex distribution and reproductive relevance. Hum Reprod. 1998;13:576–82. [PubMed: 9572415]
1011.
Pauer HU, Hinney B, Michelmann HW, Krasemann EW, Zoll B, Engel W. Relevance of genetic counselling in couples prior to intracytoplasmic sperm injection. Hum Reprod. 1997;12:1909–12. [PubMed: 9363704]
1012.
Mau UA, Backert IT, Kaiser P, Kiesel L. Chromosomal findings in 150 couples referred for genetic counselling prior to intracytoplasmic sperm injection. Hum Reprod. 1997;12:930–7. [PubMed: 9194642]
1013.
Dohle GR, Halley DJ, Van Hemel JO, van den Ouwel AM, Pieters MH, Weber RF, et al. Genetic risk factors in infertile men with severe oligozoospermia and azoospermia. Hum Reprod. 2002;17:13–6. [PubMed: 11756355]
1014.
Palermo GD, Colombero LT, Hariprashad JJ, Schlegel PN, Rosenwaks Z. Chromosome analysis of epididymal and testicular sperm in azoospermic patients undergoing ICSI. Hum Reprod. 2002;17:570–5. [PubMed: 11870105]
1015.
Burrello N, Calogero AE, De Palma A, Grazioso C, Torrisi C, Barone N, et al. Chromosome analysis of epididymal and testicular spermatozoa in patients with azoospermia. Eur J Hum Genet. 2002;10:362–6. [PubMed: 12080387]
1016.
Van de Ven K, Messer L, van der Ven H, Jeyendram RS, Ober C. Cystic fibrosis mutation screening in healthy men with reduced sperm quality. Hum Reprod. 1995;11:513–17. [PubMed: 8671256]
1017.
Van Assche E, Bonduelle M, Tournaye H, Joris H, Verheyen G, Devroey P, et al. Cytogenetics of infertile men. Hum Reprod. 1996;11(Suppl 4):1–24. [PubMed: 9147109]
1018.
van Golde RJ, Wetzels AM, de Graaf R, Tuerlings JH, Braat DD, Kremer JA. Decreased fertilization rate and embryo quality after ICSI in oligozoospermic men with microdeletions in the azoospermia factor c region of the Y chromosome. Hum Reprod. 2001;16:289–92. [PubMed: 11157822]
1019.
Oliva R, Margarit E, Ballesca JL, Carrio A, Sanchez A, Mila M, et al. Prevalence of Y chromosome microdeletions in oligospermic and azoospermic candidates for intracytoplasmic sperm injection. Fertil Steril. 1998;70:506–10. [PubMed: 9757880]
1020.
Silber SJ, Alagappan R, Brown LG, Page DC. Y chromosome deletions in azoospermic and severely oligozoospermic men undergoing intracytoplasmic sperm injection after testicular sperm extraction. Hum Reprod. 1998;13:3332–7. [PubMed: 9886509]
1021.
Kobayashi K, Mizuno K, Hida A, Komaki R, Tomita K, Matsushita I, et al. PCR analysis of the Y chromosome long arm in azoospermic patients: evidence for a second locus required for spermatogenesis. Hum Mol Genet. 1995;4:974. [PubMed: 7633461]
1022.
Reijo R, Alagappan RK, Patrizio P, Page DC. Severe oligozoospermia resulting from deletions of azoospermia factor gene on Y chromosome. Lancet. 1996;347:1290–3. [PubMed: 8622504]
1023.
Chandley AC, Hargreave TB. Genetic anomaly and ICSI. Hum Reprod. 1996;11:930–2. [PubMed: 8671364]
1024.
Kent-First MG, Kol S, Muallem A, Ofir R, Manor D, Blazer S, et al. The incidence and possible relevance of Y-linked microdeletions in babies born after intracytoplasmic sperm injection and their infertile fathers. Mol Hum Reprod. 1996;2:943–50. [PubMed: 9237238]
1025.
Griffin DK, Hyland P, Tempest HG, Homa ST. Safety issues in assisted reproduction technology: should men undergoing ICSI be screened for chromosome abnormalities in their sperm? Hum Reprod. 2003;18:229–35. [PubMed: 12571154]
1026.
Calderon G, Belil I, Aran B, Veiga A, Gil Y, Boada M, et al. Intracytoplasmic sperm injection versus conventional in-vitro fertilization: first results. Hum Reprod. 1995;10:2835–9. [PubMed: 8747028]
1027.
Stewart GJ, Tyler JP, Cunningham AL, Barr JA, Driscoll GL, Gold J, et al. Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor. Lancet. 1985;2:581–5. [PubMed: 2863597]
1028.
British Andrology Society. British Andrology Society guidelines for the screening of semen donors for donor insemination (1999). Hum Reprod. 1999;14:1823–6. [PubMed: 10402397]
1029.
Subak LL, Adamson GD, Boltz NL. Therapeutic donor insemination: a prospective randomized trial of fresh versus frozen sperm. Am J Obstet Gynecol. 1992;166:1597–604. [PubMed: 1615966]
1030.
Schover LR, Thomas AJ, Miller KF, Falcone T, Attaran M, Goldberg J. Preferences for intracytoplasmic sperm injection versus donor insemination in severe male factor infertility: a preliminary report. Hum Reprod. 1996;11:2461–4. [PubMed: 8981133]
1031.
ESHRE Task Force on Ethics and Law. III. Gamete and embryo donation. Hum Reprod. 2002;17:1407–8. [PubMed: 11980773]
1032.
Olatunbosun OA, Chizen DR, Pierson RA. Screening of potential semen donors for sexual transmitted diseases. West Afr J Med. 1998;17:19–24. [PubMed: 9643155]
1033.
Wortley PM, Hammett TA, Fleming PL. Donor insemination and human immunodeficiency virus transmission. Obstet Gynecol. 1998;91:515–8. [PubMed: 9540933]
1034.
Matorras R, Diez J, Corcostegui B, Gutierrez de Teran G, Garcia JM, Pijoan JI, et al. Spontaneous pregnancy in couples waiting for artificial insemination donor because of severe male infertility. Eur J Obstet Gynecol Reprod Biol. 1996;70:175–8. [PubMed: 9119099]
1035.
Peek JC, Godfrey B, Matthews CD. Estimation of fertility and fecundity in women receiving artificial insemination by donor semen and in normal fertile women. Br J Obstet Gynaecol. 1984;91:1019–24. [PubMed: 6487564]
1036.
Bradshaw KD, Guzick DS, Grun B, Johnson N, Ackerman G. Cumulative pregnancy rates for donor insemination according to ovulatory function and tubal status. Fertil Steril. 1987;48:1051–4. [PubMed: 3678505]
1037.
Mackenna AI, Zegers-Hochschild F, Fernandez EO, Fabres CV, Huidobro CA, Guadarrama AR. Intrauterine insemination: critical analysis of a therapeutic procedure. Hum Reprod. 1992;7:351–4. [PubMed: 1587941]
1038.
Khalil MR, Rasmussen PE, Erb K, Laursen SB, Rex S, Westergaard LG. Intrauterine insemination with donor semen. An evaluation of prognostic factors based on a review of 1131 cycles. Acta Obstet Gynecol Scand. 2001;80:342–8. [PubMed: 11264610]
1039.
Stovall DW, Toma SK, Hammond MG, Talbert LM. The effect of age on female fecundity. Obstet Gynecol. 1991;77:33–6. [PubMed: 1984224]
1040.
Shenfield F, Doyle P, Valentine A, Steele SJ, Tan SL. Effects of age, gravidity and male infertility status on cumulative conception rates following artificial insemination with cryopreserved donor semen: analysis of 2998 cycles of treatment in one centre over 10 years. Hum Reprod. 1993;8:60–4. [PubMed: 8458928]
1041.
Ahmed Ebbiary NA, Martin K, Gibbs A, D’arcy Y, Afnan M, Newton JR. Spontaneous ovulatory cycle donor insemination programme: prognostic indicators of a successful pregnancy. Hum Reprod. 1994;9:1852–8. [PubMed: 7844215]
1042.
Pittrof RU, Shaker A, Dean N, Bekir JS, Campbell S, Tan SL. Success of intrauterine insemination using cryopreserved donor sperm is related to the age of the woman and the number of preovulatory follicles. J Assist Reprod Genet. 1996;13:310–4. [PubMed: 8777345]
1043.
Kang BM, Wu TCJ. Effect of age on intrauterine insemination with frozen donor sperm. Obstet Gynecol. 1996;88:93–8. [PubMed: 8684770]
1044.
Royal College of Obstetricians and Gynaecologists. The Management of Infertility in Secondary Care Evidence-based Guideline No. 3. London: RCOG Press; 1998.
1045.
Hammond MG, Jordan S, Sloan CS. Factors affecting pregnancy rates in a donor insemination program using frozen semen. Am J Obstet Gynecol. 1986;155:480–5. [PubMed: 3752170]
1046.
Chauhan M, Barratt CL, Cooke SMS, Cooke ID. Differences in the fertility of donor insemination recipients – a study to provide prognostic guidelines as to its success and outcome. Fertil Steril. 1989;51:815–9. [PubMed: 2707456]
1047.
Stovall DW, Christman GM, Hammond MG, Talbert LM. Abnormal findings on hysterosalpingography: effects on fecundity in a donor insemination program using frozen semen. Obstet Gynecol. 1992;80:249–52. [PubMed: 1635739]
1048.
O’Brien P, Vandekerckhove P. Intra-uterine versus cervical insemination of donor sperm for subfertility. Cochrane Database Syst Rev. 2000;(2):CD000317. [PubMed: 10796709]
1049.
Patton PE, Burry KA, Thurmond A, Novy MJ, Wolf DP. Intrauterine insemination outperforms intracervical insemination in a randomized, controlled study with frozen, donor semen. Fertil Steril. 1992;57:559–64. [PubMed: 1740198]
1050.
Goldberg JM, Mascha E, Falcone T, Attaran M. Comparison of intrauterine and intracervical insemination with frozen donor sperm: a meta-analysis. Fertil Steril. 1999;72:792–5. [PubMed: 10560979]
1051.
Emperaire JC, Gauzere-Soumireu E, Audebert AJM. Female fertility and donor insemination. Fertil Steril. 1982;37:90–3. [PubMed: 7060762]
1052.
Foss GL, Hull MGR. Results of donor insemination related to specific male infertility and unsuspected female infertility. Br J Obstet Gynaecol. 1986;93:275–8. [PubMed: 3964602]
1053.
Barratt CLR, Cooke S, Chauhan M, Cooke ID. A prospective randomized controlled trial comparing urinary luteinizing hormone dipsticks and basal body temperature charts with time donor insemination. Fertil Steril. 1989;52:394–7. [PubMed: 2673842]
1054.
Federman CA, Dumesic DA, Boone WR, Shapiro SS. Relative efficiency of therapeutic donor insemination using a luteinizing hormone monitor. Fertil Steril. 1990;54:489–92. [PubMed: 2204553]
1055.
Odem RR, Durso NM, Long CA, Pineda JA, Strickler RC, Gast MJ. Therapeutic donor insemination: a prospective randomized study of scheduling methods. Fertil Steril. 1991;55:976–82. [PubMed: 2022274]
1056.
Robinson JN, Lockwood GM, Dalton JD, Franklin PA, Farr MM, Barlow DH. A randomized prospective study to assess the effect of the use of home urinary luteinizing hormone detection on the efficiency of donor insemination. Hum Reprod. 1992;7:63–5. [PubMed: 1551961]
1057.
Flierman PA, Hogerzeil HV, Hemrika DJ. A prospective, randomized, cross-over comparison of two methods of artificial insemination by donor on the incidence of conception: intracervical insemination by straw versus cervical cap. Hum Reprod. 1997;12:1945–8. [PubMed: 9363712]
1058.
Le Lannou D, Lansac J. Artificial procreation with frozen donor semen: experience of the French Federation CECOS. Hum Reprod. 1989;4:757–61. [PubMed: 2691525]
1059.
Cooke ID. Donor insemination: effect of timing and insemination method. In: Templeton A, Cooke ID, O’Brien PMS, editors. Evidence-based Fertility Treatment. London: RCOG Press; 1998.
1060.
Hoy J, Venn A, Halliday J, Kovacs G, Waalwyk K. Perinatal and obstetric outcomes of donor insemination using cryopreserved semen in Victoria, Australia. Hum Reprod. 1999;14:1760–4. [PubMed: 10402384]
1061.
Lydic ML, Liu JH, Rebar RW, Thomas MA, Cedars MI. Success of donor oocyte in in vitro fertilization-embryo transfer in recipients with and without premature ovarian failure. Fertil Steril. 1996;65:98–102. [PubMed: 8557162]
1062.
Sharara FI, Seifer DB. Testing the ovarian reserve in infertile women. Endocrinologist. 1998;8:279–83.
1063.
Weiss G. Fertility in the older woman. Clinical Consultations in Obstetrics and Gynecology. 1996;8:56–9.
1064.
Aubard Y, Teissier MP, Grandjean MH, Le Meur Y, Baudet JH. [Early menopause]. J Gynecol Obstet Biol Reprod (Paris). 1997;26:231–7. [French] [PubMed: 9265043]
1065.
Nielsen J, Sillesen I, Hansen KB. Fertility in women with Turner’s syndrome. Case report and review of literature. Br J Obstet Gynaecol. 1979;86:833–5. [PubMed: 508669]
1066.
Swapp GH, Johnston AW, Watt JL, Couzin DA, Stephen GS. A fertile woman with non-mosaic Turner’s syndrome. Case report and review of the literature. Br J Obstet Gynaecol. 1989;96:876–80. [PubMed: 2669936]
1067.
Christman GM. Turner syndrome-adulthood: reproductive health care and options. Adolesc Pediatr Gynecol. 1989;2:181–5.
1068.
Khastgir G, Abdalla H, Thomas A, Korea L, Latarche L, Studd J. Oocyte donation in Turner’s syndrome: an analysis of the factors affecting the outcome. Hum Reprod. 1997;12:279–85. [PubMed: 9070711]
1069.
Press F, Shapiro HM, Cowell CA, Oliver GD. Outcome of ovum donation in Turner’s syndrome patients. Fertil Steril. 1995;64:995–8. [PubMed: 7589649]
1070.
Foudila T, Soderstrom-Anttila V, Hovatta O. Turner’s syndrome and pregnancies after oocyte donation. Hum Reprod. 1999;14:532–5. [PubMed: 10100005]
1071.
Yaron Y, Ochshorn Y, Amit A, Yovel I, Kogosowki A, Lessing JB. Patients with Turner’s syndrome may have an inherent endometrial abnormality affecting receptivity in oocyte donation. Fertil Steril. 1996;65:1249–52. [PubMed: 8641509]
1072.
Abir R, Fisch B, Raz A, Nitke S, Ben Rafael Z. Preservation of fertility in women undergoing chemotherapy: current approach and future prospects. J Assist Reprod Genet. 1998;15:469–77. [PMC free article: PMC3455041] [PubMed: 9785194]
1073.
Rio B, Letur-Konirsch H, Ajchenbaum-Cymbalista F, Bauduer F, de Ziegler D, Pelissier C, et al. Full-term pregnancy with embryos from donated oocytes in a 36-year-old woman allografted for chronic myeloid leukemia. Bone Marrow Transplant. 1994;13:487–8. [PubMed: 8019474]
1074.
Larsen EC, Loft A, Holm K, Muller J, Brocks V, Andersen AN. Oocyte donation in women cured of cancer with bone marrow transplantation including total body irradiation in adolescence. Hum Reprod. 2000;15:1505–8. [PubMed: 10875857]
1075.
Hull MGR, Akande V, Emovon E. Uterine factors and implantation after IVF. In: Templeton A, Cooke I, O’Brien PMS, editors. Evidence-based Fertility Treatment. London: RCOG Press; 1998.
1076.
Burton G, Abdalla HI, Kirkland A, Studd JW. The role of oocyte donation in women who are unsuccessful with in-vitro fertilization treatment. Hum Reprod. 1992;7:1103–5. [PubMed: 1400934]
1077.
Borini A, Bafaro MG, Bianchi L, Violini F, Bonu MA, Flamigni C. Oocyte donation programme: results obtained with intracytoplasmic sperm injection in cases of severe male factor infertility or previous failed fertilization. Hum Reprod. 1996;11:548–50. [PubMed: 8671263]
1078.
Van Voorhis BJ, Williamson RA, Gerard JL, Hammitt DG, Syrop CH. Use of oocytes from anonymous, matched, fertile donors for prevention of heritable genetic diseases. J Med Genet. 1992;29:398–9. [PMC free article: PMC1015990] [PubMed: 1619634]
1079.
Wallerstein R, Jansen V, Grifo JA, Berkeley AS, Noyes N, Licker J, et al. Genetic screening of prospective oocyte donors. Fertil Steril. 1998;70:52–5. [PubMed: 9660420]
1080.
Cohen MA, Lindheim SR, Sauer MV. Donor age is paramount to success in oocyte donation. Hum Reprod. 1999;14:2755–8. [PubMed: 10548617]
1081.
ACOG committee opinion. Genetic screening of gamete donors. Number 192, October 1997. Committee on Genetics. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 1998;60:190–2. [PubMed: 9509963]
1082.
Aird I, Barratt C, Murdoch A, Jacobs H, Mills J, Kennedy R, et al. BFS recommendations for good practice on the screening of egg and embryo donors. Hum Fertil (Camb). 2000;3:162–5. [PubMed: 11844372]
1083.
2002 guidelines for gamete and embryo donation. Fertil Steril. 2002;77(6 Suppl 5):S1–16. [PubMed: 12069861]
1084.
Selva J. [The female donor – the male donor. A genetic control programme developed by the CECOS federation]. Contracept Fertil Sex. 1990;18:510–2. [French]
1085.
Johansson ED, Larsson-Cohn U, Gemzell C. Monophasic basal body temperature in ovulatory menstrual cycles. Am J Obstet Gynecol. 1972;113:933–7. [PubMed: 4635743]
1086.
Moomjy M, Mangieri R, Beltramone F, Cholst I, Veeck L, Rosenwaks Z. Shared oocyte donation: society’s benefits. Fertil Steril. 2000;73:1165–9. [PubMed: 10856476]
1087.
Lindheim SR, Frumovitz M, Sauer MV. Recruitment and screening policies and procedures used to establish a paid donor oocyte registry. Hum Reprod. 1998;13:2020–4. [PubMed: 9740470]
1088.
Kan AK, Abdalla HI, Ogunyemi BO, Korea L, Latarche E. A survey of anonymous oocyte donors: demographics. Hum Reprod. 1998;13:2762–6. [PubMed: 9804227]
1089.
Murray C, Golombok S. Oocyte and semen donation: a survey of UK licensed centres. Hum Reprod. 2000;15:2133–9. [PubMed: 11006186]
1090.
Frydman R, Letur-Konirsch H, de Ziegler D, Bydlowski M, Raoul-Duval A, Selva J. A protocol for satisfying the ethical issues raised by oocyte donation: the free, anonymous, and fertile donors. Fertil Steril. 1990;53:666–72. [PubMed: 2318325]
1091.
Abdalla H, Shenfield F, Latarche E. Statutory information for the children born of oocyte donation in the UK: what will they be told in 2008? Hum Reprod. 1998;13:1106–9. [PubMed: 9619580]
1092.
Khamsi F, Endman MW, Lacanna IC, Wong J. Some psychological aspects of oocyte donation from known donors on altruistic basis. Fertil Steril. 1997;68:323–7. [PubMed: 9240264]
1093.
Soderstrom-Anttila V. Follow-up study of Finnish volunteer oocyte donors concerning their attitudes to oocyte donation. Hum Reprod. 1995;10:3073–6. [PubMed: 8747077]
1094.
Oskarsson T, Dimitry ES, Mills MS, Hunt J, Winston RM. Attitudes towards gamete donation among couples undergoing in vitro fertilization. Br J Obstet Gynaecol. 1991;98:351–6. [PubMed: 2031893]
1095.
Bolton V, Golombok S, Cook R, Bish A, Rust J. A comparative study of attitudes towards donor insemination and egg donation in recipients, potential donors and the public. J Psychosom Obstet Gynaecol. 1991;12:217–28.
1096.
Schover LR, Collins RL, Quigley MM, Blankstein J, Kanoti G. Psychological follow-up of women evaluated as oocyte donors. Hum Reprod. 1991;6:1487–91. [PubMed: 1770150]
1097.
Klock SC, Braverman AM, Rausch DT. Predicting anonymous egg donor satisfaction: a preliminary study. J Womens Health. 1998;7:229–37. [PubMed: 9555688]
1098.
Lindheim SR, Chase J, Sauer MV. Assessing the influence of payment on motivations of women participating as oocyte donors. Gynecol Obstet Invest. 2001;52:89–92. [PubMed: 11586034]
1099.
Broderick P, Walker I. Information access and donated gametes: how much do we know about who wants to know? Hum Reprod. 1995;10:3338–41. [PubMed: 8822472]
1100.
McWhinnie A. Gamete donation and anonymity: should offspring from donated gametes continue to be denied knowledge of their origins and antecedents? Hum Reprod. 2001;16:807–17. [PubMed: 11331622]
1101.
Ahuja KK, Simons EG, Fiamanya W, Dalton M, Armar NA, Kirkpatrick P, et al. Egg-sharing in assisted conception: ethical and practical considerations. Hum Reprod. 1996;11:1126–31. [PubMed: 8671404]
1102.
Check JH, O’Shaughnessy A, Lurie D, Fisher C, Adelson HG. Evaluation of the mechanism for higher pregnancy rates in donor oocyte recipients by comparison of fresh with frozen embryo transfer pregnancy rates in a shared oocyte programme. Hum Reprod. 1995;10:3022–7. [PubMed: 8747065]
1103.
Ahuja KK, Mostyn BJ, Simons EG. Egg sharing and egg donation: attitudes of British egg donors and recipients. Hum Reprod. 1997;12:2845–52. [PubMed: 9455866]
1104.
Joint Council for Clinical Oncology. Management of Gonadal Toxicity Resulting from the Treatment of Adult Cancer Report of a Working Party of the Joint Council for Clinical Oncology. London: Royal College of Physicians and Royal College of Radiologists; 1998.
1105.
Anderson RA. A strategy for future reproductive services for survivors of cancer. Hum Fertil (Camb). 2003;6:113–5. [PubMed: 12960442]
1106.
Agarwal A, Newton RA. The effect of cancer on semen quality after cryopreservation of sperm. Andrologia. 1991;23:329–32. [PubMed: 1801608]
1107.
Shekarriz M, Tolentino MV Jr, Ayzman I, Lee JC, Thomas AJ Jr, Agarwal A. Cryopreservation and semen quality in patients with Hodgkin’s disease. Cancer. 1995;75:2732–6. [PubMed: 7743478]
1108.
Agarwal A, Shekarriz M, Sidhu RK, Thomas AJ Jr. Value of clinical diagnosis in predicting the quality of cryopreserved sperm from cancer patients. J Urol. 1996;155:934–8. [PubMed: 8583611]
1109.
Agarwal A, Tolentino MV Jr, Sidhu RS, Ayzman I, Lee JC, Thomas AJ Jr, et al. Effect of cryopreservation on semen quality in patients with testicular cancer. Urology. 1995;46:382–9. [PubMed: 7660514]
1110.
Chen SU, Ho HN, Chen HF, Huang SC, Lee TY, Yang YS. Pregnancy achieved by intracytoplasmic sperm injection using cryopreserved semen from a man with testicular cancer. Hum Reprod. 1996;11:2645–7. [PubMed: 9021367]
1111.
Sharma RK, Kohn S, Padron OF, Agarwal A. Effect of artificial stimulants on cryopreserved spermatozoa from cancer patients. J Urol. 1997;157:521–4. [PubMed: 8996347]
1112.
Hallak J, Sharma RK, Thomas AJ Jr, Agarwal A. Why cancer patients request disposal of cryopreserved semen specimens posttherapy: a retrospective study. Fertil Steril. 1998;69:889–93. [PubMed: 9591498]
1113.
Kelleher S, Wishart SM, Liu PY, Turner L, Di Pierro I, Conway AJ, et al. Long-term outcomes of elective human sperm cryostorage. Hum Reprod. 2001;16:2632–9. [PubMed: 11726587]
1114.
Ragni G, Somigliana E, Restelli L, Salvi R, Arnoldi M, Paffoni A. Sperm banking and rate of assisted reproduction treatment: insights from a 15-year cryopreservation program for male cancer patients. Cancer. 2003;97:1624–9. [PubMed: 12655518]
1115.
Lass A, Akagbosu F, Abusheikha N, Hassouneh M, Blayney M, Avery S, et al. A programme of semen cryopreservation for patients with malignant disease in a tertiary infertility centre: lessons from 8 years’ experience. Hum Reprod. 1998;13:3256–61. [PubMed: 9853891]
1116.
Khalifa E, Oehninger S, Acosta AA, Morshedi M, Veeck L, Bryzyski RG, et al. Successful fertilization and pregnancy outcome in in-vitro fertilization using cryopreserved/thawed spermatozoa from patients with malignant diseases. Hum Reprod. 1992;7:105–8. [PubMed: 1551943]
1117.
Hallak J, Hendin BN, Thomas AJ Jr, Agarwal A. Investigation of fertilizing capacity of cryopreserved spermatozoa from patients with cancer. J Urol. 1998;159:1217–20. [PubMed: 9507838]
1118.
Ginsburg ES, Yanushpolsky EH, Jackson KV. In vitro fertilization for cancer patients and survivors. Fertil Steril. 2001;75:705–10. [PubMed: 11287023]
1119.
Agarwal A, Sidhu RK, Shekarriz M, Thomas AJ Jr. Optimum abstinence time for cryopreservation of semen in cancer patients. J Urol. 1995;154:86–8. [PubMed: 7776463]
1120.
British Fertility Society. Fertility services. a strategy for fertility services for survivors of childhood cancer. Hum Fertil (Camb). 2003;6:A1–40. [PubMed: 12869793]
1121.
Posada MN, Kolp L, Garcia JE. Fertility options for female cancer patients: facts and fiction. Fertil Steril. 2001;75:647–53. [PubMed: 11287012]
1122.
Porcu E, Fabbri R, Seracchioli R, Ciotti PM, Magrini O, Flamigni C. Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes. Fertil Steril. 1997;68:724–6. [PubMed: 9341619]
1123.
Porcu E, Fabbri R, Ciotti PM. Cycles of human oocyte cryopreservation and intracytoplasmic sperm injection: results of 112 cycles. Abstract no. O-004. Fertil Steril. 2000;72(3):S2.
1124.
Oktay K. Ovarian tissue cryopreservation and transplantation: preliminary findings and implications for cancer patients. Hum Reprod Update. 2001;7:526–34. [PubMed: 11727860]
1125.
Kim SS. Ovarian tissue banking for cancer patients. To do or not to do? Hum Reprod. 2003;18:1759–61. [PubMed: 12923123]
1126.
National Statistics. Births, 2001: Summary of key live birth statistics. 2001. [Accessed 9 January 2004]. [http://www​.statistics​.gov.uk/StatBase/xsdataset​.asp?vlnk=5672&Pos​=&ColRank​=1&Rank=272]
1127.
Lambert RD. Safety issues in assisted reproduction technology: the children of assisted reproduction confront the responsible conduct of assisted reproductive technologies. Hum Reprod. 2002;17:3011–5. [PubMed: 12456595]
1128.
Ludwig M, Katalinic A. Malformation rate in fetuses and children conceived after ICSI: results of a prospective cohort study. Reprod Biomed Online. 2002;5:171–8. [PubMed: 12419043]
1129.
Van Steirteghem A, Bonduelle M, Devroey P, Liebaers I. Follow-up of children born after ICSI. Hum Reprod Update. 2002;8:111–6. [PubMed: 12099626]
1130.
Maher ER, Brueton LA, Bowdin SC, Luharia A, Cooper W, Cole TR, et al. Beckwith–Wiedemann syndrome and assisted reproduction technology (ART). J Med Genet. 2003;40:62–4. [PMC free article: PMC1735252] [PubMed: 12525545]
1131.
DeBaun MR, Niemitz EL, Feinberg AP. Association of in vitro fertilization with Beckwith–Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am J Hum Genet. 2003;72:156–60. [PMC free article: PMC378620] [PubMed: 12439823]
1132.
Cox GF, Burger J, Lip V, Mau UA, Sperling K, Wu BL, et al. Intracytoplasmic sperm injection may increase the risk of imprinting defects. Am J Hum. 2002;71:162–4. [PMC free article: PMC384973] [PubMed: 12016591]
1133.
Tanbo T, Bakketeig LS, Jacobsen G, Orstavik KH, Lie RT, Lyngstadaas A. Children Born from Intracytoplasmic Sperm Injection. Oslo: The Norwegian Centre for Health Technology Assessment (SMM); 2002.
1134.
Doyle P, Bunch KJ, Beral V, Draper GJ. Cancer incidence in children conceived with assisted reproduction technology. Lancet. 1998;352:452–3. [PubMed: 9708757]
1135.
Bergh T, Ericson A, Hillensjo T, Nygren KG, Wennerholm UB. Deliveries and children born after in-vitro fertilisation in Sweden 1982–95: a retrospective cohort study. Lancet. 1999;354:1579–85. [PubMed: 10560671]
1136.
Bruinsma F, Venn A, Lancaster P, Speirs A, Healy D. Incidence of cancer in children born after in-vitro fertilization. Hum Reprod. 2000;15:604–7. [PubMed: 10686204]
1137.
Klip H, Burger CW, de Kraker J, van Leeuwen FE. Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. Hum Reprod. 2001;16:2451–8. [PubMed: 11679537]
1138.
Moll AC, Imhof SM, Cruysberg JR, Schouten-van Meeteren AY, Boers M, van Leeuwen FE. Incidence of retinoblastoma in children born after in-vitro fertilisation. Lancet. 2003;361:309–10. [PubMed: 12559867]
1139.
Brandes JM, Scher AI. Growth and development of children conceived by in vitro fertilization. Pediatrics. 1992;90:424–9. [PubMed: 1518701]
1140.
Raoul-Duval A, Bertrand-Servais M, Letur-Konirsch H, Frydman R. Psychological follow-up of children born after in-vitro fertilization. Hum Reprod. 1994;9:1097–101. [PubMed: 7962382]
1141.
Golombok S, Cook R, Bish A, Murray C. Families created by the new reproductive technologies: quality of parenting and social and emotional development of the children. Child Dev. 1995;66:285–98. [PubMed: 7750366]

References from 2013 guideline

  • Abdel et al., 1990

    Abdel Gadir A, Mowafi RS, Alnaser HM, Alrashid AH, Alonezi OM, Shaw RW. Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Clinical Endocrinology. 1990;33:585–592. [PubMed: 2123759]
  • Aboulghar et al., 2003

    Aboulghar MA, Mansour RT, Serour GI, Al-Inany HG. Diagnosis and management of unexplained infertility: an update. Archives of Gynecology and Obstetrics. 2003;267(4):177–188. [PubMed: 12592415]
  • Aboulghar et al., 2010

    Aboulghar M, Saber W, Amin Y, Aboulghar M, Mansour R, Serour G. Prospective, randomized study comparing highly purified urinary follicle-stimulating hormone (FSH) and recombinant FSH for in vitro fertilization/intracytoplasmic sperm injection in patients with polycystic ovary syndrome. Fertility and Sterility. 2010;94:2332–2334. [PubMed: 20188364]
  • Abu et al., 2011

    Abu Hashim H, El Lakany N, Sherief L. Combined metformin and clomiphene citrate versus laparoscopic ovarian diathermy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial. Journal of Obstetrics and Gynaecology Research. 2011;37:169–177. [PubMed: 21114583]
  • Abu et al., 2011c

    Abu Hashim H, El-Shafei M, Badawy A, Wafa A, Zaglol H. Does laparoscopic ovarian diathermy change clomiphene-resistant PCOS into clomiphene-sensitive? Archives of Gynecology and Obstetrics. 2011;284:503–507. [PubMed: 21594601]
  • Abu et al., 2010a

    Abu Hashim H, Shokeir T, Badawy A. Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial. Fertility and Sterility. 2010;94:1405–1409. [PubMed: 19732888]
  • Abu et al., 2011b

    Abu Hashim H, Wafa A, El Rakhawy M. Combined metformin and clomiphene citrate versus highly purified FSH for ovulation induction in clomiphene-resistant PCOS women: a randomised controlled trial. Gynecological Endocrinology. 2011;27:190–196. [PubMed: 20568955]
  • Abu et al., 2011a

    Abu Hashim H, Wafa A, El Rakhawy M. Combined metformin and clomiphene citrate versus highly purified FSH for ovulation induction in clomiphene-resistant PCOS women: A randomised controlled trial. Gynecological Endocrinology. 2011;27:196. [PubMed: 20568955]
  • Aflatoonian et al., 2009

    Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L. Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-Mullerian hormone versus small antral follicle count 2–6 mm). Journal of Assisted Reproduction and Genetics. 2009;26:319–325. [PMC free article: PMC2729857] [PubMed: 19543966]
  • Agarwal et al., 2004

    Agarwal A, Ranganathan P, Kattal N, Pasqualotto F, Hallak J, Khayal S, Mascha E. Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimens. Fertility and Sterility. 2004;81:342–348. [PubMed: 14967371]
  • Agostini et al., 2011

    Agostini F, Monti F, De Pascalis L, Paterlini M, La Sala G, Blickstein I. Psychosocial support for infertile couples during assisted reproductive technology treatment. Fertility and Sterility. 2011;95:707–710. [PubMed: 20643403]
  • Al-Azemi et al., 2011

    Al-Azemi M, Killick SR, Duffy S, Pye C, Refaat B, Hill N, Ledger W. Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction. Human Reproduction. 2011;26:414–422. [PubMed: 21147822]
  • AlInany et al., 2011

    AlInany Hesham G, Youssef AFM Mohamed, Aboulghar Mohamed, Broekmans Frank, Sterrenburg Monique, Smit Janine, Abou Setta Ahmed M. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database of Systematic Reviews. 2011 [PubMed: 21563131]
  • Althuis et al., 2005a

    Althuis MD, Moghissi KS, Westhoff CL, Scoccia B, Lamb EJ, Lubin JH, Brinton LA. Uterine cancer after use of clomiphene citrate to induce ovulation. American Journal of Epidemiology. 2005;161:607–615. [PubMed: 15781949]
  • Althuis et al., 2005

    Althuis MD, Scoccia B, Lamb EJ, Moghissi KS, Westhoff CL, Mabie JE, Brinton LA. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. American Journal of Obstetrics and Gynecology. 2005;193:668–674. [PubMed: 16150258]
  • Andersen et al., 2011

    Andersen AN, Goossens V, Gianaroli L, Felberbaum R, de MJ, Nygren KG. Assisted reproductive technology in Europe, 2003. Results generated from European registers by ESHRE. Hum Reprod. 2007;22(6):1513–1525. [PubMed: 17470881]
  • Andersen et al., 2011

    Andersen AN, Witjes H, Gordon K, Mannaerts B. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Human Reproduction. 2011;26:3413–3423. [PubMed: 21954280]
  • Anderson et al., 2000

    Anderson A-M, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320:1708–12. [PMC free article: PMC27416] [PubMed: 10864550]
  • Antoine et al., 1990

    Antoine JM, Salat-Baroux J, Alvarez S, Cornet D, Tibi C, Mandelbaum J, Plachot M. Ovarian stimulation using human menopausal gonadotrophins with or without LHRH analogues in a long protocol for in-vitro fertilization: a prospective randomized comparison. Human Reproduction. 1990;5:565–569. [PubMed: 2144296]
  • Ashrafi et al., 2011

    Ashrafi M, Kiani K, Ghasemi A, Rastegar F, Nabavi M. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety. Archives of Gynecology and Obstetrics. 2011;284:1431–1438. [PubMed: 21210134]
  • Ata et al., 2010

    Ata B, Kucuk M, Seyhan A, Urman B. Effect of high-dose estrogen in luteal phase support on live birth rates after assisted reproduction treatment cycles. Journal of Reproductive Medicine. 2010;55:485–490. [PubMed: 21291034]
  • Atay et al., 2006

    Atay V, Cam C, Muhcu M, Cam M, Karateke A. Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of International Medical Research. 2006;34:73–76. [PubMed: 16604826]
  • Audrins et al., 1999

    Audrins P, Holden CA, McLachlan RI, Kovacs GT. Semen storage for special purposes at Monash IVF from 1977 to 1997. Fertility and Sterility. 1999;72:179–181. [PubMed: 10428172]
  • Baart et al., 2007

    Baart EB, Martini E, Eijkemans MJ, Van Opstal D, Beckers NG, Verhoeff A, Macklon NS, Fauser BC. Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Human Reproduction. 2007;22:980–988. [PubMed: 17204525]
  • Badawy et al., 2009b

    Badawy A, Abdel Aal I, Abulatta M. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertility and Sterility. 2009;92:849–852. [PubMed: 17582406]
  • Badawy et al., 2009a

    Badawy A, Shokeir T, Allam AF, Abdelhady H. Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility. Acta Obstetricia et Gynecologica Scandinavica. 2009;88:187–191. [PubMed: 19089782]
  • Badawy et al., 2008a

    Badawy AM, Allam A, Abulatta M. Extending clomiphene treatment in clomiphene-resistant women with PCOS: A randomized controlled trial. Reproductive Biomedicine Online. 2008;16:825–829. [PubMed: 18549692]
  • Balasch et al., 2001

    Balasch J, Creus M, Fabregues F, Civico S, Carmona F, Puerto B, Casamitjana R, Vanrell JA. The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction. Journal of Assisted Reproduction and Genetics. 2001;18:250–256. [PMC free article: PMC3455335] [PubMed: 11464575]
  • Balasch et al., 2000

    Balasch J, Fabregues F, Creus M, Casamitjana R, Puerto B, Vanrell JA. Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: A prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol. Journal of Assisted Reproduction and Genetics. 2000;17:561–565. [PMC free article: PMC3455454] [PubMed: 11209536]
  • Balasch et al., 1996

    Balasch J, Fabregues F, Creus M, Moreno V, Puerto B, Penarrubia J, Carmona F, Vanrell JA. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization. Human Reproduction. 1996;11:2400–2404. [PubMed: 8981119]
  • Bancsi et al., 2004

    Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, te Velde ER. Impact of repeated antral follicle counts on the prediction of poor ovarian response in women undergoing in vitro fertilization. Fertility and Sterility. 2004;81:35–41. [PubMed: 14711542]
  • Bancsi et al., 2004a

    Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, te Velde ER. Predicting poor ovarian response in IVF: use of repeat basal FSH measurement. Journal of Reproductive Medicine. 2004;49:187–194. [PubMed: 15098888]
  • Bancsi et al., 2002

    Bancsi LFJM, Broekmans FJM, Eijkemans MJC, de Jong F, Habbema J, Dik F, te Velde E. Predictors of poor ovarian response in in vitro fertilization: A prospective study comparing basal markers of ovarian reserve. Fertility and Sterility. 2002;77:328–336. [PubMed: 11821092]
  • Baran et al., 2010

    Baran S, Api M, Goksedef BP, Cetin A. Comparison of metformin and clomiphene citrate therapy for induction of ovulation in the polycystic ovary syndrome. Archives of Gynecology and Obstetrics. 2010;282:439–443. [PubMed: 20473763]
  • Barrenetxea et al., 2008

    Barrenetxea G, Agirregoikoa JA, Jiménez MR, de Larruzea AL, Ganzabal T, Carbonero K. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertility and Sterility. 2008;89:546–553. [PubMed: 17531989]
  • Barri et al., 2010

    Barri PN, Tur R, Martinez F, Coroleu B. Mild stimulation in assisted reproduction. Gynecological Endocrinology. 2010;26:261–264. [PubMed: 20059432]
  • Battaglia et al., 2000

    Battaglia C, Regnani G, Petraglia F, Genazzani AR, Artini PG, Volpe A. The use of a starting dose of recombinant follicle stimulating hormone for controlled ovarian hyperstimulation: a randomized pilot study2837. Gynecological Endocrinology. 2000;14:311–315. [PubMed: 11109969]
  • Bayar et al., 2006

    Bayar U, Basaran M, Kiran S, Coskun A, Gezer S. Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility. 2006;86:1447–1451. [PubMed: 17070196]
  • Bayram et al., 2004

    Bayram N, van Wely M, Kaaijk EM, Bossuyt PM, van der V. Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial. BMJ. 2004;328:192. [PMC free article: PMC318481] [PubMed: 14739186]
  • Begum et al., 2009

    Begum MR, Ferdous J, Begum A, Quadir E. Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility. 2009;92:853–857. [PubMed: 18177867]
  • Ben-Haroush et al., 2011

    Ben-Haroush A, Farhi J, Zahalka Y, Sapir O, Meizner I, Fisch B. Small antral follicle count 2–5 mm) and ovarian volume for prediction of pregnancy in in vitro fertilization cycles. Gynecological Endocrinology. 2011;27:748–752. [PubMed: 21879794]
  • Bensdorp et al., 2010

    Bensdorp Alexandra, Cohlen Ben J, Heineman Jan Maas, Vanderkerchove Patrick. Intra-uterine insemination for male subfertility. Cochrane Database of Systematic Reviews. 2010 [PubMed: 17636632]
  • Berkkanoglu & Ozgur, 2010

    Berkkanoglu M, Ozgur K. What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders? Fertility and Sterility. 2010;94:662–665. [PubMed: 19368912]
  • BFS joint working party, 2008

    Association of Biomedical Andrologists, Association of Clinical Embryologists, British Andrology Society, British Fertility Society and Royal College of Obstetricians and Gynaecologists. 2008’UK guidelines for the medical and laboratory screening of sperm, egg and embryo donors 2008’ Human Fertility. 2008;11(4):201–210. [PubMed: 19085256]
  • Bhattacharya et al., 2008

    Bhattacharya S, Harrild K, Mollison J, Wordsworth S, Tay C, Harrold A, McQueen D, Lyall H, Johnston L, Burrage J, Grossett S, Walton H, Lynch J, Johnstone A, Kini S, Raja A, Templeton A. Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial. BMJ (Clinical research ed.). 2008;337:a716. [PMC free article: PMC2505091] [PubMed: 18687718]
  • Bhattacharya et al., 2010

    Bhattacharya S, Johnson N, Tijani HA, Hart R, Pandey S, Gibreel AF. Female infertility. Clinical Evidence. 2010;2010 2010. [PMC free article: PMC3217752] [PubMed: 21406133]
  • Bloch et al., 2011

    Bloch M, Azem F, Aharonov I, Ben Avi I, Yagil Y, Schreiber S, Amit A, Weizman A. GnRH-agonist induced depressive and anxiety symptoms during in vitro fertilization-embryo transfer cycles. Fertility and Sterility. 2011;95:307–309. [PubMed: 20801439]
  • Blockeel et al., 2011b

    Blockeel C, Baumgarten M, De Vos M, Verheyen G, Devroey P. Administration of GnRH antagonists in case of elevated progesterone at initiation of the cycle: a prospective cohort study. Current Pharmaceutical Biotechnology. 2011;12:423–428. [PubMed: 21133851]
  • Blockeel et al., 2009

    Blockeel C, De Vos M, Verpoest W, Stoop D, Haentjens P, Devroey P. Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study. Human Reproduction. 2009;24:2910–2916. [PubMed: 19617207]
  • Blockeel et al., 2011a

    Blockeel C, Riva A, De Vos M, Haentjens P, Devroey P. Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study. Fertility and Sterility. 2011;95:1714–1719. [PubMed: 21300334]
  • Blockeel et al., 2011

    Blockeel C, Sterrenburg MD, Broekmans FJ, Eijkemans MJ, Smitz J, Devroey P, Fauser BC. Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5. Journal of Clinical Endocrinology and Metabolism. 2011;96:1122–1128. [PubMed: 21307142]
  • Bodri et al., 2011

    Bodri D, Sunkara SK, Coomarasamy A. Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis. Fertility and Sterility. 2011;95:164–169. [PubMed: 20684954]
  • Bosch et al., 2011

    Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Pellicer A. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertility and Sterility. 2011;95:1031–1036. [PubMed: 21067717]
  • Bowen et al., 1998

    Bowen JR, Gibson FL, Leslie GI, Saunders DM. Medical and developmental outcome at 1 year for children conceived by intracytoplasmic sperm injection. Lancet. 1998;351:1529–1534. [PubMed: 10326534]
  • Braat et al., 2010

    Braat, Schutte, Bernardus, Mooij, Van Leeuwen Maternal death related to IVF in the Netherlands 1984–2008. Hum Reprod. 2010;25(7):1782–1786. [PubMed: 20488805]
  • Brandes et al., 1992

    Brandes JM, Scher AI, Itzkovits J, Thaler I, Sarid M, Gershoni-Baruch R. Growth and development of children conceived by in vitro fertilization. Pediatrics. 1992;90:424–429. [PubMed: 1518701]
  • Brandes et al., 2009

    Brandes M, van der Steen J, Bokdam B, Hamilton C, de Bruin J, Nelen W, Kremer J. When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility clinic. Hum Reprod. 2009;24:3127–3135. [PubMed: 19783833]
  • Brinton et al., 2004a

    Brinton LA, Kruger, Kjaer S, Thomsen BL, Sharif HF, Graubard BI, Olsen JH, Bock JE. Childhood tumor risk after treatment with ovulation-stimulating drugs. Fertility and Sterility. 2004;81:1083–1091. [PubMed: 15066468]
  • Brinton et al., 2004b

    Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL. Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstetrics and Gynecology. 2004;103:1194–1203. [PubMed: 15172852]
  • Brinton et al., 2004

    Brinton LA, Scoccia B, Moghissi KS, Westhoff CL, Althuis MD, Mabie JE, Lamb EJ. Breast cancer risk associated with ovulation-stimulating drugs. Human Reproduction. 2004;19:2005–2013. [PubMed: 15217997]
  • Brinsden et al., 1995

    Brinsden PR, Wada I, Tan SL, Balen A, Jacobs HS. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J. Obstet. Gynaecol. 1995;10:767–772. [PubMed: 7547731]
  • Broekmans et al., 2010

    Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010 Aug;94(3):1044–51. Epub 2009 Jul 8. [PubMed: 19589513]
  • Broer et al., 2011

    Broer SL, Dolleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Human Reproduction Update. 2011;17:46–54. [PubMed: 20667894]
  • Brown et al., 2010

    Brown Julie, Farquhar Cindy, Beck James, Boothroyd Clare, Hughes Edward. Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database of Systematic Reviews. 2010 [PubMed: 19821295]
  • Bujan et al., 2007a

    Bujan L, Hollander L, Coudert M, Gilling-Smith C, Vucetich A, Guibert J, Vernazza P, Ohl J, Weigel M, Englert Y, Semprini AE. CREAThE,network, Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS. 2007;21:1909–1914. [PubMed: 17721098]
  • Bujan et al., 2007

    Bujan L, Sergerie M, Kiffer N, Moinard N, Seguela G, Mercadier B, Rhone P, Pasquier C, Daudin M. Good efficiency of intrauterine insemination programme for serodiscordant couples with HIV-1 infected male partner: a retrospective comparative study. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2007;135:76–82. [PubMed: 17544201]
  • Bungum et al., 2003

    Bungum M, Bungum L, Humaidan P, Yding, Andersen C. Day 3 versus day 5 embryo transfer: a prospective randomized study. Reproductive Biomedicine Online. 2003;7:98–104. [PubMed: 12930586]
  • Calderon-Margalit et al., 2009

    Calderon-Margalit R, Friedlander Y, Yanetz R, Kleinhaus K, Perrin MC, Manor O, Harlap S, Paltiel O. Cancer risk after exposure to treatments for ovulation induction. American Journal of Epidemiology. 2009;169:365–375. [PMC free article: PMC2720715] [PubMed: 19037008]
  • Cantineau et al., 2010

    Cantineau AEP, Janssen MJ, Cohlen BJ. Synchronised approach for intrauterine insemination in subfertile couples. Cochrane Database of Systematic Reviews. 2010;(4) Art. No.: CD006942. [PubMed: 20393953] [CrossRef]
  • Cao et al., 2009

    Cao YX, Xing Q, Li L, Cong L, Zhang ZG, Wei ZL, Zhou P. Comparison of survival and embryonic development in human oocytes cryopreserved by slow-freezing and vitrification. Fertility and Sterility. 2009;92:1306–1311. [PubMed: 18930218]
  • Caserta et al., 2011

    Caserta D, Lisi F, Marci R, Ciardo F, Fazi A, Lisi R, Moscarini M. Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation? Gynecological Endocrinology. 2011;27:862–866. [PubMed: 21391759]
  • Castilla et al., 2005

    Castilla J, Del Romero J, Hernando V, Marincovich B, Garcia S, Rodriguez C. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. Journal of Acquired Immune Deficiency Syndromes: JAIDS. 2005;40:96–101. [PubMed: 16123689]
  • Cavagna, 2006

    Cavagna M. Comparison of 150 and 225 IU of follitropin (beta) in a fixed-dose regimen for ovarian stimulation using a depot formulation of GnRH agonist: a prospective randomised clinical trial. J Bras Reproducao Assistida. 2006;10:21–24.
  • Cavagna et al., 2006

    Cavagna M, Dzik A, Freitas GC, Soares JB, De Pawn K, Sales ALM, Andrade PC, Mantese JC, Gebrim LH. Comparison of 150 IU and 225 IU of follitropin-beta in a fixed-dose regimen for ovarian stimulation using a depot formulation of GnRH agonist: A prospective randomized clinical trial. Jornal Brasileiro de Reproducao Assistida. 2006;10:21–24.
  • Chang et al., 2001

    Chang P, Kenley S, Burns T, Denton G, Currie K, DeVane G, O’Dea L. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertility and Sterility. 2001;76:67–74. [PubMed: 11438321]
  • Check et al., 2009

    Check JH, Davies E, Brasile D, Choe JK, Amui J. A prospective comparison of in vitro fertilization (IVF) outcome following controlled ovarian hyperstimulation (COH) regimens using follitropin alpha exclusively or with the addition of low dose human chorionic gonadotropin (hCG) and ganirelix. Clinical and Experimental Obstetrics and Gynecology. 2009;36:217–218. [PubMed: 20101851]
  • Chen, 1986

    Chen C. Pregnancy after human oocyte cryopreservation. Pregnancy after human oocyte cryopreservation. 1986;1(8486):884–6. [PubMed: 2870356]
  • Cheng et al., 2010

    Cheng J, Lv J, Li CY, Xue Y, Huang Z, Zheng W. Clinical outcomes of ovulation induction with metformin, clomiphene citrate and human menopausal gonadotrophin in polycystic ovary syndrome. Journal of International Medical Research. 2010;38:1250–1258. [PubMed: 20925997]
  • Chung et al., 2011

    Chung K, Fogle R, Bendikson K, Christenson K, Paulson R. Microdose gonadotropin-releasing hormone agonist in the absence of exogenous gonadotropins is not sufficient to induce multiple follicle development. Fertility and Sterility. 2011;95:317–319. [PubMed: 20813363]
  • Coelingh et al., 1998

    Coelingh, Bennink H, Fauser BCJM, Out HJ. Recombinant follicle-stimulating hormone (FSH; puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate- resistant, normogonadotropic, chronic anovulation: A prospective, multicenter, assessor-blind, randomized, clinical trial. Fertility and Sterility. 1998;69:25. [PubMed: 9457926]
  • Cohen et al., 2011

    Cohen Myron S, Chen Ying Q, McCauley Marybeth, Gamble Theresa, Hosseinipour Mina C, Kumarasamy Nagalingeswaran, Hakim James G, Kumwenda Johnstone, Grinsztejn Beatriz, Pilotto Jose HS, Godbole Sheela V, Mehendale Sanjay, Chariyalertsak Suwat, Santos Breno R, Mayer Kenneth H, Hoffman Irving F, Eshleman Susan H, Piwowar-Manning Estelle, Wang Lei, Makhema Joseph, Mills Lisa A, de Bruyn Guy, Sanne Ian, Eron Joseph, Gallant Joel, Havlir Diane, Swindells Susan, Ribaudo Heather, Elharrar Vanessa, Burns David, Taha Taha E, Nielsen-Saines Karin, Celentano David, Essex Max, Fleming Thomas R. Prevention of HIV-1 Infection with Early Antiretroviral Therapy. New England Journal of Medicine, N Engl J Med. 2011;365:493–505. [PMC free article: PMC3200068] [PubMed: 21767103]
  • Cohlen et al., 1998

    Cohlen BJ, te Velde ER, van Kooij RJ, Looman CW, Habbema JD. Controlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study. Human Reproduction. 1998;13:1553–1558. [PubMed: 9688391]
  • Collins, 2002

    Collins J. An international survey of the health economics of IVF and ICSI. Hum Reprod Update. 2002;8:265–77. [PubMed: 12078837]
  • Collins et al., 1995

    Collins JA, Burrows EA, Wilan AR. The prognosis for live birth among untreated infertile couples. Fertil Steril. 1995;64:22–28. [PubMed: 7789569]
  • Cooper et al., 2009

    Cooper, Noonan, Eckardstein, Auger, Baker, Behre, Haugen, Kruger, Wang, Mbizvo, Vogelsong World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010;16(3):231–245. first published online November 24, 2009. [PubMed: 19934213] [CrossRef]
  • Coskun et al., 2000

    Coskun S, Hollanders J, Al-Hassan S, Al-Sufyan H, Al-Mayman H, Jaroudi K. Day 5 versus day 3 embryo transfer: A controlled randomized trial. Human Reproduction. 2000;15:1952. [PubMed: 10966992]
  • Costello et al., 2006

    Costello MF, Chapman M, Conway U. A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome. Human Reproduction. 2006;21:1387–1399. [46 refs][Erratum appears in Hum Reprod. 2006 Oct;21(10):2728] [PubMed: 16449310]
  • Crawshaw et al., 2007

    Crawshaw MA, Glaser AW, Pacey AA. The use of pornographic materials by adolescent male cancer patients when banking sperm in the UK: legal and ethical dilemmas. Human Fertility. 2007;10(3):159–63. [PubMed: 17786648]
  • Crha et al., 2009

    Crha I, Ventruba P, Zakova J, Huser M, Kubesova B, Hudecek R, Jarkovsky J. Survival and infertility treatment in male cancer patients after sperm banking. Fertility and Sterility. 2009;91:2344–2348. [PubMed: 18554588]
  • Crosignani et al., 1993

    Crosignani PC, Collins J, Cooke ID, Diczfalusy E, Rubin B. Unexplained infertility (recommendations of ESHRE workshop). Hum Reprod. 1993;8:977–980. [PubMed: 8345094]
  • Custers et al., 2008

    Custers IM, Steures P, Hompes P, Flierman P, van Kasteren Y, van Dop PA, van der Veen F, Mol BW. Intrauterine insemination: how many cycles should we perform? Hum Reprod. 2008 Apr;23(4):885–8. Epub 2008 Feb 8. [PubMed: 18263638]
  • Cutting et al., 2008

    Cutting R, Morroll D, Roberts SA, Pickering S, Rutherford A. Elective single embryo transfer: guidelines for practice British Fertility Society and Association of Clinical Embryologists. Hum Fertil. 2008;11:131–146. [PubMed: 18766953]
  • Dasari & Pranahita, 2009

    Dasari P, Pranahita G. The efficacy of metformin and clomiphene citrate combination compared with clomiphene citrate alone for ovulation induction in infertile patients with PCOS. Journal of Human Reproductive Sciences. 2009;2:18–22. [PMC free article: PMC2700688] [PubMed: 19562069]
  • Davar et al., 2010

    Davar R, Oskouian H, Ahmadi S, Firouzabadi RD. GnRH antagonist/letrozole versus microdose GnRH agonist flare protocol in poor responders undergoing in vitro fertilization. Taiwanese Journal of Obstetrics and Gynecology. 2010;49:297–301. [PubMed: 21056314]
  • De et al., 2010a

    De Greef R, Zandvliet AS, De Haan A, Ijzerman-Boon PC, Marintcheva-Petrova M, Mannaerts BMJL. Dose selection of corifollitropin alfa by modeling and simulation in controlled ovarian stimulation. Clinical Pharmacology and Therapeutics. 2010;88:79–87. [PubMed: 20520605]
  • de et al., 2000

    de Jong D, Macklon NS, Fauser BC. A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the “follicle-stimulating hormone window” combined with the gonadotropin-releasing hormone antagonist cetrorelix. Fertility and Sterility. 2000;73:1051–1054. [PubMed: 10785238]
  • De Sutter et al., 2001

    De Sutter P, Gerris J, Dhont M. A health-economic decision-analytic model comparing double with single embryo transfer in IVF/ICSI. Human Reproduction. 2002;17:2891–2896. [PubMed: 12407045]
  • De et al., 2001

    De Placido G, Mollo A, Alviggi C, Strina I, Varricchio MT, Ranieri A, Colacurci N, Tolino A, Wilding M. Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH. Human Reproduction. 2001;16:1875–1879. [PubMed: 11527891]
  • Dehbashi et al., 2009

    Dehbashi S, Kazerooni T, Robati M, Alborzi S, Parsanezhad ME, Shadman A. Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences. 2009;34:23–28.
  • Devesa et al., 2010

    Devesa M, Martinez F, Coroleu B, Tur R, Gonzalez C, Rodriguez I, Barri PN. Poor prognosis for ovarian response to stimulation: results of a randomised trial comparing the flare-up GnRH agonist protocol vs. the antagonist protocol. Gynecological Endocrinology. 2010;26:509–515. [PubMed: 20196635]
  • Devlin and Parkin, 2003

    Devlin N, Parkin D. Funding fertility: issues in the allocation and distribution of resources to assisted reproduction technologies. Human Fertility. 2003;6 Supplement:S2–S6. [PubMed: 12869768]
  • Dhont et al., 1995

    Dhont M, Onghena A, Coetsier T, De Sutter P. Prospective randomized study of clomiphene citrate and gonadotrophins versus goserelin and gonadotrophins for follicular stimulation in assisted reproduction. Human Reproduction. 1995;10:791–796. [PubMed: 7650122]
  • Dhont et al., 1995a

    Dhont M, Onghena A, Coetsier T, De Sutter P. Prospective randomized study of clomiphene citrate and gonadotrophins versus goserelin and gonadotrophins for follicular stimulation in assisted reproduction. Human Reproduction. 1995;10:791–796. [PubMed: 7650122]
  • DiLuigi et al., 2011

    DiLuigi AJ, Engmann L, Schmidt DW, Benadiva CA, Nulsen JC. A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders. Fertility and Sterility. 2011;95:2531–2533. [PubMed: 21324455]
  • Dixon et al., 2008

    Dixon S, Faghih Nasiri F, Ledger W, Lenton E, Duenas A, Sutcliffe P, Chilcott J. Cost-effectiveness analysis of different embryo transfer strategies in England. BJOG: An International Journal of Obstetrics & Gynaecology. 2008;115:758–766. [PubMed: 18355368] [CrossRef]
  • Donnez et al., 2004

    Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364(9443):1405–10. [PubMed: 15488215]
  • Drakakis et al., 2009

    Drakakis P, Loutradis D, Beloukas A, Sypsa V, Anastasiadou V, Kalofolias G, Arabatzi H, Kiapekou E, Stefanidis K, Paraskevis D, Makrigiannakis A, Hatzakis A, Antsaklis A. Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation. Reproductive Biology and Endocrinology. 2009;7:110. [PMC free article: PMC2770481] [PubMed: 19825188]
  • Drakakis et al., 2005

    Drakakis P, Loutradis D, Kallianidis K, Liapi A, Milingos S, Makrigiannakis A, onyssiou-Asteriou A, Michalas S. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2005;121:77–80. [PubMed: 15989987]
  • Duffy et al., 2010a

    Duffy JM, Ahmad G, Mohiyiddeen L, Nardo LG, Watson A. Growth hormone for in vitro fertilization. Cochrane Database of Systematic Reviews. 2010:CD000099. [38 refs][Update of Cochrane Database Syst Rev. 2009(4):CD000099; PMID: 19821264] [PMC free article: PMC7058116] [PubMed: 20091500]
  • Duffy et al., 2010

    Duffy MN James, Ahmad Gaity, Mohiyiddeen Lamiya, Nardo Luciano G, Watson Andrew. Growth hormone for in vitro fertilization. Cochrane Database of Systematic Reviews. 2010 [PMC free article: PMC7058116] [PubMed: 20091500]
  • Dunson et al., 2004

    Dunson DB, Baird DD, Colombo B. Increased infertility with age in men and women. Obstet Gynecol. 103:51–56. [PubMed: 14704244]
  • Durnerin et al., 2008

    Durnerin CI, Erb K, Fleming R, Hillier H, Hillier SG, Howles CM, Hugues JN, Lass A, Lyall H, Rasmussen P, Thong J, Traynor I, Westergaard L, Yates R. Luveris Pretreatment Group. Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation. Human Reproduction. 2008;23:421–426. [PubMed: 18084048]
  • Eimers et al., 1994

    Eimers JM, te Velde ER, Gerritse R, Vogelzang ET, Looman CW, Habbema JD. The prediction of the chance to conceive in subfertile couples. Fertil Steril. 1994;61:44–52. [PubMed: 8293843]
  • Eijkemans et al., 2008

    Eijkemans M, Lintsen A, Hunault C, Bouwmans C, Hakkaart L, Braat D, Habbema J. Pregnancy chances on an IVF/ICSI waiting list: a national prospective cohort study. Hum Reprod. 2008;23:1627–1632. [PubMed: 18456667]
  • Eiser et al., 2011

    Eiser C, Arden-Close E, Morris K, Pacey AA. The legacy of sperm banking: how fertility monitoring and disposal of sperm are linked with views of cancer treatment. Human Reproduction. 2011;26(10):2791–8. [PubMed: 21778285]
  • Elassar et al., 2011

    Elassar A, Mann JS, Engmann L, Nulsen J, Benadiva C. Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor responders. Fertility and Sterility. 2011;95:324–326. [PubMed: 20797708]
  • Elmashad, 2011

    Elmashad AI. Impact of laparoscopic ovarian drilling on anti-Mullerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women with anovulatory polycystic ovary syndrome. Fertility and Sterility. 2011;95:2342–2346. [PubMed: 21514928]
  • Elsedeek et al., 2011

    Elsedeek M, Elmaghraby HAH. Predictors and characteristics of letrozole induced ovulation in comparison with clomiphene induced ovulation in anovulatory PCOS women. Middle East Fertility Society Journal. 2011;16:125–130.
  • Emiliani et al., 2003

    Emiliani S, Delbaere A, Vannin AS, Biramane J, Verdoodt M, Englert Y, Devreker F. Similar delivery rates in a selected group of patients, for day 2 and day 5 embryos both cultured in sequential medium: a randomized study. Human Reproduction. 2003;18:2145–2150. [PubMed: 14507836]
  • Engmann et al., 2011

    Engmann L, Romak J, Nulsen J, Benadiva C, Peluso J. In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of[NON-BREAKING SPACE]oocyte maturation. Fertility and Sterility. 2011;96:198–202. [PubMed: 21601197]
  • 2010

    Exercise for dysmenorrhoea. Obstetrics and Gynecology. 2010;116:186–187. [PubMed: 20567186]
  • Fabregues et al., 2011

    Fabregues F, Iraola A, Casals G, Creus M, Carmona F, Balasch J. Evaluation of two doses of recombinant human luteinizing hormone supplementation in down-regulated women of advanced reproductive age undergoing follicular stimulation for IVF: A randomized clinical study. European Journal of Obstetrics Gynecology and Reproductive Biology. 2011;158:56–61. [PubMed: 21600688]
  • Faddy et al., 1992

    Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Human Reproduction. 1992;7:1342–1346. [PubMed: 1291557]
  • Faddy et al., 1996

    Faddy MJ, Gosden RG. A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod. 1996;11:1484–6. [PubMed: 8671489]
  • Farquhar et al., 2002

    Farquhar CM, Williamson K, Gudex G, Johnson NP, Garland J, Sadler L. A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome. Fertility and Sterility. 2002;78:404–411. [PubMed: 12137881]
  • Fasano et al., 2010

    Fasano G, Vannin AS, Biramane J, Delbaere A, Englert Y. Cryopreservation of human failed maturation oocytes shows that vitrification gives superior outcomes to slow cooling. Cryobiology. 2010;61:243–247. [PubMed: 20727873]
  • Fernandez et al., 2011

    Fernandez H, Morin-Surruca M, Torre A, Faivre E, Deffieux X, Gervaise A. Ovarian drilling for surgical treatment of polycystic ovarian syndrome: a comprehensive review. Reproductive Biomedicine Online. 2011;22:556–568. [PubMed: 21511534]
  • Ferraretti et al., 2004

    Ferraretti AP, Gianaroli L, Magli MC, D’Angelo A, Farfalli V, Montanaro N. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques1838. Fertility and Sterility. 2004;82:1521–1526. [PubMed: 15589853]
  • Ferraretti et al., 2011

    Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of ‘poor response to ovarian stimulation for in vitro fertilization: The Bologna criteria. Human Reproduction. 2011;26:1616–1624. [PubMed: 21505041]
  • Fiddelers et al., 2006

    Fiddelers A, van Montfoort A, Dirksen C, Dumoulin J, Jolande A, Dunselman A, Janssen A, Severens J, Evers J. Single versus double embryo transfer: cost-effectiveness analysis alongside a randomized clinical trial. Human Reproduction. 2006;21:2090–2097. [PubMed: 16613886]
  • Fiddelers et al., 2009

    Fiddelers A, Dirksen C, Dumoulin J, Aafke P, van Montfoort A, Jolande A, Janssen A, Evers J, Severens J. Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model. Human Reproduction. 2009;24:1648–1655. [PubMed: 19318703]
  • Fitoussi et al., 2000

    Fitoussi O, Eghbali H, Tchen N, Berjon JP, Soubeyran P, Hoerni B. Semen analysis and cryoconservation before treatment in Hodgkin’s disease. Annals of Oncology. 2000;11:679–684. [PubMed: 10942055]
  • Flyckt & Goldberg, 2011

    Flyckt RL, Goldberg JM. Laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome. Seminars in Reproductive Medicine. 2011;29:138–146. [PubMed: 21437828]
  • Forman et al., 2007

    Forman R, Gill S, Moretti M, Tulandi T, Koren G, Casper R. Fetal safety of letrozole and clomiphene citrate for ovulation induction. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC. 2007;29:668–671. [PubMed: 17714621]
  • Gabbanini et al., 2010

    Gabbanini M, Privitera L, Monzó A, Higueras G, Fuster S, Garrido N, Bosch E, Pellicer A. The use of prediction models of spontaneous pregnancy in in vitro fertilization units reveals differences between the expected results of public and private clinics in Spain. Fertil Steril. 2010 Nov;94(6):2376–8. Epub 2010 Mar 29. [PubMed: 20347077]
  • Garcia-Velasco et al., 2011a

    Garcia-Velasco JA, Bennink HJ, Epifanio R, Escudero E, Pellicer A, Simon C. High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist. Reproductive Biomedicine Online. 2011;22 Suppl 1:S52–S59. [Reprint of Reprod Biomed Online. 2007 Sep;15(3):280–7 PMID: 17854525] [PubMed: 21575850]
  • Garcia-Velasco et al., 2011

    Garcia-Velasco JA, Bermejo A, Ruiz F, Martinez-Salazar J, Requena A, Pellicer A. Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: A randomized, controlled trial. Fertility and Sterility. 2011;96:590–593. [PubMed: 21718992]
  • Garcia-Velasco et al., 2010

    Garcia-Velasco JA, Motta L, Lopez A, Mayoral M, Cerrillo M, Pacheco A. Low-dose human chorionic gonadotropin versus estradiol/progesterone luteal phase support in gonadotropin-releasing hormone agonist-triggered assisted reproductive technique cycles: understanding a new approach. Fertility and Sterility. 2010;94:2820–2823. [PubMed: 20673892]
  • Gardner et al., 1998

    Gardner DK, Schoolcraft WB, Wagley L, Schlenker T, Stevens J, Hesla J. A prospective randomized trial of blastocyst culture and transfer in in-vitro fertilization. Human Reproduction. 1998;13:3434–3440. [PubMed: 9886530]
  • Gardner et al., 2004

    Gardner DK, Surrey E, Minjarez D, Leitz A, Stevens J, Schoolcraft WB. Single blastocyst transfer: a prospective randomized trial. Fertility and Sterility. 2004;81:551–555. [PubMed: 15037401]
  • Garrido et al., 2004

    Garrido N, Meseguer M, Bellver J, Remohi J, Simon C, Pellicer A. Report of the results of a 2 year programme of sperm wash and ICSI treatment for human immunodeficiency virus and hepatitis C virus serodiscordant couples. Human Reproduction. 2004;19:2581–2586. [PubMed: 15319386]
  • Gauthier et al., 2004

    Gauthier E, Paoletti X, Clavel-Chapelon F. the E3N group. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Human Reproduction. 2004;19:2216–2221. [PubMed: 15271872]
  • George et al., 2003

    George SS, George K, Irwin C, Job V, Selvakumar R, Jeyaseelan V, Seshadri MS. Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: A randomized, controlled trial. Human Reproduction. 2003;18:299–304. [PubMed: 12571165]
  • Gerris et al., 1999

    Gerris J, De Neubourg D, Mangelschots K, Van Royen E, Van de Meerssche M, Valkenburg M. Prevention of twin pregnancy after in-vitro fertilization or intracytoplasmic sperm injection based on strict embryo criteria: a prospective randomized clinical trial. Human Reproduction. 1999;14:2581–2587. [PubMed: 10527991]
  • Gerris et al., 2004

    Gerris J, De Sutter P, De Neubourg D, Van Royen E, Vander Elst J, Mangelschots K, Vercruyssen M, Kok P, Elseviers M, Annemans L, Pauwels P, Dhont M. A real-life prospective health economic study of elective single embryo transfer versus two-embryo transfer in IVF/ICSI cycles. Human Reproduction. 2004;19:917–923. [PubMed: 14990547]
  • Gholami et al., 2010

    Gholami H, Vicari E, Molis M, La Vignera S, Papaleo E, Cappiello F. Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged < 37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study. European Review for Medical and Pharmacological Sciences. 2010;14:97–102. [PubMed: 20329567]
  • Goldfarb et al., 1996

    Goldfarb J, Kinzer DJ, Boyle M, Kurit D. Attitudes of in vitro fertilization and intrauterine insemination couples toward multiple gestation pregnancy and multifetal pregnancy reduction. Fertil Steril. 1996;65:815–20. [PubMed: 8654645]
  • Gomes et al., 2007

    Gomes MKO, Vieira CS, Moura MD, Manetta LA, Leite SP, Reis RM, Ferriani RA. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG. European Journal of Obstetrics Gynecology and Reproductive Biology. 2007;130:99–106. [PubMed: 16835006]
  • Goswami et al., 2004

    Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, Chakravarty BN, Kabir SN. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Human Reproduction. 2004;19:2031–2035. [PubMed: 15217999]
  • Goudge et al., 2010

    Goudge CS, Nagel TC, Damario MA. Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: A randomized, controlled trial. Fertility and Sterility. 2010;94:946–951. [PubMed: 19523613]
  • Goverde et al., 2005

    Goverde AJ, Lambalk CB, McDonnell J, Schats R, Homburg R, Vermeiden JP. Further considerations on natural or mild hyperstimulation cycles for intrauterine insemination treatment: effects on pregnancy and multiple pregnancy rates. Human Reproduction. 2005;20:3141–3146. [PubMed: 16037113]
  • Goverde et al., 2005a

    Goverde AJ, Lambalk CB, McDonnell J, Schats R, Homburg R, Vermeiden JPW. Further considerations on natural or mild hyperstimulation cycles for intrauterine insemination treatment: Effects on pregnancy and multiple pregnancy rates. Human Reproduction. 2005;20:3141–3146. [PubMed: 16037113]
  • 2000

    Goverde AJ, McDonnell JV. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet. 2000;355:13–18. [PubMed: 10615885]
  • Goverde et al., 2000

    Goverde AJ, McDonnell J, Vermeiden JPW, Schats R, Rutten FFH, Schoemaker J. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: A randomised trial and cost-effectiveness analysis. Lancet. 2000;355:13–18. [PubMed: 10615885]
  • Griesinger et al., 2005

    Griesinger G, Schultze-Mosgau A, Dafopoulos K, Schroeder A, Schroer A, von Otte S, Hornung D, Diedrich K, Felberbaum R. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol. Human Reproduction. 2005;20:1200–1206. [PubMed: 15665010]
  • Grochowski et al., 1999

    Grochowski D, Wolczynski S, Kuczynski W, Domitrz J, Szamatowicz J, Szamatowicz M. Good results of milder form of ovarian stimulation in an in vitro fertilization/intracytoplasmic sperm injection program. Gynecological Endocrinology. 1999;13:297–304. [PubMed: 10599545]
  • Guzick et al., 1998

    Guzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP, Steinkampf MP. Efficacy of treatment for unexplained infertility. Fertility Sterility. 1998;70(2):207–13. [PubMed: 9696208]
  • Guzick et al., 1999

    Guzick DS, Carson SA, Coutifaris C, Overstreet JW, Factor-Litvak P, Steinkampf MP, Hill JA, Mastroianni L, Buster JE, Nakajima ST, Vogel DL, Canfield RE. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. New England Journal of Medicine. N Engl J Med. 1999;340:177–183. [PubMed: 9895397]
  • Guzick et al., 1999a

    Guzick DS, Carson SA, Coutifaris C, Overstreet JW, Factor-Litvak P, Steinkampf MP, Hill JA, Mastroianni L, Buster JE, Nakajima ST, Vogel DL, Canfield RE. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network. New England Journal of Medicine. 1999;340:177–183. [PubMed: 9895397]
  • Hamed et al., 2010

    Hamed HO, Hasan AF, Ahmed OG, Ahmed MA. Metformin versus laparoscopic ovarian drilling in clomiphene- and insulin-resistant women with polycystic ovary syndrome. International Journal of Gynecology and Obstetrics. 2010;108:143–147. [PubMed: 19892338]
  • Hannibal et al., 2008a

    Hannibal CG, Jensen A, Sharif H, Kjaer SK. Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study. Cancer Causes and Control. 2008;19:759–765. [PubMed: 18340541]
  • Hannibal et al., 2008

    Hannibal CG, Jensen A, Sharif H, Kjaer SK. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Human Reproduction. 2008;23:451–456. [PubMed: 18065402]
  • Hansen et al., 2002

    Hansen M, Kurinczuk JJ, Bower C, Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. New England Journal of Medicine. 2002;346:725–730. [PubMed: 11882727]
  • Harrison et al., 2001

    Harrison RF, Jacob S, Spillane H, Mallon E, Hennelly B. A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-beta) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles. Fertility and Sterility. 2001;75:23–31. [PubMed: 11163812]
  • Harrison et al., 1994

    Harrison RF, Kondaveeti U, Barry-Kinsella C, Gordon A, Drudy L, Cottell E, Hennelly B, Frankish A, Unwin A. Should gonadotropin-releasing hormone down-regulation therapy be routine in in vitro fertilization? Fertility and Sterility. 1994;62:568–573. [PubMed: 8062954]
  • Hashim et al., 2010

    Hashim HA, Anwar K, El-Fatah RA. N-acetyl cysteine plus clomiphene citrate versus metformin and clomiphene citrate in treatment of clomiphene-resistant polycystic ovary syndrome: a randomized controlled trial. Journal of Women’s Health. 2010;19:2043–2048. [PubMed: 20939675]
  • Heffner, 2004

    Heffner LJ. Advanced maternal age–how old is too old? N Engl J Med. 2004;351:1927–1929. [PubMed: 15525717]
  • Heijnen et al., 2007

    Heijnen EM, Eijkemans MJ, de Klerk C, Polinder S, Beckers NG, Klinkert ER, Broekmans FJ, Passchier J, te Velde ER, Macklon NS, Fauser BC. A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet. 2007;369:743–749. [Reprint in Ned Tijdschr Geneeskd. 2008 Apr 5;152(14):80916. PMID: 18491824] [PubMed: 17336650]
  • Hendriks et al., 2005

    Hendriks DJ, Broekmans FJ, Bancsi LF, de Jong FH, Looman CW, te Velde ER. Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve. Human Reproduction. 2005;20:163–169. [PubMed: 15471926]
  • Herbert et al., 2012

    Herbert DL, Lucke JC, Dobson AJ. Birth outcomes after spontaneous or assisted conception among infertile Australian women aged 28 to 36 years: a prospective, population-based study. Fertil Steril. 2012;97(3):630–8. [PubMed: 22265037]
  • HFEA, 2008

    Human Fertilisation and Embryology Authority, Code practice. 8th edition. 2008.
  • Hohmann et al., 2003

    Hohmann FP, Macklon NS, Fauser BC. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. Journal of Clinical Endocrinology and Metabolism. 2003;88:166–173. [PubMed: 12519847]
  • Hojgaard et al., 2001

    Hojgaard A, Ingerslev HJ, Dinesen J. Friendly IVF: Patient opinions. Human Reproduction. 2001;16:1391–1396. [PubMed: 11425818]
  • Hoomans et al., 2002

    Hoomans EH, Mulder BB. Asian Purgeon Study Group. A group-comparative, randomized, double-blind comparison of the efficacy and efficiency of two fixed daily dose regimens (100- and 200-IU) of recombinant follicle stimulating hormone (rFSH, Puregon) in Asian women undergoing ovarian stimulation for IVF/ICSI. Journal of Assisted Reproduction and Genetics. 2002;19:470–476. [PMC free article: PMC3455678] [PubMed: 12416651]
  • Hosseini et al., 2010

    Hosseini MA, Aleyasin A, Saeedi H, Mahdavi A. Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients. Journal of Obstetrics and Gynaecology Research. 2010;36:605–610. [PubMed: 20598044]
  • Hourvitz et al., 2008

    Hourvitz A, Goldschlag DE, Davis OK, Gosden LV, Palermo GD, Rosenwaks Z. Intracytoplasmic sperm injection (ICSI) using cryopreserved sperm from men with malignant neoplasm yields high pregnancy rates. Fertility and Sterility. 2008;90:557–563. [PubMed: 18692822]
  • Hreinsson et al., 2004

    Hreinsson J, Rosenlund B, Fridström M, Ek I, Levkov L, blom P, Hovatta O. Embryo transfer is equally effective at cleavage stage and blastocyst stage: a randomized prospective study. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2004;117:194–200. [PubMed: 15541857]
  • Huang et al., 2005

    Huang CC, Lee TH, Chen SU, Chen HH, Cheng TC, Liu CH, Yang YS, Lee MS. Successful pregnancy following blastocyst cryopreservation using super-cooling ultra-rapid vitrification. Human Reproduction. 2005;20:122–128. [PubMed: 15471932]
  • Hughes et al., 2010

    Hughes E, Brown J, Collins J, Vanderkerchove P. Clomiphene citrate for unexplained subfertility in women. Cochrane Database of Systematic Reviews. 2010 [PMC free article: PMC7052733] [PubMed: 20091498]
  • Hughes et al., 2010a

    Hughes E, Brown J, Collins J, Vanderkerchove Pk. Clomiphene citrate for unexplained subfertility in women. Cochrane Database of Systematic Reviews. 2010 [PMC free article: PMC7052733] [PubMed: 20091498]
  • Hull et al., 1985

    Hull MG, Glazener CM, Kelly NJ, Conway DI, Foster PA, Hinton RA, et al. Population study of causes, treatment, and outcome of infertility. BMJ. 1985;291:1693–7. [PMC free article: PMC1418755] [PubMed: 3935248]
  • Humaidan et al., 2011

    Humaidan P, Kol S, Papanikolaou EG. GnRH agonist for triggering of final oocyte maturation: Time for a change of practice? Human Reproduction Update. 2011;17:510–524. [PubMed: 21450755]
  • Hunault et al., 2004

    Hunault CC, Habbema JDF, Eijkemans MJC, Collins JA, Evers JLH, te Velde ER. Two new prediction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models. Hum Reprod. 2004;19(9):2019–2026. [PubMed: 15192070] [CrossRef]
  • Hvidtjorn et al., 2011

    Hvidtjorn D, Grove J, Schendel D, Schieve LA, Svaerke C, Ernst E, Thorsen P. Risk of autism spectrum disorders in children born after assisted conception: a population-based follow-up study. Journal of Epidemiology and Community Health. 2011;65:497–502. [PubMed: 20584728]
  • Hwu et al., 2005

    Hwu YM, Lin SY, Huang WY, Lin MH, Lee RKK. Ultra-short metformin pretreatment for clomiphene citrate-resistant polycystic ovary syndrome. International Journal of Gynecology and Obstetrics. 2005;90:39–43. [PubMed: 15921686]
  • Ingerslev et al., 2001

    Ingerslev HJ, Hojgaard A, Hindkjaer J, Kesmodel U. A randomized study comparing IVF in the unstimulated cycle with IVF following clomiphene citrate. Human Reproduction. 2001;16:696–702. [PubMed: 11278221]
  • Ingerslev et al., 2001a

    Ingerslev HJ, Højgaard A, Hindkjaer J, Kesmodel U. A randomized study comparing IVF in the unstimulated cycle with IVF following clomiphene citrate. Human Reproduction. 2001;16:696–702. [PubMed: 11278221]
  • Isachenko et al., 2009

    Isachenko V, Lapidus I, Isachenko E, Krivokharchenko A, Kreienberg R, Woriedh M, Bader M, Weiss JM. Human ovarian tissue vitrification versus conventional freezing: Morphological, endocrinological, and molecular biological evaluation. Reproduction. 2009;138:319–327. [PubMed: 19439559]
  • Isaksson and Tiitinen, 1998

    Isaksson R, Tiitinen A. Obstetric outcome in patients with unexplained infertility: comparison of treatment-related and spontaneous pregnancies. Acta Obstet. Gynecol, Scand. 1998;77:849–853. [PubMed: 9776600]
  • Isaksson and Tiitinen, 2004

    Isaksson R, Tiitinen A. Present concept of unexplained infertility. Gynecol Endocrinol. 2004;18:278–290. [PubMed: 15346664]
  • Jayaprakasan et al., 2010a

    Jayaprakasan K, Hopkisson J, Campbell B, Johnson I, Thornton J, Raine-Fenning N. A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count. BJOG: An International Journal of Obstetrics and Gynaecology. 2010;117:853–862. [PubMed: 20353458]
  • Jensen et al., 2009

    Jensen A, Sharif H, Frederiksen K, Kjaer SK. Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study. BMJ. 2009;338:b249. [PMC free article: PMC2640154] [PubMed: 19196744]
  • Jensen et al., 2009a

    Jensen A, Sharif H, Kjaer SK. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study. American Journal of Epidemiology. 2009;170:1408–1414. [PubMed: 19884127]
  • Jensen et al., 2007

    Jensen A, Sharif H, Svare EI, Frederiksen K, Kjaer SK. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study. Cancer Epidemiology, Biomarkers and Prevention. 2007;16:1400–1407. [PubMed: 17585058]
  • Johnson, 2011

    Johnson N. Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome--a meta-analysis of randomised trials. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2011;51:125–129. [PubMed: 21466513]
  • Johnson et al., 2010

    Johnson NP, Stewart AW, Falkiner J, Farquhar CM, Milsom S, Singh VP, Okonkwo QL, Buckingham KL. REACT-NZ (REproduction And Collaborative Trials in New Zealand), PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene. Human Reproduction. 2010;25:1675–1683. [PubMed: 20435692]
  • Kahn et al., 1999

    Kahn JA, Sunde A, von During V, Out HJ. A prospective randomized comparative cohort study of either recombinant FSH (Puregon) or urinary FSH (Metrodin) in in vitro fertilization treatment. Middle East Fertility Society Journal. 1999;4:206–214.
  • Kahraman et al., 2010

    Kahraman S, Karlikaya G, Kavrut M, Karagozoglu H. A prospective, randomized, controlled study to compare two doses of recombinant human chorionic gonadotropin in serum and follicular fluid in woman with high body mass index. Fertility and Sterility. 2010;93:2087. [PubMed: 19782346]
  • Kallen et al., 2010

    Kallen B, Finnstrom O, Lindam A, Nilsson E, Nygren KG, Olausson PO. Blastocyst versus cleavage stage transfer in in vitro fertilization: differences in neonatal outcome? Fertility and Sterility. 2010;94:1680–1683. [PubMed: 20137785]
  • Kallen et al., 2005

    Kallen B, Finnstrom O, Nygren KG, Olausson PO. In vitro fertilization in Sweden: child morbidity including cancer risk. Fertility and Sterility. 2005;84:605–610. [PubMed: 16169392]
  • Kamel et al., 2004

    Kamel MA, Abdel Hamid A, bdel-Rahim M, Mostafa SA. Laparoscopic ovarian re-electro cautery versus ovulation induction with FSH for persistant anovulation after laparoscopic PCOS treatment. Middle East Fertility Society Journal. 2004;9:70–78.
  • Karaki et al., 2002

    Karaki RZ, Samarraie SS, Younis NA, Lahloub TM, Ibrahim MH. Blastocyst culture and transfer: a step toward improved in vitro fertilization outcome. Fertility and Sterility. 2002;77:114–118. [PubMed: 11779600]
  • Karande et al., 1999

    Karande V, Korn A, Morris R, Rao R, Balin M, Rinehart J, Dohn K, Gleicher N. Prospective randomized trial comparing the outcome and cost of in vitro fertilization with that of a traditional treatment algorithm as first-line therapy for couples with infertility. Fertility and Sterility. 1999;71:468–475. [PubMed: 10065784]
  • Karimzadeh et al., 2010

    Karimzadeh MA, Ahmadi S, Oskouian H, Rahmani E. Comparison of mild stimulation and conventional stimulation in ART outcome. Archives of Gynecology and Obstetrics. 2010;281:741–746. [PubMed: 19834718]
  • Karimzadeh & Javedani, 2010

    Karimzadeh MA, Javedani M. An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome. Fertility and Sterility. 2010;94:216–220. [PubMed: 19463994]
  • Karimzadeh et al., 2011

    Karimzadeh MA, Mashayekhy M, Mohammadian F, Moghaddam FM. Comparison of mild and microdose GnRH agonist flare protocols on IVF outcome in poor responders. Archives of Gynecology and Obstetrics. 2011;283:1159–1164. [PubMed: 21221982]
  • Kashima et al., 2009

    Kashima K, Takakuwa K, Suzuki M, Makino M, Kaneko S, Kato S, Hanabusa H, Tanaka K. Studies of assisted reproduction techniques (ART) for HIV-1-discordant couples using washed sperm and the nested PCR method: A comparison of the pregnancy rates in HIV-1-discordant couples and control couples. Japanese Journal of Infectious Diseases. 2009;62:173–176. [PubMed: 19468174]
  • Kelleher et al., 2001

    Kelleher S, Wishart SM, Liu PY, Turner L, Di Pierro I, Conway AJ, Handelsman DJ. Long-term outcomes of elective human sperm cryostorage. Human Reproduction, Hum Reprod. 2001;16:2632–2639. [PubMed: 11726587]
  • Keye et al., 2004

    Keye WR Jr, Marrs RP, Check JH, Schnell V, Surrey M, Marshall DC. EMBRACE Study Group. Evaluation of mixed protocols with Bravelle (human-derived FSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE) in women undergoing in vitro fertilization. Fertility and Sterility. 2004;82:348–357. [PubMed: 15302283]
  • Khairy et al., 2008

    Khairy M, Clough A, El-Toukhy T, Coomarasamy A, Khalaf Y. Antral follicle count at down-regulation and prediction of poor ovarian response. Reproductive Biomedicine Online. 2008;17:508–514. [PubMed: 18854104]
  • Khalifa et al., 1992

    Khalifa E, Oehninger S, Acosta AA, Morshedi M, Veeck L, Bryzyski RG, Muasher SJ. Successful fertilization and pregnancy outcome in in-vitro fertilization using cryopreserved/thawed spermatozoa from patients with malignant diseases. Human Reproduction, Hum. Reprod. 1992;7:105–108. [PubMed: 1551943]
  • Kim et al., 2011

    Kim CH, Howles CM, Lee HA. The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertility and Sterility. 2011;95:679–683. [PubMed: 20801436]
  • Kim et al., 2000

    Kim SH, Lee SW, Lee JH, Kang SM, Oh HJ, Lee SM, Lee SG, Yoon HG, Yoon SH, Park SP, Song HB, Lim JH. Study on the vitrification of human blastocysts: II. Effect of vitrification on the implantation and the pregnancy of human blastocysts. Korean Journal of Fertility and Sterility. 2000;27:67–74.
  • Kjellberg et al., 2006

    Kjellberg AT, Carlsson P, Bergh C. Randomized single versus double embryo transfer: obstetric and paediatric outcome and a cost-effectiveness analysis. Human Reproduction. 2006;21:210–216. [PubMed: 16172148]
  • Kjotrod et al., 2011

    Kjotrod SB, Carlsen SM, Rasmussen PE, Holst-Larsen T, Mellembakken J, Thurin-Kjellberg A, Haapaniemikouru K, Morin-Papunen L, Humaidan P, Sunde A, von During V. Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomized, double-blind, multi-centre study. Human Reproduction. 2011;26:2045–2053. [PubMed: 21606131]
  • Klemetti et al., 2006

    Klemetti R, Sevon T, Gissler M, Hemminki E. Health of children born as a result of in vitro fertilization. Pediatrics. 2006;118:1819–1827. [PubMed: 17079550]
  • Klinkert et al., 2005

    Klinkert ER, Broekmans FJ, Looman CW, Habbema JD, te Velde ER. Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Human Reproduction. 2005;20:611–615. [PubMed: 15591079]
  • Klip et al., 2001

    Klip H, Burger CW, de Kraker J, van Leeuwen FE. OMEGA-project group. Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. Human Reproduction. 2001;16:2451–2458. [PubMed: 11679537]
  • Klip et al., 2000

    Klip H, Burger CW, Kenemans P, van Leeuwen FE. Cancer risk associated with subfertility and ovulation induction: a review. Cancer Causes and Control. 2000;11:319–344. [196 refs] [PubMed: 10843444]
  • Kolibianakis et al., 2004

    Kolibianakis EM, Zikopoulos K, Verpoest W, Camus M, Joris H, Van Steirteghem AC, Devroey P. Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer? Human Reproduction. 2004;19:2550–2554. [PubMed: 15298978]
  • Koundouros, 2008

    Koundouros SN. A comparison study of a novel stimulation protocol and the conventional low dose step-up and step-down regimens in patients with polycystic ovary syndrome undergoing in vitro fertilization. Fertility and Sterility. 2008;90:569–575. [PubMed: 17880950]
  • Kovacs et al., 2010

    Kovacs P, Kovats T, Kaali SG. Results with early follicular phase recombinant luteinizing hormone supplementation during stimulation for in vitro fertilization. Fertility and Sterility. 2010;93:475–479. [PubMed: 19200991]
  • Kristiansson et al., 2007

    Kristiansson P, Bjor O, Wramsby H. Tumour incidence in Swedish women who gave birth following IVF treatment. Human Reproduction. 2007;22:421–426. [PubMed: 17071821]
  • Ku et al., 2003

    Ku SY, Suh CS, Kim SH, Choi YM, Kim JG, Moon SY. A pilot study of the use of low dose human menopausal gonadotropin in ovulation induction. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2003;109:55–59. [PubMed: 12818444]
  • Kumbak et al., 2010

    Kumbak B, Akbas H, Sahin L, Karlikaya G, Karagozoglu H, Kahraman S. Ovarian stimulation in women with high and low body mass index: GnRH agonist versus GnRH antagonist. Reproductive Biomedicine Online. 2010;20:314–319. [PubMed: 20093087]
  • Kunt et al., 2011

    Kunt C, Ozaksit G, Keskin Kurt R, Cakir Gungor A, Kanat-Pektas M, Kilic S, Dede A. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization. Archives of Gynecology and Obstetrics. 2011;283:1415–1421. [PubMed: 21562964]
  • Kwee et al., 2007

    Kwee J, Elting ME, Schats R, McDonnell J, Lambalk CB. Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization. Reproductive Biology and Endocrinology. 2007;5:9. [PMC free article: PMC1847823] [PubMed: 17362511]
  • Kwee et al., 2006

    Kwee J, Schats R, McDonnell J, Schoemaker J, Lambalk CB. The clomiphene citrate challenge test versus the exogenous follicle-stimulating hormone ovarian reserve test as a single test for identification of low responders and hyperresponders to in vitro fertilization. Fertility and Sterility. 2006;85:1714–1722. [PubMed: 16650416]
  • Kyrou et al., 2011

    Kyrou D, Fatemi HM, Zepiridis L, Riva A, Papanikolaou EG, Tarlatzis BC, Devroey P. Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH/GnRH antagonist affect ongoing pregnancy rates? A randomized controlled trial. Human Reproduction. 2011;26:1020–1024. [PubMed: 21296803]
  • La et al., 2007

    La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, Volpe A. Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Human Reproduction. 2007;22:766–771. [PubMed: 17071823]
  • La et al., 2011

    La Marca A, Nelson SM, Sighinolfi G, Manno M, Baraldi E, Roli L, Xella S, Marsella T, Tagliasacchi D, D’Amico R, Volpe A. Anti-Mullerian hormone-based prediction model for a live birth in assisted reproduction. Reproductive Biomedicine Online. 2011;22:341–349. [PubMed: 21317041]
  • La Rochebrochard et al., 2009

    Rochebrochard, Quelen Céline, Peikrishvili Rusudan, Guibert Juliette M.D.,e, Bouyer Jean Ph.D. Long-term outcome of parenthood project during in vitro fertilization and after discontinuation of unsuccessful in vitro fertilization. 2009 July;92(1):149. [PubMed: 18706550] [CrossRef]
  • Lass et al., 1998

    Lass A, Akagbosu F, Abusheikha N, Hassouneh M, Blayney M, Avery S, Brinsden P. A programme of semen cryopreservation for patients with malignant disease in a tertiary infertility centre: lessons from 8 years’ experience. Human Reproduction, Hum, Reprod. 1998;13:3256–3261. [PubMed: 9853891]
  • 2001a

    Latin-American Puregon IVF Study Group. A double-blind clinical trial comparing a fixed daily dose of 150 and 250 IU of recombinant follicle-stimulating hormone in women undergoing in vitro fertilization. Fertility and Sterility. 2001;76:950–956. [PubMed: 11704116]
  • Ledger et al., 2006

    Ledger WL, Anumba D, Marlow N, Thomas CM, Wilson E. The costs to the NHS of multiple births after IVF treatment in the UK. British Journal of Obstetrics & Gynaecology. 2006;113(1):21–5. [PubMed: 16398766]
  • Lee et al., 2011

    Lee RK, Wu FS, Lin MH, Lin SY, Hwu YM. The predictability of serum anti-Mullerian level in IVF/ICSI outcomes for patients of advanced reproductive age. Reproductive Biology and Endocrinology. 2011;9:115. [PMC free article: PMC3175456] [PubMed: 21843363]
  • Lee et al., 2009

    Lee TH, Liu CH, Huang CC, Hsieh KC, Lin PM, Lee MS. Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles. Reproductive Biology and Endocrinology. 2009;7:100. [PMC free article: PMC2754482] [PubMed: 19761617]
  • Legro et al., 2007

    Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Giudice LC, Leppert PC, Myers ER. Cooperative Multicenter Reproductive Medicine Network. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. New England Journal of Medicine. 2007;356:551–566. [PubMed: 17287476]
  • Lehert et al., 2010

    Lehert P, Schertz JC, Ezcurra D. Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis. Reproductive Biology and Endocrinology. 2010;8:112. [PMC free article: PMC2954883] [PubMed: 20846363]
  • Lerner-Geva et al., 2003

    Lerner-Geva L, Geva E, Lessing JB, Chetrit A, Modan B, Amit A. The possible association between in vitro fertilization treatments and cancer development. International Journal of Gynecological Cancer. 2003;13:23–27. [PubMed: 12631215]
  • Leslie et al., 2003

    Leslie GI, Gibson FL, McMahon C, Cohen J, Saunders DM, Tennant C. Children conceived using ICSI do not have an increased risk of delayed mental development at 5 years of age. Human Reproduction. 2003;18:2067–2072. [PubMed: 14507822]
  • Leushuis et al., 2009

    Leushuis E, van der Steeg J, Steures P, Bossuyt PMM, Eijkemans MJC, vander Veen F, Mol BWJ, Hompes PGA. Prediction models in reproductive medicine: A critical appraisal. Human Reproduction Update. 2009;15:537–552. [PubMed: 19435779]
  • Levi-Setti et al., 2006

    Levi-Setti PE, Cavagna M, Bulletti C. Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: comparison of r-FSH alone and in combination with r-LH1268. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2006;126:212–216. [PubMed: 16377062]
  • Levron et al., 2002

    Levron J, Shulman A, Bider D, Seidman D, Levin T, Dor J. A prospective randomized study comparing day 3 with blastocyst-stage embryo transfer. Fertility and Sterility. 2002;77:1300–1301. [PubMed: 12057748]
  • Li et al., 2010

    Li HWR, Yeung WSB, Lau EYL, Ho PC, Ng EHY. Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination. Fertility and Sterility. 2010;94:2177–2181. [PubMed: 20171627]
  • Li et al., 2011

    Li XJ, Yu YX, Liu CQ, Zhang W, Zhang HJ, Yan B, Wang LY, Yang SY, Zhang SH. Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis. Clinical Endocrinology. 2011;74:332–339. [PubMed: 21050251]
  • Li et al., 2007

    Li YB, Zhou CQ, Yang GF, Wang Q, Dong Y. Modified vitrification method for cryopreservation of human ovarian tissues. Chinese Medical Journal. 2007;120:110–114. [PubMed: 17335651]
  • Lin et al., 2006

    Lin YH, Hwang JL, Seow KM, Huang LW, Hsieh BC, Tzeng CR. Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study. Gynecological Endocrinology. 2006;22:297–302. [PubMed: 16785154]
  • Lin et al., 2006a

    Lin YH, Hwang JL, Seow KM, Huang LW, Hsieh BC, Tzeng CR. Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study1251. Gynecological Endocrinology. 2006;22:297–302. [PubMed: 16785154]
  • Linsten et al., 2007

    Lintsen A, Eijkemans M, Hunault C, Bouwmans C, Hakkaart L, Habbema J, Braat D. Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study. Hum Reprod. 2007;22:2455–2462. [PubMed: 17636281]
  • Long et al., 1995

    Long CA, Sopelak VM, Lincoln SR, Cowan BD. Luteal phase consequences of low-dose gonadotropin-releasing hormone agonist therapy in nonluteal-supported in vitro fertilization cycles. Fertility and Sterility. 1995;64:573–576. [PubMed: 7641913]
  • Lopez et al., 2004

    Lopez E, Gunby J, Daya S, Parrilla JJ, Abad L, Balasch J. Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy. Reproductive Biomedicine Online. 2004;9:382–390. [PubMed: 15511336]
  • Loutradis et al., 2003

    Loutradis D, Stefanidis K, Drakakis P, Kallianidis K, Kallipolitis G, El Sheih A, Milingos S, Michalas S. Does the addition of menopausal gonadotropin to recombinant FSH in pituitary suppressed women improve clinical pregnancy in an intracytoplasmic sperm injection program? 12460. Middle East Fertility Society Journal. 2003;8:30–35.
  • Lukassen et al., 2005

    Lukassen HG, Braat DD, Wetzels AM, Zielhuis GA, Adang EM, Scheenjes E, Kremer JA. Two cycles with single embryo transfer versus one cycle with double embryo transfer: a randomized controlled trial. Human Reproduction. 2005;20:702–708. [PubMed: 15618254]
  • Luke et al., 2010

    Luke B, Brown MB, Grainger DA, Cedars M, Klein N, Stern JE. Society for Assisted Reproductive Technology Writing Group. Practice patterns and outcomes with the use of single embryo transfer in the United States. Fertility and Sterility. 2010;93:490–498. [PubMed: 19376512]
  • MacDougall et al., 1994

    MacDougall MJ, Tan SL, Hall V, Balen A, Mason BA, Jacobs HS. Comparison of natural with clomiphene citrate-stimulated cycles in in vitro fertilization: a prospective, randomized trial. Fertility and Sterility. 1994;61:1052–1057. [PubMed: 8194616]
  • Magelssen et al., 2005

    Magelssen H, Haugen TB, von D, Melve KK, Sandstad B, Fosså SD. Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it? European Urology. 2005;48:779–785. [PubMed: 15963629]
  • Maheshwari et al., 2010

    Maheshwari A, Scotland G, Bell J, McTavish A, Hamilton M, Bhattacharya S. The direct health services costs of providing assisted reproduction services in overweight or obese women: a retrospective cross-sectional analysis. Hum Reprod. 2009;24(3):633–639. [PubMed: 19059947]
  • Maheshwari et al., 2011

    Maheshwari A, Gibreet A, Siristatidia CS, Bhattacharya S. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction. 2011. [PubMed: 21833958]
  • Malkawi & Qublan, 2002

    Malkawi HY, Qublan HS. The effect of metform plus clomiphene citrate on ovulation and pregnancy rates in clomiphene-resistant women with polycystic ovary syndrome. Saudi Medical Journal. 2002;23:663–666. [PubMed: 12070543]
  • Malizia et al., 2009

    Malizia, Hacker, Penzias Cumulative Live-Birth Rates after In Vitro Fertilization. N Engl J Med. 2009;360:236–243. [PubMed: 19144939]
  • Marees et al., 2009

    Marees T, Dommering CJ, Imhof SM, Kors WA, Ringens PJ, van Leeuwen FE, Moll AC. Incidence of retinoblastoma in Dutch children conceived by IVF: an expanded study. Human Reproduction. 2009;24:3220–3224. [PubMed: 19783550]
  • Marina et al., 1998

    Marina S, Marina F, Alcolea R, Exposito R, Huguet J, Nadal J, Verges A. Human immunodeficiency virus type 1--serodiscordant couples can bear healthy children after undergoing intrauterine insemination. Fertility and Sterility. 1998;70:35–39. [PubMed: 9660417]
  • Marrs et al., 2004

    Marrs R, Meldrum D, Muasher S, Schoolcraft W, Werlin L, Kelly E. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment2049. Reproductive Biomedicine Online. 2004;8:175–182. [PubMed: 14989794]
  • Martikainen et al., 2001

    Martikainen H, Tiitinen A, Tom C, Tapanainen J, Orava M, Tuomivaara L, Vilska S, Granskog C, Hovatta O. Finnish ET Study Group. One versus two embryo transfer after IVF and ICSI: a randomized study. Human Reproduction. 2001;16:1900–1903. [PubMed: 11527895]
  • Matorras et al., 2009

    Matorras R, Prieto B, Exposito A, Mendoza R, Crisol L, Herranz P, Burgués S. Mid-follicular LH supplementation in women aged 35–39 years undergoing ICSI cycles: a randomized controlled study 184. Reproductive Biomedicine Online. 2009;19:879–887. [PubMed: 20031032]
  • Matorras et al., 2011

    Matorras R, Prieto B, Exposito A, Mendoza R, Crisol L, Herranz P, Burgues S. Mid-follicular LH supplementation in women aged 35–39 years undergoing ICSI cycles: a randomized controlled study. Reproductive Biomedicine Online. 2011;22 Suppl 1:S43–S51. [Reprint of Reprod Biomed Online. 2009 Dec;19(6):879–87. PMID: 20031032] [PubMed: 21575849]
  • McIlveen et al., 2007

    McIlveen M, Skull JD, Ledger WL. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population. Human Reproduction. 2007;22:778–785. [PubMed: 17114197]
  • McLernon et al., 2010

    McLernon DJ, Harrild K, Bergh C, Davies MJ, de Neubourg D, Dumoulin JC, Gerris J, Kremer JA, Martikainen H, Mol BW, Norman RJ, Thurin-Kjellberg A, Tiitinen A, van Montfoort AP, van Peperstraten AM, Van Royen E, Bhattacharya S. Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials. BMJ. 2010;341:c6945. [PMC free article: PMC3006495] [PubMed: 21177530]
  • Meldrum et al., 1998

    Meldrum DR, Silverberg KM, Bustillo M, Stokes L. Success rate with repeated cycles of in vitro fertilization-embryo transfer. Fertil Steril. 1998;69:1005–9. [PubMed: 9627284]
  • Melo et al., 2010

    Melo M, Bellver J, Garrido N, Meseguer M, Pellicer A, Remohi J. A prospective, randomized, controlled trial comparing three different gonadotropin regimens in oocyte donors: ovarian response, in vitro fertilization outcome, and analysis of cost minimization. Fertility and Sterility. 2010;94:958–964. [PubMed: 19931075]
  • Melo et al., 2008

    Melo MG, Santos BR, De Cassia Lira R, Varella IS, Turella ML, Rocha TM, Nielsen-Saines K. Sexual transmission of HIV-1 among serodiscordant couples in Porto Alegre, southern Brazil. Sexually Transmitted Diseases. 2008;35:912–915. [PubMed: 18607309]
  • Mencaglia et al., 2005

    Mencaglia L, Falcone P, Lentini GM, Consigli S, Pisoni M, Lofiego V, Guidetti R, Piomboni P, De Leo V. ICSI for treatment of human immunodeficiency virus and hepatitis C virus-serodiscordant couples with infected male partner. Human Reproduction. 2005;20:2242–2246. [PubMed: 15946998]
  • Menken et al., 1986

    Menken J, Trussell J, Larsen U. Age and fertility. Science. 1986;233:1389–1394. [PubMed: 3755843]
  • Menon et al., 2009

    Menon S, Rives N, Mousset Sim, Sibert L, Vannier JP, Mazurier S, Mass L, Duchesne V, Mac B. Fertility preservation in adolescent males: experience over 22 years at Rouen University Hospital. Human Reproduction. 2009;24:37–44. [PubMed: 18945713]
  • Meseguer et al., 2006

    Meseguer M, Molina N, Velasco JA, Remoh J, Pellicer A, Garrido N. Sperm cryopreservation in oncological patients: a 14-year follow-up study. Fertility and Sterility. 2006;85:640–645. [PubMed: 16500332]
  • Mikkelsen et al., 2000

    Mikkelsen AL, Smith S, Lindenberg S. Possible factors affecting the development of oocytes in in-vitro maturation. Human Reproduction. 2000;15 Suppl 5:11–17. [PubMed: 11263532]
  • Mol et al., 2000

    Mol B, Bonsel G, Collins J, Wiegerinck M, van der Veen F, Bossuyt P. Cost-effectiveness of in vitro fertilization and embryo transfer. Fertility and Sterility. 2000;73:748–54. [PubMed: 10731536]
  • Moll et al., 2003

    Moll AC, Imhof SM, Cruysberg JR, Schouten-van Meeteren AY, Boers M, van Leeuwen FE. Incidence of retinoblastoma in children born after in-vitro fertilisation. Lancet. 2003;361:309–310. [PubMed: 12559867]
  • Moll et al., 2006

    Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, vander V. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ. 2006;332:1485. [PMC free article: PMC1482338] [PubMed: 16769748]
  • Montgomery et al., 1999

    Montgomery TR, Aiello F, Adelman RD, Wasylyshyn N, Andrews MC, Brazelton TB, Jones GS, Jones HW Jr. The psychological status at school age of children conceived by in-vitro fertilization. Human Reproduction. 1999;14:2162–2165. [PubMed: 10438444]
  • Moran et al., 2011

    Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews. 2011;7:CD007506. [PubMed: 21735412]
  • Morgia et al., 2004

    Morgia F, Sbracia M, Schimberni M, Giallonardo A, Piscitelli C, Giannini P, Aragona C. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertility and Sterility. 2004;81:1542–1547. [PubMed: 15193474]
  • Morin et al., 1989

    Morin NC, Wirth FH, Johnson DH, Frank LM, Presburg HJ, Van de Water V, Chee EM, Mills JL. Congenital malformations and psychosocial development in children conceived by in vitro fertilization. Journal of Pediatrics. 1989;115:222–227. [PubMed: 2666626]
  • Mukherjee et al., 2010

    Mukherjee S, Sharma S, Chakravarty BN. Comparative evaluation of pregnancy outcome in gonadotrophin-clomiphene combination vs clomiphene alone in polycystic ovarian syndrome and unexplained infertility-A prospective clinical trial. Journal of Human Reproductive Sciences. 2010;3:80–84. [PMC free article: PMC2970796] [PubMed: 21209751]
  • Nahuis et al., 2010

    Nahuis M, vander V, Oosterhuis J, Mol BW, Hompes P, van Wely M. Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women. International Journal of Women’s Health. 2010;1:205–211. [PMC free article: PMC2971716] [PubMed: 21072289]
  • Nahuis et al., 2011

    Nahuis MJ, Kose N, Bayram N, Van Dessel H, Braat DDM, Hamilton CJCM, Hompes PGA, Bossuyt PM, Mol BWJ, Van Der Veen F, Van Wely M. Long-term outcomes in women with polycystic ovary syndrome initially randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotrophins. Human Reproduction. 2011;26:1899–1904. [PubMed: 21576081]
  • Nelson & Lawlor, 2011

    Nelson SM, Lawlor DA. Predicting live birth, preterm delivery, and low birth weight in infants born from in vitro fertilisation: a prospective study of 144,018 treatment cycles. PLoS medicine. 2011;8:e1000386. [PMC free article: PMC3014925] [PubMed: 21245905]
  • Neumann et al., 1994

    Neumann J, Soheyla D, Garib M, Weinstein M. The cost of a successful delivery with in vitro fertilization. NELM. 1994;331:239–43. [PubMed: 8015571]
  • Neveu et al., 1987

    Neveu S, Hedon B, Bringer J, Chinchole JM, Arnal F, Humeau C, Cristol P, Viala JL. Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertility and Sterility. 1987;47:639–643. [PubMed: 3106101]
  • Nicopoullos et al., 2010

    Nicopoullos JD, Almeida P, Vourliotis M, Goulding R, Gilling-Smith C. A decade of the sperm-washing programme: where are we now? Human Fertility. 2010;13:90–97. [PubMed: 20722578]
  • Nyboe et al., 2002

    Nyboe Andersen A, Popovic-Todorovic B, Schmidt KT, Loft A, Lindhard A, Højgaard A, Ziebe S, Hald F, Hauge B, Toft B. Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial. Human Reproduction. 2002;17:357–361. [PubMed: 11821278]
  • Nyboeandersen et al., 2008

    Nyboeandersen A, Humaidan P, Fried G, Hausken J, Antila L, Bangsboll S, Rasmussen PE, Lindenberg S, Bredkjaer HE, Meinertz H. Nordic LH study group. Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial. Human Reproduction. 2008;23:427–434. [PubMed: 18024487]
  • Out et al., 2000

    Out HJ, Braat DD, Lintsen BM, Gurgan T, Bukulmez O, Gokmen O, Keles G, Caballero P, Gonzalez JM, Fabregues F, Balasch J, Roulier R. Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation. Human Reproduction. 2000;15:29–35. [PubMed: 10611184]
  • Out et al., 2001

    Out HJ, David I, Ron-El R, Friedler S, Shalev E, Geslevich J, Dor J, Shulman A, Ben-Rafael Z, Fisch B, Dirnfeld M. A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles. Human Reproduction. 2001;16:1104–1109. [PubMed: 11387277]
  • Out et al., 1999

    Out HJ, Lindenberg S, Mikkelsen AL, Eldar-Geva T, Healy DL, Leader A, Rodriguez-Escudero FJ, Garcia-Velasco JA, Pellicer A. A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation. Human Reproduction. 1999;14:622–627. [PubMed: 10221686]
  • Out et al., 2004

    Out HJ, Rutherford A, Fleming R, Tay CCK, Trew G, Ledger W, Cahill D. A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction. Human Reproduction. 2004;19:90–95. [PubMed: 14688163]
  • Owen et al., 1991

    Owen EJ, Shoham Z, Mason BA, Ostergaard H, Jacobs HS. Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility. 1991;56:1104–1110. [PubMed: 1743329]
  • Ozkan et al., 2008

    Ozkan S, Murk W, Arici A. Endometriosis and Infertility Epidemiology and Evidence-based Treatments Ann. New York Academy of Sciences; NY Acad Sci. 2008;1127:92–100. 2008. [PubMed: 18443335] [CrossRef]
  • Ozmen et al., 2009

    Ozmen B, Sönmezer M, Atabekoglu CS, Olmus H. Use of aromatase inhibitors in poor-responder patients receiving GnRH antagonist protocols. Reproductive Biomedicine Online. 2009;19:478–485. [PubMed: 19909587]
  • Pacchiarotti et al., 2007

    Pacchiarotti A, Aragona C, Gaglione R, Selman H. Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle. Journal of Assisted Reproduction and Genetics. 2007;24:400–405. [PMC free article: PMC3454948] [PubMed: 17653846]
  • Pacchiarotti et al., 2010

    Pacchiarotti A, Sbracia M, Frega A, Selman H, Rinaldi L, Pacchiarotti A. Urinary hMG (Meropur) versus recombinant FSH plus recombinant LH (Pergoveris) in IVF: a multicenter, prospective, randomized controlled trial. Fertility and Sterility. 2010;94:2467–2469. [PubMed: 20537626]
  • Pacey, 2005

    Pacey AA. Is quality assurance in semen analysis still really necessary? A view from the andrology laboratory. Human Reproduction. 2006;21(5):1105–9. [PubMed: 16396933]
  • Pacey, 2007

    Pacey AA. Fertility issues in survivors from adolescent cancers. Cancer Treat Rev. 2007;33(7):646–55. [PubMed: 17499440]
  • Pacey and Eiser, 2011

    Pacey AA, Eiser C. Banking sperm is only the first of many decisions for men: what healthcare professionals and men need to know. Human Fertility. 2011;14(4):208–17. [PubMed: 22088127]
  • Palomba et al., 2010

    Palomba S, Falbo A, Battista L, Russo T, Venturella R, Tolino A, Orio F, Zullo F. Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial. American Journal of Obstetrics and Gynecology. 2010;202:577–578. [PubMed: 20096821]
  • Palomba et al., 2010a

    Palomba S, Falbo A, Giallauria F, Russo T, Rocca M, Tolino A, Zullo F, Orio F. Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial. Human Reproduction. 2010;25:2783–2791. [PubMed: 20858697]
  • Palomba et al., 2005a

    Palomba S, Orio F Jr, Falbo A, Manguso F, Russo T, Cascella T, Tolino A, Carmina E, Colao A, Zullo F. Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism. 2005;90:4068–4074. [PubMed: 15840746]
  • Pandian et al., 2010

    Pandian Z, McTavish AR, Aucott L, Hamilton MP, Bhattacharya S. Interventions for ‘poor responders’ to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database of Systematic Reviews. 2010:CD004379. [81 refs][Update of Cochrane Database Syst Rev. 2007(1):CD004379; PMID: 17253503] [PubMed: 20091563]
  • Papanikolaou et al., 2006

    Papanikolaou EG, Camus M, Kolibianakis EM, Van Landuyt L, Van Steirteghem A, Devroey P. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. New England Journal of Medicine. 2006;354:1139–1146. [PubMed: 16540614]
  • Papanikolaou et al., 2005

    Papanikolaou EG, D’haeseleer E, Verheyen G, Van DeVelde H, Camus M, Van Steirteghem A, Devroey P, Tournaye H. Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective study. Human Reproduction. 2005;20:3198–3203. [PubMed: 16055454]
  • Papanikolaou et al., 2010

    Papanikolaou EG, Fatemi H, Camus M, Kyrou D, Polyzos NP, Humaidan P, Tarlatzis B, Devroey P, Tournaye H. Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trial. Fertility and Sterility. 2010;94:2902–2904. [PubMed: 20580358]
  • Papanikolaou et al., 2011

    Papanikolaou EG, Verpoest W, Fatemi H, Tarlatzis B, Devroey P, Tournaye H. A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study. Fertility and Sterility. 2011;95:1174–1177. [PubMed: 20979997]
  • Pappo et al., 2008

    Pappo I, Lerner-Geva L, Halevy A, Olmer L, Friedler S, Raziel A, Schachter M, Ron-El R. The possible association between IVF and breast cancer incidence. Annals of Surgical Oncology. 2008;15:1048–1055. [PubMed: 18214616]
  • Parsanezhad et al., 2010

    Parsanezhad ME, Zarei A, Sayadi M, Jaafarzadeh A, Rajaeefard A, Frank V, Schmidt EH. Surgical ovulation induction in women with polycystic ovary syndrome: A systematic review. Iranian Journal of Medical Sciences. 2010;35:225–241.
  • Peskin et al., 1996

    Peskin B, Austin C, Lisbona H, Goldfarb J, Clapp M. Cost-analysis of shared oocyte in vitro fertilization. Obstet Gynecol. 1996;88:428–30. [PubMed: 8752253]
  • Peterson, 2007

    Peterson L. Tenofovir Disoproxil Fumarate for Prevention of HIV Infection in Women: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial. PLoS Clinical Trials. 2007;2 [PMC free article: PMC1876601] [PubMed: 17525796]
  • Pezzuto et al., 2010

    Pezzuto A, Ferrari B, Coppola F, Nardelli GB. LH supplementation in down-regulated women undergoing assisted reproduction with baseline low serum LH levels. Gynecological Endocrinology. 2010;26:118–124. [PubMed: 19718561]
  • Pinborg et al., 2004

    Pinborg A, Loft A, Schmidt L, Greisen G, Rasmussen S, Andersen AN. Neurological sequelae in twins born after assisted conception: controlled national cohort study. BMJ. 2004;329:311. [PMC free article: PMC506847] [PubMed: 15256418]
  • Place & Englert, 2003

    Place I, Englert Y. A prospective longitudinal study of the physical, psychomotor, and intellectual development of singleton children up to 5 years who were conceived by intracytoplasmic sperm injection compared with children conceived spontaneously and by in vitro fertilization. Fertility and Sterility. 2003;80:1388–1397. [PubMed: 14667874]
  • Polinder et al., 2008

    Polinder S, Heijnen E, Macklon N, Habbema J, Fauser B, Eijkemans M. Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint. Human Reproduction. 2008;23:316–323. [PubMed: 18033807]
  • Polson et al., 1991

    Polson DW, MacLachlan V, Krapez JA, Wood C, Healy DL. A controlled study of gonadotropin-releasing hormone agonist (buserelin acetate) for folliculogenesis in routine in vitro fertilization patients. Fertility and Sterility. 1991;56:509–514. [PubMed: 1909978]
  • Polyzos et al., 2008

    Polyzos NP, Tzioras S, Mauri D, Tsappi M, Cortinovis I, Tsali L, Casazza G. Treatment of unexplained infertility with aromatase inhibitors or clomiphene citrate: a systematic review and meta-analysis. Obstet Gynecol Surv. 2008;b63(7):472–479. [PubMed: 18559123]
  • Popovic-Todorovic et al., 2003

    Popovic-Todorovic B, Loft A, Bredkjaeer HE, Bangsboll S, Nielsen IK, Andersen AN. A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a ‘standard’ dose of 150 IU/day in ‘standard’ patients undergoing IVF/ICSI treatment. Human Reproduction. 2003;18:2275–2282. [PubMed: 14585873]
  • Porrati et al., 2010

    Porrati L, Vilela M, Viglierchio MI, Valcarcel A, Lombardi E, Marconi G. Oral contraceptive pretreatment achieves better pregnancy rates in IVF antagonists GnRH flexible protocols: A prospective randomized study. Human Reproduction. 2010;25 suppl 1:i102–i259.
  • Pruksananonda et al., 2004

    Pruksananonda K, Suwajanakorn S, Sereepapong W, Virutamasen P. Comparison of two different fixed doses of follitropin-beta in controlled ovarian hyperstimulation: A prospective randomized, double blind clinical trial. Journal of the Medical Association of Thailand. 2004;87:1151–1155. [PubMed: 15560689]
  • Qublan et al., 2007

    Qublan HS, Yannakoula EK, Al-Qudah MA, El-Uri FI. Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovary syndrome. A prospective comparative study. Saudi Medical Journal. 2007;28:1694–1699. [PubMed: 17965792]
  • Quigley et al., 1988

    Quigley MM, Collins RL, Blankstein J. Pure follicle stimulating hormone does not enhance follicular recruitment in clomiphene citrate/gonadotropin combinations. Fertility and Sterility. 1988;50:562–566. [PubMed: 3139463]
  • Quinn et al., 2000

    Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo T, Gray RH. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. New England Journal of Medicine. 2000;342:921–929. [PubMed: 10738050]
  • Raffone et al., 2010

    Raffone E, Rizzo P, Benedetto V. Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. Gynecological Endocrinology. 2010;26:275–280. [PubMed: 20222840]
  • Raga et al., 1999

    Raga F, Bonilla-Musoles F, Casañ EM, Bonilla F. Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome3140. Human Reproduction. 1999;14:1431–1434. [PubMed: 10357953]
  • Ragni et al., 2000

    Ragni G, De Lauretis Yankowski L, Piloni S, Vegetti W, Guermandi E, Colombo M, Crosignani PG. In vitro fertilization for patients with poor response and occult ovarian failure: A randomized trial. Reproductive Technologies. 2000;10:98–102.
  • Ragni et al., 2003

    Ragni G, Somigliana E, Restelli L, Salvi R, Arnoldi M, Paffoni A. Sperm banking and rate of assisted reproduction treatment. Cancer. 2003;97:1624–1629. [PubMed: 12655518]
  • Rama Raju et al., 2005

    Rama Raju GA, Haranath GB, Krishna KM, Prakash GJ, Madan K. Vitrification of human 8-cell embryos, a modified protocol for better pregnancy rates. Reproductive Biomedicine Online. 2005;11:434–437. [PubMed: 16274602]
  • Raoul-Duval et al., 1994

    Raoul-Duval A, Bertrand-Servais M, Letur-Konirsch H, Frydman R. Psychological follow-up of children born after in-vitro fertilization. Human Reproduction, Hum Reprod. 1994;9:1097–1101. [PubMed: 7962382]
  • RCP Joint working party, 2007

    Royal College of Physicians, The Royal College of Radiologists, Royal College of Obstetricians and Gynaecologists. The effects of cancer treatment on reproductive functions: Guidance on management Report of a Working Party. London: RCP; 2007.
  • Revel et al., 2005

    Revel A, Haimov-Kochman R, Porat A, Lewin A, Simon A, Laufer N, Gino H, Meirow D. In vitro fertilization-intracytoplasmic sperm injection success rates with cryopreserved sperm from patients with malignant disease. Fertility and Sterility. 2005;84:118–122. [PubMed: 16009166]
  • Rienzi et al., 2002

    Rienzi L, Ubaldi F, Iacobelli M, Ferrero S, Minasi MG, Martinez F, Tesarik J, Greco E. Day 3 embryo transfer with combined evaluation at the pronuclear and cleavage stages compares favourably with day 5 blastocyst transfer. Human Reproduction. 2002;17:1852–1855. [PubMed: 12093851]
  • Roberts et al., 2010

    Roberts S, McGowan L, Hirst W, Brison D, Vail A, Lieberman B. Towards single embryo transfer? Modelling clinical outcomes of potential treatment choices using multiple data sources: predictive models and patient perspectives. Health Technology Assessment (Winchester, England). 2010;14:1–237. [PubMed: 20684810]
  • Roberts et al., 2010a

    Roberts SA, Hirst WM, Brison DR, Vail A. toward SET, collaboration, Embryo and uterine influences on IVF outcomes: an analysis of a UK multi-centre cohort. Human Reproduction. 2010;25:2792–2802. [PubMed: 20813807]
  • Roberts et al., 2010b

    Roberts SA, McGowan L, Hirst WM, Brison DR, Vail A, Lieberman BA. Towards single embryo transfer? modelling clinical outcomes of potential treatment choices using multiple data sources: Predictive models and patient perspectives. Health Technology Assessment. 2010;14:1–237. [PubMed: 20684810]
  • Ron-El et al., 1991

    Ron-El R, Herman A, Golan A, Nachum H, Soffer Y, Caspi E. Gonadotropins and combined gonadotropin-releasing hormone agonist--gonadotropins protocols in a randomized prospective study. Fertility and Sterility. 1991;55:574–578. [PubMed: 1900483]
  • Rossing et al., 1994

    Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. New England Journal of Medicine. 1994;331:771–776. [PubMed: 8065405]
  • Sahin et al., 2004

    Sahin Y, Yirmibeş U, Keleştimur F, Aygen E. The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2004;113:214–220. [PubMed: 15063963]
  • Salhab et al., 2005

    Salhab M, Al Sarakbi W, Mokbel K. In vitro fertilization and breast cancer risk: A review. International journal of fertility and women’s medicine. 2005;50:259–266. [PubMed: 16526416]
  • Sanner et al., 2009

    Sanner K, Conner P, Bergfeldt K, Dickman P, Sundfeldt K, Bergh T, Hagenfeldt K, Janson PO, Nilsson S, Persson I. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden. Fertility and Sterility. 2009;91:1152–1158. [PubMed: 18371964]
  • Sauer et al., 2009

    Sauer MV, Wang JG, Douglas NC, Nakhuda GS, Vardhana P, Jovanovic V, Guarnaccia MM. Providing fertility care to men seropositive for human immunodeficiency virus: reviewing 10 years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection. Fertility and Sterility. 2009;91:2455–2460. [PubMed: 18555235]
  • Savasi et al., 2007

    Savasi V, Ferrazzi E, Lanzani C, Oneta M, Parrilla B, Persico T. Safety of sperm washing and ART outcome in 741 HIV-1-serodiscordant couples. Human Reproduction. 2007;22:772–777. [PubMed: 17107974]
  • Sazonova et al., 2011

    Sazonova A, Kallen K, Thurin-Kjellberg A, Wennerholm UB, Bergh C. Obstetric outcome after in vitro fertilization with single or double embryo transfer. Human Reproduction. 2011;26:442–450. [PubMed: 21126967]
  • Schuffner et al., 2011

    Schuffner A, Lisboa AP, da Rosa V, da Silva MM. Use of assisted reproductive technology to separate sperm from human immunodeficiency virus infected men resulting in pregnancy among serodiscordant couples. Brazilian Journal of Infectious Diseases. 2011;15:397–398. [PubMed: 21861015]
  • Scotland et al., 2011

    Scotland G, McLernon D, Kurinczuk J, McNamee P, Harrild K, Lyall H, Rajkhowa M, Hamilton M, Bhattacharya S. Minimising twins in in vitro fertilisation: a modelling study assessing the costs, consequences and cost–utility of elective single versus double embryo transfer over a 20-year time horizon. BJOG. 2011;118:1073–1083. [PubMed: 21477172]
  • Schwartz et al., 1982

    Schwartz D, Mayaux MJ. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with 173 azoospermic husbands. Federation CECOS. N Engl J Med. 1982;306:404–6. [PubMed: 7057832]
  • Segal & Casper, 1992

    Segal S, Casper RF. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization. Fertility and Sterility. 1992;57:1254–1258. [PubMed: 1601147]
  • Selman et al., 2010

    Selman H, Pacchiarotti A, El-Danasouri I. Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome. Fertility and Sterility. 2010;94:1782–1786. [PubMed: 19939369]
  • Semprini et al., 1992

    Semprini AE, Levi-Setti P, Bozzo M, Ravizza M, Taglioretti A, Sulpizio P, Albani E, Oneta M, Pardi G. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet. 1992;340:1317–1319. [PubMed: 1360037]
  • Sherwal et al., 2010

    Sherwal V, Malik S, Bhatia V. Effect of bromocriptine on the severity of ovarian hyperstimulation syndrome and outcome in high responders undergoing assisted reproduction. Journal of Human Reproductive Sciences. 2010;3:85–90. [PMC free article: PMC2970797] [PubMed: 21209752]
  • Silver et al., 1999

    Silver RI, Rodriguez R, Chang TS, Gearhart JP. In vitro fertilization is associated with an increased risk of hypospadias. Journal of Urology. 1999;161:1954–1957. [PubMed: 10332480]
  • Smith et al., 2010

    Smith GD, Serafini PC, Fioravanti J, Yadid I, Coslovsky M, Hassun P, Alegretti JR, Motta EL. Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Fertility and Sterility. 2010;94:2088–2095. [PubMed: 20171613]
  • Smith et al., 2011

    Smith J, Eisenberg M, Millstein S, Nachtigall R, Sadetsky N, Cedars M, Katz P. Infertility Outcomes Program Project Group. Fertility treatments and outcomes among couples seeking fertility care: data from a prospective fertility cohort in the United States. Fertil Steril. 2011 Jan;95(1):79–84. Epub 2010 Jul 25. [PMC free article: PMC2966858] [PubMed: 20659733]
  • Smulders et al., 2010a

    Smulders B, van Oirschot SM, Farquhar C, Rombauts L, Kremer JA. Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane Database of Systematic Reviews. 2010:CD006109. [127 refs] [PubMed: 20091585]
  • Smulders et al., 2010

    Smulders B, van Oirschot S, Farquhar C, Rombauts L, Kremer JA. Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane database of systematic reviews (Online), #2010. 2010:CD006109-. Date of Publication. [PubMed: 20091585]
  • Snick et al., 1997

    Snick HK, Snick TS, Evers JL, Collins JA. The spontaneous pregnancy prognosis in untreated subfertile couples: the Walcheren primary care study. Hum Reprod. 1997;12:1582–1588. [PubMed: 9262301]
  • Sohrabvand et al., 2006

    Sohrabvand F, Ansari Sh, Bagheri M. Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Human Reproduction. 2006;21:1432–1435. [PubMed: 16478764]
  • Sohrabvand et al., 2010

    Sohrabvand F, Golestan B, Kashani H, Saberi M, Haghollahi F, Maasomi M, Bagheri M. Comparison of ART Outcomes between two COH Protocols: Gonal-F versus Gonal-F Plus HMG. International Journal of Fertility and Sterility. 2010;3:161–164.
  • Stadtmauer et al., 2011

    Stadtmauer LA, Sarhan A, Duran EH, Beydoun H, Bocca S, Pultz B, Oehninger S. The impact of a gonadotropin-releasing hormone antagonist on gonadotropin ovulation induction cycles in women with polycystic ovary syndrome: a prospective randomized study. Fertility and Sterility. 2011;95:216–220. [PubMed: 20594551]
  • Steiner and Paulson, 2006

    Steiner AZ, Paulson RJ. Oocyte donation. Clinical Obstetrics & Gynecology. 2006;49:44–54. [PubMed: 16456342]
  • Sterrenburg et al., 2011a

    Sterrenburg MD, Veltman-Verhulst SM, Eijkemans MJ, Hughes EG, Macklon NS, Broekmans FJ, Fauser BC. Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis. Human Reproduction Update. 2011;17:184–196. [PubMed: 20843965]
  • Steures et al., 2006

    Steures P, van der Steeg JW, Hompes PG, Habbema JD, Eijkemans MJ, Broekmans FJ, Verhoeve HR, Bossuyt PM, van der V, Mol BW. Collaborative Effort on the Clinical Evaluation in Reproductive Medicine. Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomised clinical trial. Lancet. 2006;368:216–221. [PubMed: 16844491]
  • Stewart et al., 2011

    Stewart L, Holman C, Hart R, Finn J, Mai Q, Preen D. How effective is in vitro fertilization, and how can it be improved? Fertil Steril. 2011 Apr;95(5):1677–83. Epub 2011 Feb 12. [PubMed: 21316660]
  • Stromberg et al., 2002

    Stromberg B, Dahlquist G, Ericson A, Finnstrom O, Koster M, Stjernqvist K. Neurological sequelae in children born after in-vitro fertilisation: A population-based study. Lancet. 2002;359:461–465. [PubMed: 11853790]
  • Suikkari et al., 1996

    Suikkari A, MacLachlan V, Koistinen R, Seppälä M, Healy D. Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility. 1996;65:800–805. [PubMed: 8654642]
  • Sundstrom et al., 1997

    Sundstrom I, Ildgruben A, Hogberg U. Treatment related and treatment independent deliveries among infertile couples, a long term follow up. Acta Obstet. Gynecol, Scand. 1997;76:238–243. [PubMed: 9093138]
  • Sunkara et al., 2011

    Sunkara SK, Pundir J, Khalaf Y. Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: A meta-analysis. Reproductive BioMedicine Online. 2011;22:545–555. [PubMed: 21493151]
  • Swanton et al., 2011

    Swanton A, Lighten A, Granne I, McVeigh E, Lavery S, Trew G, Talmor A, Raine-Fenning N, Jayaprakasan K, Child T. Do women with ovaries of polycystic morphology without any other features of PCOS benefit from short-term metformin co-treatment during IVF? A double-blind, placebo-controlled, randomized trial. Human Reproduction. 2011;26:2178–2184. [PubMed: 21593045]
  • Tan et al., 2005

    Tan SL, Child TJ, Cheung AP, Fluker MR, Yuzpe A, Casper R, Leung P, Cadesky K, Davis VJ. A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment. Journal of Assisted Reproduction and Genetics. 2005;22:81–88. [PMC free article: PMC3455475] [PubMed: 15844733]
  • Tanbo et al., 2001

    Tanbo T, Dale PO, Abyholm T. Recombinant follicle-stimulating hormone stimulates ovarian androgen synthesis in down-regulated ovulatory women. Gynecological Endocrinology. 2001;15:407–412. [PubMed: 11826763]
  • Tang et al., 2010

    Tang Thomas, Lord Jonathan M, Norman Robert J, Yasmin Ephia, Balen Adam H. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database of Systematic Reviews. 2010 [PubMed: 20091537]
  • Tarlatzis et al., 2006

    Tarlatzis B, Tavmergen E, Szamatowicz M, Barash A, Amit A, Levitas E, Shoham Z. The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study. Human Reproduction. 2006;21:90–94. [PubMed: 16172149]
  • Te Velde et al., 2000

    Te Velde ER, Eijkemans R, Habbema HD. Variation in couple fecundity and time to pregnancy, an essential concept in human reproduction. Lancet. 2000;355(9219):1928–9. [PubMed: 10859034]
  • Tehraninejad et al., 2011

    Tehraninejad E, Nezamabadi AG, Rashidi B, Sohrabi M, Bagheri M, Haghollahi F, Nekoo EA, Jafarabadi M. Gnrh antagonist versus agonist in normoresponders undergoing ICSI: A randomized clinical trial in Iran. Iranian Journal of Reproductive Medicine. 2011;9:171–176. [PMC free article: PMC4575750] [PubMed: 26396560]
  • Tehraninejad et al., 2010

    Tehraninejad ES, Nasiri R, Rashidi B, Haghollahi F, Ataie M. Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients. Archives of Gynecology and Obstetrics. 2010;282:319–325. [PubMed: 20379731]
  • Thurin et al., 2004

    Thurin A, Hausken J, Hillensjö T, Jablonowska B, Pinborg A, Strandell A, Bergh C. Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization. New England Journal of Medicine. 2004;351:2392–2402. [PubMed: 15575055]
  • Tredway et al., 2011a

    Tredway D, Schertz JC, Bock D, Hemsey G, Diamond MP. Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose-response study. Fertility and Sterility. 2011;95:1725–1729. [PubMed: 21316048]
  • Tredway et al., 2011

    Tredway D, Schertz JC, Bock D, Hemsey G, Diamond MP. Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study. Fertility and Sterility. 2011;95:1720–1724. [PubMed: 21300344]
  • Trolle et al., 2010

    Trolle B, Lauszus FF, Frystyk J, Flyvbjerg A. Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study. Fertility and Sterility. 2010;94:2234–2238. [PubMed: 20189560]
  • Trounson, 1983

    Trounson A, Mohr L. Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature. 1983;305(5936):707–9. [PubMed: 6633637]
  • Tulandi et al., 2006

    Tulandi T, Martin J, Al-Fadhli R, Kabli N, Forman R, Hitkari J, Librach C, Greenblatt E, Casper RF. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertility and Sterility. 2006;85:1761–1765. [PubMed: 16650422]
  • Tummon et al., 1997

    Tummon IS, Asher LJ, Martin JS, Tulandi T. Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis. Fertility and Sterility. 1997;68:8–12. [PubMed: 9207576]
  • Van der Steeg et al., 2007

    van der Steeg JW, Steures P, Eijkemans MJ, Habbema JD, Hompes PG, Broekmans FJ, van Dessel HJ, Bossuyt PM, van der Veen F, Mol BW. Pregnancy is predictable: a large-scale prospective external validation of the prediction of spontaneous pregnancy in subfertile couples. Hum Reprod. 2007;22:536–542. [PubMed: 16997935]
  • van Casteren et al., 2008

    van Casteren NJ, van Santbrink EJ, van Inzen W, Romijn JC, Dohle GR. Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients. Fertility and Sterility. 2008;90:2245–2250. [PubMed: 18191846]
  • vande-Helder et al., 1990

    van de-Helder AB, Helmerhorst FM, Blankhart A, Brand R, Waegemaekers C, Naaktgeboren N. Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study. Journal of in Vitro Fertilization and Embryo Transfer. 1990;7:358–362. [PubMed: 2127604]
  • vander et al., 2011

    van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database of Systematic Reviews. 2011:CD009154. [PubMed: 21975790]
  • van Leeuwen FE et al., 2011

    van Leeuwen FE, Klip H, Mooij TM, van de Swaluw AM, Lambalk CB, Kortman M, Laven JS, Jansen CA, Helmerhorst FM, Cohlen BJ, Willemsen WN, Smeenk JM, Simons AH, van der Veen F, Evers JL, van Dop PA, Macklon NS, Burger CW. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Human Reproduction. 2011 [PMC free article: PMC3212878] [PubMed: 22031719]
  • van Loendersloot LL et al., 2010

    van Loendersloot LL, van Wely M, Limpens J, Bossuyt PM, Repping S, van der Veen F. Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis. Human Reproduction. 2010;16:577–589. [PubMed: 20581128]
  • van Montfoort et al., 2006

    van Montfoort AP, Fiddelers AA, Janssen JM, Derhaag JG, Dirksen CD, Dunselman GA, Land JA, Geraedts JP, Evers JL, Dumoulin JC. In unselected patients, elective single embryo transfer prevents all multiples, but results in significantly lower pregnancy rates compared with double embryo transfer: a randomized controlled trial. Human Reproduction. 2006;21:338–343. [PubMed: 16253973]
  • Van Noord-Zaadstra et al., 1991

    Noord-Zaadstra BM, Looman CWN, Alsbach H, Habbema JDF, te Velde ER, Karbaat J. Delaying childbearing: effect of age on fecundity and outcome of pregnancy. BMJ. 1991;302:1361–5. [PMC free article: PMC1670055] [PubMed: 2059713]
  • van Wely et al., 2011

    van Wely Madelon, Kwan Irene, Burt Anna L, Thomas Jane, Vail Andy, Van der Veen Fulco, AlInany Hesham G. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. Cochrane Database of Systematic Reviews. 2011 [PMC free article: PMC7388278] [PubMed: 21328276]
  • Van et al., 2002a

    Vander Auwera I, Debrock S, Spiessens C, Afschrift H, Bakelants E, Meuleman C, Meeuwis L, D’Hooghe TM. A prospective randomized study: day 2 versus day 5 embryo transfer. Human Reproduction. 2002;17:1507–1512. [PubMed: 12042269]
  • Van et al., 1994

    Vander Auwera I, Meuleman C, Koninckx PR. Human menopausal gonadotrophin increases pregnancy rate in comparison with clomiphene citrate during replacement cycles of frozen/thawed pronucleate ova. Human Reproduction. 1994;9:1556–1560. [PubMed: 7989521]
  • van et al., 2002

    van Rooij I, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, Themmen AP. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Human Reproduction. 2002;17:3065–3071. [PubMed: 12456604]
  • Vandermolen et al., 2001

    Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertility and Sterility. 2001;75:310–315. [PubMed: 11172832]
  • Vause et al., 2010a

    Vause TD, Cheung AP, Sierra S, Claman P, Graham J, Guillemin JA, Lapensee L, Steward S, Wong BC. Society of Obstetricians and Gynaecologists of Canada. Ovulation induction in polycystic ovary syndrome: No. 242, May 2010. International Journal of Gynaecology and Obstetrics. 2010;111:95–100. [PubMed: 20848729]
  • Vause et al., 2010

    Vause TD, Cheung AP, Sierra S, Claman P, Graham J, Guillemin JA, Lapensee L, Steward S, Wong BC. Society of Obstetricians and Gynecologists of Canada. Ovulation induction in polycystic ovary syndrome. Journal of Obstetrics and Gynaecology Canada: JOGC. 2010;32:495–502. [PubMed: 20500959]
  • Veltman Verhulst et al., 2010

    Veltman Verhulst Susanne M, Cohlen Ben J, Hughes Edward, Heineman Jan Maas, Te Velde Egbert. Intra-uterine insemination for unexplained subfertility. Cochrane Database of Systematic Reviews. 2010 [PubMed: 22972053]
  • Venn et al., 2001

    Venn A, Hemminki E, Watson L, Bruinsma F, Healy D. Mortality in a cohort of IVF patients. Human Reproduction. 2001;16:2691–2696. [PubMed: 11726597]
  • Vernazza et al., 2011

    Vernazza PL, Graf I, Sonnenberg-Schwan U, Geit M, Meurer A. Pre-exposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child. AIDS. 2011 ePub Ahead of Print. [PubMed: 21716070]
  • Verpoest et al., 2006

    Verpoest WM, Kolibianakis E, Papanikolaou E, Smitz J, Van Steirteghem A, Devroey P. Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. Reproductive Biomedicine Online. 2006;13:166–172. [PubMed: 16895628]
  • Wallace et al., 2005

    Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered. Lancet Oncology. 2005;6(4):209–18. [PubMed: 15811616]
  • Wang et al., 2010a

    Wang YA, Chapman M, Costello M, Sullivan EA. Better perinatal outcomes following transfer of fresh blastocysts and blastocysts cultured from thawed cleavage embryos: a population-based study. Human Reproduction. 2010;25:1536–1542. [PubMed: 20356898]
  • Wang et al., 2010

    Wang YA, Kovacs G, Sullivan EA. Transfer of a selected single blastocyst optimizes the chance of a healthy term baby: a retrospective population based study in Australia 2004–2007. Human Reproduction. 2010;25:1996–2005. [PubMed: 20519249]
  • Weigert et al., 2002a

    Weigert M, Krischker U, Pöhl M, Poschalko G, Kindermann C, Feichtinger W. Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study. Fertility and Sterility. 2002;78:34–39. [PubMed: 12095487]
  • Weigert et al., 2002

    Weigert M, Krischker U, Pohl M, Poschalko G, Kindermann C, Feichtinger W. Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study. Fertility and Sterility. 2002;78:34–39. [PubMed: 12095487]
  • Wikland et al., 2001

    Wikland M, Bergh C, Borg K, Hillens T, Howles CM, Knutsson A, Nilsson L, Wood M. A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI. Human Reproduction. 2001;16:1676–1681. [PubMed: 11473962]
  • Wilding et al., 2010

    Wilding MG, Capobianco C, Montanaro N, Kabili G, Di Matteo L, Fusco E, Dale B. Human cleavage-stage embryo vitrification is comparable to slow-rate cryopreservation in cycles of assisted reproduction. Journal of Assisted Reproduction and Genetics. 2010;27:549–554. [PMC free article: PMC2965340] [PubMed: 20640501]
  • Wiser et al., 2010

    Wiser A, Gonen O, Ghetler Y, Shavit T, Berkovitz A, Shulman A. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Human Reproduction. 2010;25:2496–2500. [PubMed: 20729538]
  • WHO, 2010

    Cooper TG, Elizabeth N, Von Eckardstein S, Auger4 JHW, Baker G, Behre HM, Haugen TB, Kruger T, Wang C, Mbizvo MT, Vogelsong KM. World Health Organization reference values for human semen characteristics. Human Reproduction Update. 2010;16(3):231–245. [PubMed: 19934213]
  • Wolner et al., 1998

    Wolner-Hanssen P, Rydhstroem H. Cost-effectiveness analysis of in-vitro fertilization: estimated costs per successful pregnancy after transfer of one or two embryos. Hum Reprod. 1998;13:88–94. [PubMed: 9512235]
  • Wordsworth et al., 2011

    Wordsworth S, Buchanan J, Mollison J, Harrild K, Robertson L, Tay C, Harrold A, McQueen D, Lyall H, Johnston L, Burrage J, Grossett S, Walton H, Lynch J, Johnstone A, Kini S, Raja A, Templeton A, Bhattacharya S. Clomifene citrate and intrauterine insemination as first-line treatments for unexplained infertility: Are they cost-effective? Human Reproduction. 2011;26:369–375. [PubMed: 21127355]
  • Wu et al., 2011

    Wu MY, Chang LJ, Chen MJ, Chao KH, Yang YS, Ho HN. Outcomes of assisted reproductive techniques for HIV-1-discordant couples using thawed washed sperm in Taiwan: Comparison with control and testicular sperm extraction/microscopic epididymal sperm aspiration groups. Journal of the Formosan Medical Association. 2011;110:495–500. [PubMed: 21783018]
  • Wylie and Pacey, 2011

    Wylie K, Pacey AA. Using erotica in government-funded health service clinic. The journal of sexual medicine. 2011;8(5):1261–5. [PubMed: 21521479]
  • Xue et al., 2010

    Xue T, Li SW, Wang Y. Effectiveness of bromocriptine monotherapy or combination treatment with clomiphene for infertility in women with galactorrhea and normal prolactin: A systematic review and meta-analysis. Current Therapeutic Research - Clinical and Experimental. 2010;71:199–210. [PMC free article: PMC3969621] [PubMed: 24688144]
  • Yanushpolsky et al., 2011

    Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein M. Patterns of luteal phase bleeding in in vitro fertilization cycles supplemented with Crinone vaginal gel and with intramuscular progesterone--impact of luteal estrogen: prospective, randomized study and post hoc analysis. Fertility and Sterility. 2011;95:617–620. [PubMed: 20537624]
  • Yong et al., 2003a

    Yong PY, Brett S, Baird DT, Thong KJ. A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment. Fertility and Sterility. 2003;79:308–315. [PubMed: 12568839]
  • Younis et al., 2010

    Younis JS, Jadaon J, Izhaki I, Haddad S, Radin O, Bar-Ami S, Ben-Ami M. A simple multivariate score could predict ovarian reserve, as well as pregnancy rate, in infertile women. Fertility and Sterility. 2010;94:655–661. [PubMed: 19368907]
  • Youssef et al., 2011b

    Youssef AFM Mohamed, AlInany Hesham G, Aboulghar Mohamed, Mansour Ragaa, AbouSetta Ahmed M. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles. Cochrane Database of Systematic Reviews. 2011 [PubMed: 21491386]
  • Youssef et al., 2011a

    Youssef AFM Mohamed, AlInany Hesham G, Aboulghar Mohamed, Mansour Ragaa, Proctor Michelle. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles. Cochrane Database of Systematic Reviews. 2011 [PubMed: 21491386]
  • Youssef et al., 2011

    Youssef AFM Mohamed, Van der Veen Fulco, AlInany Hesham G, Griesinger Georg, Mochtar Monique H, Aboulfoutouh Ismail, Khattab M Sherif, van Wely Madelon. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database of Systematic Reviews. 2011 [PubMed: 21249699]
  • Youssef et al., 2009

    Youssef Mohamed AFM, Van der Veen Fulco, Al-Inany Hesham G, Griesinger Georg, Mochtar Monique H, van Wely Madelon. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database of Systematic Reviews. 2009 [PubMed: 21249699]
  • Zain et al., 2009

    Zain MM, Jamaluddin R, Ibrahim A, Norman RJ. Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial. Fertility and Sterility. 2009;91:514–521. [PubMed: 18321486]
  • Zakherah et al., 2010a

    Zakherah MS, Nasr A, El Saman AM, Shaaban OM, Shahin AY. Clomiphene citrate plus tamoxifen versus laparoscopic ovarian drilling in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics. 2010;108:240–243. [PubMed: 19944418]
  • Zakherah et al., 2010

    Zakherah MS, Nasr A, El Saman A, Shaaban OM, Shahin AY. Clomiphene citrate plus tamoxifen versus laparoscopic ovarian drilling in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynecology and Obstetrics. 2010;108:240–243. [PubMed: 19944418]
  • Zarek & Muasher, 2011

    Zarek SM, Muasher SJ. Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited. Fertility and Sterility. 2011;95:2449–2455. [PubMed: 21550037]
  • Zech et al., 2007

    Zech NH, Lejeune B, Puissant F, Vanderzwalmen S, Zech H, Vanderzwalmen P. Prospective evaluation of the optimal time for selecting a single embryo for transfer: day 3 versus day 5. Fertility and Sterility. 2007;88:244–246. [PubMed: 17292362]
  • Zheng et al., 2005

    Zheng WT, Zhuang GL, Zhou CQ, Fang C, Ou JP, Li T, Zhang MF, Liang XY. Comparison of the survival of human biopsied embryos after cryopreservation with four different methods using non-transferable embryos. Hum Reprod. 2005;20:1615–1618. [PubMed: 15746196]
  • Zhu et al., 2009

    Zhu L, QUAN S, XING F, Zhang W. Application of Ultra-low-dose Incremental Gn Protocol in Controlled Ovarian Hyperstimulation of the Patients with Ovary Hyperreaction. Journal of Reproduction and Contraception. 2009;20:145–152.
  • Zreik et al., 2010

    Zreik TG, Mazloom A, Chen Y, Vannucci M, Pinnix CC, Fulton S, Hadziahmetovic M, Asmar N, Munkarah AR, Ayoub CM, Shihadeh F, Berjawi G, Hannoun A, Zalloua P, Wogan C, Dabaja B. Fertility drugs and the risk of breast cancer: a meta-analysis and review. Breast Cancer Research and Treatment. 2010;124:13–26. [PubMed: 20809361]
Copyright © 2013, National Collaborating Centre for Women’s and Children’s Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

Bookshelf ID: NBK327764

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (5.4M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...